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CHAPTER I

INTRODUCTION

Central nervous system (CNS) serotonin (5-hydroxytryptamine;
5-HT) neurons appear to be involved in a number of important physiological and psychological processes,
emotional

including the regulation of sleep-

wakefulness

cycles,

states,

and

behaviors.

Dysfunctions in CNS 5-HT neurotransmission are thought to

contribute to the development of eating,

sexual

and

consummatory

anxiety and depressive dis-

orders.
CNS 5-HT perikarya are organized in distinct clusters which are
found only in the mesial brain stem, in association with the raphe nuclei

(Taber et al. ,

1964),

these

1960).

Designated Bl - B9

5-HT containing cell groups

(Dahlstrom and Fuxe,

are the source of the

doleamine innervation of the entire neuraxis.

in-

The Bl - B3 cell groups

provide the primary 5-HT innervation to the spinal cord, while the B7B9 and,

to a

origin of the
brain).
dorsal

lesser extent,

the B4-B6 cell groups are the principal

5-HT innervation of the

Anatomically,

di-

and telencephalon

(fore-

the B7 and· B8 groups are associated with the

and median midbrain raphe

nuclei

(DR and MR,

respectively).

Only about 30% and 70% of the neurons in the MR and DR, respectively,
contain 5-HT (Crunelli and Segal, 1985).
It is important to note that the CNS contains low 5-HT concentrations (in the ng/g range), and that well over 90% of the 5-HT in the

1

2

body is

found peripherally in the enteric nervous system and blood

platelets.
Early attempts to elucidate the function of central 5-HT systems
employed pharmacological and lesion techniques to deplete or reduce CNS
5-HT content.

Unfortunately, these methods produce dissimilar effects

on central and peripheral 5-HT levels.

For instance, parenteral treat-

ment with parachlorophenylalanine (PCPA), a tryptophan hydroxylase inhibitor, produces short-term depletion of both peripheral and central
5-HT stores.

Systemic administration of parachloroamphetamine (PCA),

on the other hand, results in the acute release of 5-HT and norepinephrine (NE) from nerve terminals, and long-term neurotoxic effects on
5-HT processes in the brain, but not in the spinal cord or periphery.
The behavioral effects of these drugs also differ.

For example, in

contrast to PCA, PCPA enhances an animal's response to noxious stimuli
[see Lorens (1978) for a review].
Electrolytic destruction of the DR and/or MR has been used to
study the functional role of the 5-HT projections to the forebrain.
These lesions produce significant reductions in forebrain 5-HT levels
and major behavioral changes, including increases in locomotor activity
(LMA) and abnormalities in conditioned avoidance learning (Jacobs et
al. , 1974;

Srebro and Lorens,

1975;

Geyer et al. , 1976).

However,

subsequent lesion studies employing the selective 5-HT neurotoxin, 5,7dihydroxytryptamine (5,7-DHT; Baumgarten et al., 1972, 1973), failed to
reproduce the behavioral effects obtained following electrolytic raphe
lesions (Geyer et al., 1976; Hole et al., 1976; Lorens et al., 1976;

3
Lorens, 1978).

Thus, the depletion approach has not been successful in

ascertaining the role of 5-HT in behavior.
The discovery of multiple 5-HT recognition sites (5-HT1

23

' '

and

subtypes) has led to the development of a number of novel pharmacological

tools

for

studying

5-HT

function

(Peroutka

and

Snyder,

Goodwin and Green, 1985; Tricklebank, 1985; Peroutka, 1988).

1979;

However,

parenteral administration of 5-HT agonists and antagonists will affect
peripheral as well as central 5-HT receptors.
administration appears

to provide

Thus, intracerebral drug

the best available means to study

central 5-HT processes.
Electrophysiologic investigations suggest that raphe 5-HT neurons
are modulated by local -y-aminobutyric acid (GABA) neurons
and Aghajanian,

1976; Mugnaini and Oertel,

1984).

(Gallagher

Przewlocka et al.

(1979) were the first to report that intra-DR injections of the GABAA
agonist,

muscimol,

increase

LMA and

induce

feeding.

Subsequently,

Sainati and Lorens (1982) found that muscimol infusions into the DR and
MR dose-dependently

increase LMA,

and that the MR was approximately

four times more sensitive than the DR to the hyperkinetic effects of
muscimol.

The effects of muscimol also were shown to be potentiated by

benzodiazepine pretreatment (Sainati and Lorens, 1983).
Little work has been done to study the regulation of raphe cells
by extrinsic neurons,

such as

those which release substance P (SP).

The midbrain raphe has been shown to contain SP-like immunoreactive
fibers, but not SP-like perikarya (Ljungdahl et al., 1979; Neckers et
al.,

1979).

Paris and Lorens

(1987 a,b)

demonstrated that infusions

into the MR of the metabolically stable SP analog, DiMe-C7 (Sandberg et

4
al.,

1981),

produce

dose-dependent

increases

in

LMA

which

can

be

blocked by prior treatment with PCPA and by intra-MR 5, 7-DHT inj ections.

These observations suggest that the LMA effects of intra-raphe

DiMe-C7 administration depends on the integrity of 5-HT neurons.
contrast,

In

the effects of intra-MR muscimol on LMA are not mediated by

5-HT neurons (Paris and Lorens, 1987 a,b; Wirtshafter et al., 1987).
Infusions of DiMe-C7 into the ventral tegmental area (VTA), just
rostral to the MR, have been reported to produce locomotor hyperactivity

(Eison et al.,

behavioral

effects

These observations suggest that the

1982 a,b).
observed

following

intra-MR

infusions

of DiMe-C7

might be due to diffusion of the peptide to the adjacent VTA.

However,

it has been demonstrated that lesions of the MR produced by the excitatory amino acid neurotoxin, ibotenic acid, which destroys cell bodies
but spares

fibers

of passage

(Coyle and Schwarcz,

1983),

completely

prevent the effects of intra-MR DiMe-C7 and muscimol on LMA (Paris and
Lorens,

1987

a).

In addition,

pretreatment with

antagonist, haloperidol (200 µg/ml,

the dopamine

i.p.), has been shown to block the

hyperactivity produced by intra-MR infusions of DiMe-C7.
haloperidol does

not affect

(DA)

In contrast,

the LMA effects of intra-raphe muscimol

(Wirtshafter et al., 1987; our unpublished data).
These observations suggest that two distinct pathways involving
the MR modulate behavioral arousal: one is a GABA---non-5-HT---non-DA
circuit, and the second is a neurokinin---5-HT---DA circuit.

This view

is supported by observations that, in contrast to DiMe-C7, muscimol infusions into the MR produce dose-dependent increases in food intake and

5

in plasma adrenocorticotrophic hormone (ACTH) and corticosterone levels
(Klitenick and Wirtshafter, 1986; Lee, J. et al., 1987).
SP belongs to a family of bioactive peptides called tachykinins.
The tachykinins share the common C-terminal amino acid sequence, Phe-XThree of these pep-

Gly-Leu-Ket-NH2 (Erspamer, 1981; Harmar, 1984).

tides and their messenger RNA (mRNA) precursors have been localized in
the periphery and CNS of mammals: SP, neurokinin A (NKA), and neurokinin B (NKB).

Non-mammalian tachykinins include eledoisin, physal-

aemin, and kassinin.
The neurokinins possess three distinct binding sites in the CNS
and periphery

(Quirion,

1985).

These

recognition sites have been

designated NK-1, NK-2, and NK-3, and correspond to the preferred binding sites for SP, NKA, and NKB, respectively (Lee, C.M. et al., 1986;
Henry, 1987).
Several investigators have studied the distribution of neurokinin
recognition sites in the CNS.

Moderate numbers of NK-1 and NK-3 sites

(measured as [1251]-Bolton-Hunter SP and eledoisin binding) have been
observed in the MR and DR (Beauj ouan et al.,
1988).

NKA-binding also has been detected in the midbrain raphe, as

well as in other brain areas
1986).

(Quirion and Dam,

Kanaza~a,

1985;

Buck et al.,

The existence of NK-2 recognition sites in the CNS, however,

has been debated (Saffroy et al., 1988).
reactive

1986; Saffroy et al.,

(SPLI)

fibers,

Nevertheless, SP-like immuno-

as well as NKA-immunoreactivity (Cuello and

1978; Ljungdahl et al., 1978 a; Takano et al., 1987), have

been discerned in the midbrain raphe.

6

Our preliminary studies indicated that much higher doses of SP
than DiMe-C7 had to be injected into the MR in order to elicit hyperactivity.

DiMe-C7, furthermore, has been recently shown to have a·great-

er affinity for the NK-3 than for the NK-1 binding site (Regoli et al.,
1987; Weinrich et al., 1987).

Thus, the first major goal of the dis-

sertation project was to determine which neurokinin(s) and receptor(s)
mediate(s)

the I.MA effects observed following intra-MR infusion.

To

achieve this aim, we compared the behavioral effects of the distinct
tachykinins and their analogues following their injection into the MR.
Optimally, in order to reach any conclusions concerning receptor
selectivity, one should use a specific competitive antagonist to block
the action of a particular group of agonists.
however,

this pharmacological approach has

For the tachykinins,

several limitations.

Al-

though a number of neurokinin antagonists have been developed (Folkers
et al., 1981; Regoli et al., 1984 b), they have been shown to be neurotoxic,

to have local anesthetic properties, and to have non-specific

actions following their central administration in the rat (Hokfelt et
al., 1981; Freedman et al., 1986; Yusof and Coote, 1987).

Tachykinin

antagonists have been used in behavioral studies (Elliott and Iversen,
1987).

However,

these authors found that the neurokinin antagonists

produced extensive histological damage following their central administration into the rat (Dr. Peter J. Elliott, personal communication,
On the basis of these data, neurokinin antagonists were not

1986).
employed.

Two

series

of experiments

were performed.

The

first

series

consisted of ten experiments which analyzed the behavioral effects of

7

tachykinin administration into the MR.
ments

The second series of experi-

studied the anatomical origin of the neurokinin innervation of

the MR.
The

first

behavioral

effects of DiMe-C7 on I.MA.
malian tachykinins,

as well

experiments

examined

the

dose-dependent

The effects of the non-mammalian and mamas

the selective NKB selective agonist,

senktide (Laufer et al., 1986 b; Wormser et al., 1986), then were compared to the effects of vehicle and DiMe-C7.

Subsequently, lower doses

of NKA, senktide and NKB were studied.
The objective of the next experiment was to determine whether the
hyperkinetic

effects

of

the

neurokinins

are mediated by raphe

neurons and their projections to the forebrain.

5-HT

This was examined by

producing 5,7-DHT lesions in the MR and in the 5-HT fibers which ascend
in the medial forebrain bundle.
To further characterize the behavioral effects of intra-MR neurokinin infusions,

rats were observed in an open field arena.

In the

first experiment, we injected the neurokinins into the MR, then placed
the animals in a novel environment.

In the second experiment, we ex-

amined the effects of the neurokinins on the animals'
familiar environment.

behavior in a

The purpose of these studies was 1) to analyze

the types of behaviors elicited by intra-MR neurokinin injections, and
2)

to

determine whether

the behavioral patterns

evoked varied as

a

function of the novelty of the test environment.
Although SP-like and other neurokinin-like afferents to the MR
have

been postulated

(Neckers et al.,

to

1979),

originate

in the

lateral habenular nucleus

this region does not contain neurokinin-like

8
cell bodies (Ljungdahl et al., 1978 a).

Thus, the second major goal of

the dissertation project was to determine the origin of the neurokinin
This was investigated by injecting the.retro-

innervation of the MR.
gradely

transported

fluorescent

mapping the labeled cells.

dye,

Fluoro-Gold,

MR

and

Next,

using irnmunocyto-

SP- and neurokinin-like fibers were localized in

the raphe.

Finally,

tracing,

attempt was

an

the

This was necessary because the afferents to

the MR have not been thoroughly documented.
chemical techniques,

into

by combining irnmunocytochemistry and retrograde
made

to

localize

the

neurokinin-containing

perikarya which send axons to the MR.
Thus, the overall goals of the dissertation project were to study
the regulation of median raphe 5-HT neurons by a particular group of
peptides,

the neurokinins,

kinin projections to the MR.

and to determine the origin of the neuro-

CHAPTER II
REVIEW OF THE RELEVANT LITERATURE
A. Midbrain Raphe Nuclei
The groups of neurons which occupy the midsagittal plane of the
brain stem are referred to as the raphe nuclei.

Although recognized

since the earliest studies of neuroanatomy, the seminal reports concerning the nomenclature, topography, afferent and efferent connections
were first published in 1960 (Brodal et al. , 1960 a, b; Taber et al. ,
Interest in the raphe nuclei was piqued after Dahlstrom and

1960).

Fuxe (1964), utilizing the Falck-Hillarp formaldehyde-induced fluorescence technique,

identified nine distinct clusters of 5-HT containing

neurons in the brain stem raphe nuclei of the rat.

These 5-HT cell

groups were designated Bl - B9, according to their caudorostral position (Dahlstrom and Fuxe, 1964).

The B7 and BS 5-HT cell groups over-

lap the midbrain dorsal and median raphe nuclei (DR and MR), respectively.

These observations subsequently have been substantiated and

extended using immunocytochemical techniques (see Steinbusch and Nieuwenhuys, 1983, for a review).
Perikarya also have been localized within the midbrain raphe
which contain dopamine (DA; Ochi and Shimizu, 1978), GABA (Mugnaini and
Oertel,

1985),

cholecystokinin (Vanderhaeghen et al.,

1980), met-en-

kephalin (Uhl et al., 1979; Murakami et al., 1987), and corticotropin9

10

releasing factor

(CRF;

Sakanaka et al.,

1987).

SP-containing cell

bodies have been observed in the DR, but not in the MR (Ljungdahl et
al., 1978; Chan-Palay et al., 1978).
Co-localization of Transmitters within the Midbrain Raphe
One of the most exciting but least understood aspects of neurotransmission is the coexistence of more than one neurotransmitter in
the same neuron.

Several questions have been raised concerning the

possible co-release, pre- versus post-synaptic effects, and neurohumoral roles of the co-localized substances.

In most instances, little is

known beyond the anatomical information.

The potential coexistence of

5-HT with

other neurotransmitters has been investigated by several

laboratories.

Cell bodies which contain both 5-HT and GABA have been

observed in various raphe nuclei, with the greatest number being found
in the DR (Belin et al., 1983; Magoul et al., 1986; Harandi et al.,
1987; Millhorn et al., 1987).
preted cautiously.

However, these results should be inter-

Some have relied on the combined use of immunocyto-

chemistry with the uptake of radiolabeled 5-HT and GABA (Magoul et al.,
1986; Harandi et al., 1987).

False-positive staining can occur due to

non-specific cellular accumulation, particularly by glial cells (Kelly
and Dick, 1976).

The fixation procedures used for combined autoradiog-

raphy and immunocytochemistry represent a compromise between the optimal techniques for one of the methods alone, and may actually interfere
with the visualization of the reaction products (Harandi et al., 1987).
Similarly, the visualization of one-substance by the peroxidase-antiperoxidase (PAP) method can interfere with the fluorescent label used
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to view the other (Belin et al., 1983).

The coexistence of GABA and 5-

HT in the midbrain raphe is an interesting possibility, but requires
additional confirmatory evidence.
Serotonin and leu-enkephalin also have been reported to coexist
in the cat DR and nucleus raphe magnus (Glazier et al., 1981).

The co-

localization of serotonin with N-acetyl-aspartyl-glutamate, an acidic
dipeptide proposed as a neurotransmitter in some putative glutaminergic
pathways (Koller and Coyle,

1984), has been found in the brain stem

raphe, including the rat MR and DR (Forloni et al., 1987).
Co-localization with Substance P
The coexistence of SP and 5-HT in the caudal brain stem raphe has
been demonstrated in several species (Chan-Palay et al., 1978; Hokfelt
et al. , 1978; Pelletier et al. , 1981).

In addition,

thyrotropin-re-

leasing hormone (TRH) has been found to coexist with both SP and 5-HT
in the same neuron (Johansson et al., 1981).

The 5-HT/SP containing

neurons send axons exclusively to the spinal cord and a great deal of
work has focussed on their interactions in this region (see Holstege
and Kuypers,

1987; Thor and Helke, 1987).

Only one report has sug-

gested the possibility of SP/5-HT co-localization within the DR (Magoul
et al.,
uptake,

1986).

This study relied on the use of radiolabeled 5-HT

combined with SP immunocytochemistry,

firmed by other investigators.

and has not been con-
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Efferent Projections of the Midbrain Raphe

The 5-HT and non-5-HT projections of the midbrain raphe have been
Early reports indicated that the MR and DR are

studied extensively.
the

source

of the

5-HT fibers

which ascend in the medial forebrain

bundle and innervate the forebrain (Heller and Moore,
al., 1966).

1965; Anden et

It also has been shown that neurons of the midbrain raphe

project to almost all areas of the brain (Conrad et al., 1974; Bobillier et al., 1975; Parent et al., 1981).

Although the axonal projec-

tions of the raphe nuclei overlap and are highly collateralized, they
are

topographically

organized.

For

instance,

the

hippocampus

and

neostriatum receive 5-HT projections which arise predominantly in the
MR and DR,
1974;

respectively

Geyer

et al.,

Steinbusch, 1982).

(Jacobs et al.,

1976

a, b;

1974;

Lorens and Guldberg,

Azmitia and Segal,

1978;

Kohler and

There also is a great deal of evidence concerning

the divergence and collateralization of raphe projections (de Olmos and
Heimer,

1980;

van der Kooy and Hattori,

1982).

Recently,

Imai and colleagues

1980;

Fallon and Loughlin,

(1986) have suggested that the

projections of the midbrain raphe are topographically organized.
authors

reported

that

cells

positioned rostrally

in

the

These

MR and

DR

project to the basal ganglia, while those situated caudally send axons
to limbic structures.

Projections to the amygdala appear to arise from

a distinct group of cells in the DR (Imai et al., 1986).

Thus, neurons

within the midbrain raphe are in a position to modulate neuronal systerns
which

throughout
these

the di-

forebrain

and telencephalon.
systems

reciprocally

neurons has not been adequately examined.

However,

the extent

communicate

with

to

raphe
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Afferent Connections of the Midbrain Raphe

A number of transmitter-specific fibers and terminals have been
localized within the midbrain raphe.
GABA,

cholecystokinin,

These include DA, norepinephrine,

neurotensin,

Steinbusch and Nieuwenhuys, 1983).

and

enkephalin

(see

review

by

The origin of the afferent projec-

tions to the raphe in the cat were studied originally using a retrograde degeneration technique (Brodal et al., 1960 b).
retrograde

transport

of horseradish-peroxidase has

Since then, the
been employed to

study MR and DR afferents in the rat and rabbit, but only in comparison
to those of the pontine reticular formation

(Pasquier et al.,

Aghajanian and Wang, 1977; Hayakawa and Zyo, 1986).
afferents

to

the rat MR (summarized below)

1976;

The origin of the

is based on a review of

studies which focussed primarily on the efferents from various forebrain regions.

In most of these studies, the efferent projections to

the MR are diagrammatically plotted, but rarely commented upon.

The

anterograde transport of tritiated amino acids has been the most frequent technique used.
lectin,

Phaseolus

Recent studies have employed the kidney bean

vulgaris

leucoagglutinin

(Gerfen

and

Sawchenko,

1984).
Afferents
frontal cortex,

to

the MR have been

reported

to

originate

in:

the

septal region and diagonal band of Broca (Aghaj anian

and Wang, 1977; Swanson and Cowan, 1979; Swanson, 1982; Swanson et al.,
1987;

Tomimoto et al. ,

1987);

the medial and lateral preoptic areas

(Swanson et al., 1984, 1987); the lateral border of the internal capsule

(Haber et al.,

1985);

the

lateral hypothalamus

(Saper et al.,

1979; Swanson et al., 1984); the perifornical nucleus (Pasquier et al.,
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1976); the subfornical organ (Lind, 1986); the laterodorsal tegmental
nucleus

(Satoh and Fibiger,

1986);

and,

the interpeduncular nucleus

(Hamill and Jacobowitz, 1984; Groenewegen et al., 1986; Shibata et al.,
1986).

A major fiber system from the lateral habenular nucleus to the

MR has been demonstrated as well (Pasquier et al., 1976; Aghajanian and
Wang, 1977).

Projections from the B9 5-HT cell group to the brain stem

also have been reported (Aghajanian and Wang, 1977).

A thorough ex-

amination of the afferents to the MR using a retrograde tracing technique is important in order to substantiate the results reviewed above.
Behavioral Effects of Midbrain Raphe Lesions
Some of the earliest experiments investigating the role of forebrain 5-HT in behavior focussed on the 5-HT depleting effects of electrolytic destruction of the midbrain raphe nuclei.

Electrolytic les-

ions of the MR, which produce a greater than 80% reduction in hippocampal 5-HT levels, also produce significant increases in LMA (Jacobs et
al., 1974).

These authors suggested that the reduction in hippocampal

5-HT concentrations could account for the increase in activity.

These

effects were subsequently corroborated by others (Srebro and Lorens,
1975; Geyer et al., 1976).

Combined MR and DR lesions also were found

to facilitate avoidance acquisition in a shuttle box and a Y-maze (Lorens et al., 1971; Steranka and Barrett, 1974).
lytic raphe lesions have been found to

More recently, electro-

impair the acquisition and

performance. of an 8-arm radial maze task, and the reversal of a learned
position habit, but not the acquisition or reversal of a simultaneous
brightness discrimination task (Wirtshafter and Asin, 1983, 1986).
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Subsequent lesion studies found that electrolytic destruction of
the DR and MR enhanced the hyperkinetic effects of d-amphetamine (Lucki
and Harvey,

1979).

Studies by Asin and Fibiger (1983) indicate that

lesions of the MR with ibotenic acid,

a neurotoxic excitatory amino

acid which destroys cell bodies in a region but spares fibers of passage (Coyle and Schwarcz, 1983), also produce hyperactivity and potentiate the locomotor stimulant effect of d-amphetamine.
These

studies

suggest

that

the

midbrain raphe nuclei play an

important role in several behavioral processes, but say little about
the role of 5-HT neurons.

Since mechanical and excitotoxic lesions of

the midbrain raphe simultaneously produce reductions in forebrain 5-HT
concentrations, there was a consensus that the behavioral effects were
due to the degeneration of ascending 5-HT fibers.

However, these types

of lesions also destroy non-5-HT elements within the raphe.

With the

discovery and use of the serotonergic neurotoxins, 5,6-dihydroxytryptamine and 5, 7 -DHT
selectively produce

(Baumgarten et al. ,
deficits

in

1972,

forebrain

1973),

5-HT was

a new method to
available.

The

potential of these neurotoxins was great since discrepancies had been
noted with various other methods of depleting forebrain 5-HT (Lorens,
1978).
HT

It was found that 5,7-DHT lesions of the MR, DR or ascending 5-

fibers,

which produced significant

reductions

in

forebrain

5-HT

concentrations, did not affect activity levels or avoidance conditioning (Hole et al., 1976; Lorens et al., 1976; Asin and Fibiger, 1983).
Wirtshafter and colleagues

(1986)

subsequently demonstrated that the

LMA effects following raphe damage can be disassociated from forebrain
5-HT depletion, and suggest that a descending pathway may be involved
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in the generation of MR mediated changes in LMA.

It had become ap-

parent that other techniques besides lesions were necessary to study
the function of· midbrain raphe 5-HT neurons.
Pharmacological Manipulations of Midbrain Raphe Neurons
A method developed to specifically and acutely affect the activity of raphe neurons was the microinjection of compounds directly into
brain areas containing 5-HT perikarya.

Several investigators have used

this approach to confirm that GABA serves as an inhibitory transmitter
within the raphe (Gallager and Aghajanian, 1976; Gallager, 1978; Forchetti and Meek, 1981), and that benzodiazepine/GABA interactions are
important to drug induced changes in raphe function (Gallager, 1978).
Przewlocka and associates
GABAA agonist, muscimol,
food intake.

(1979)

demonstrated that injection of the

into the DR, produces increases in LMA and

At the same time, Arnt and Scheel-Kruger (1979) demon-

strated a similar effect after muscimol injections into the "caudalVTA" (which most likely affected neurons within the rostral portion of
the MR).

Subsequently, Sainati and Lorens (1982) found that muscimol

produced dose-dependent increases in LMA when injected into the MR and
DR, and that the MR was approximately four times more sensitive.

The

effect of intra-MR muscimol injections also was shown to be potentiated
by intra-raphe administration of benzodiazepines (Sainati and Lorens,
1983).

Although originally thought to be mediated by 5-HT neurons

{Sainati and Lorens, 1982), it has subsequently been demonstrated that
the hyperkinetic effects of intra-MR muscimol infusions are not media-
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ted by 5-HT neurons

(Paris and Lorens,

1987 a,b; Wirtshafter et al.,

1987 a).
It has been suggested that the projection from the lateral habenular nucleus to the MR utilizes an excitatory amino acid neurotransmitter

(Kalen et al.,

logue,

kainic

acid,

1985,
into

Injection of the glutamate ana-

1986).

the

MR has been reported

(Wirtshafter and McWilliams, 1987).

However,

to

suppress LMA

these results are some-

what equivocal since injections of N-methyl-D-aspartate (NMDA) into the
MR produce explosive short bursts of hyperactivity which can be blocked
by the NMDA antagonist,

DL-2-amino-5-phosphonovaleric acid (APV;

published observations).

Further studies are necessary to clarify this

phenomenon.

More

paraquat

analogue

[an

hydropyridine)

recently,
of

metabolite,

intra-MR

the

MPTP

MPP+

injections

of

the

un-

herbicide,

(N-rnethyl-4-phenyl-1,2,3,6-tetra-

(N-methyl-4-phenyl-pyridinium)],

have

been reported to produce increases in LMA, circling, and wet-dog shakes
(DeGori et al.,

1988).

The mechanism of these effects is not under-

stood.
Thus,

the local application of substances has demonstrated that

behavioral effects can be elicited by acutely affecting the activity of
raphe neurons.

Raphe 5-HT Neurons and Ingestive Behaviors

The role of 5-HT in food intake and eating disorders has been
extensively reviewed
stems

from

releasing

early
drug,

(Sugrue,

observations
fenfluramine

1987;
of
(as

Morley and Blundell,

the

anorectic

reviewed

in

effect
Rowland

1988),
of

and

the

and
5-HT

Carlton,
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The role of raphe neurons in the regulation of food intake

1986).

initially was

investigated pharmacologically by Przewlocka and col-

leagues (1979); who reported that injections of muscimol into the DR
produced increases in food intake in non-food deprived rats.

Arnt and

Scheel-Kruger (1979) found that muscimol injections into the "caudal
VTA" (rostral MR) produce similar effects.

It was reported subsequent-

ly that the hyperphagia induced by muscimol could be inhibited by (+)fenfluramine pretreatment (Borsini et al., 1983).

The involvement of

5-HT in muscimol induced hyperphagia also was suggested by the observation that 5-HT or norfenfluramine (a bioactive metabolite of fenfluramine) infusions into the nucleus. accumbens could inhibit muscimol, but
not starvation-induced eating in rats (Bendotti et al., 1986 b).

These

authors went on to suggest that muscimol's effects were modulated in
part by DA neurons since the DA antagonist, fluphenazine, could attenuate intra-DR muscimol-induced eating when the antagonist was injected
into either the caudate-putamen or the nucleus accumbens (Bendotti et
al., 1986 a).

On the other hand, it has been shown that the MR is more

sensitive than the DR to the hyperphagic effects of muscimol, and that
5,7-DHT lesions of the MR or DR do not prevent the feeding induced by
muscimol infusions into the raphe (Borsini et al., 1983; Klitenick and
Wirtshafter, 1986, 1987).

These results suggest that, like the effects

of muscimol on LMA, muscimol-induced hyperphagia is mediated by non-5HT elements within the midbrain raphe.
The results observed with muscimol are interesting in light of
the fact that there is a considerable body of evidence that the 5-HT1A
agonist,

8-hydroxy-2-(di-N-propylamino)-tetralin (8-0HDPAT; Arvridsson
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et al., 1981; Hj orth et al., 1982) elicits feeding following its administration either peripherally or directly into the raphe (Dourish et
al., 1985 a,b,c,
1986).

1986 b; Bendotti and Samanin, 1986; Hutson et al.,

It is postulated that these effects occur through a decrease in

the firing rate of 5-HT neurons via activation of 5-HT1A somatodendritic autoreceptors (de Montigny et al., 1984; Dourish et al., 1985 a,
1986 a; Verge et al., 1985; Weissmann-Nanapoulos et al., 1985).

How-

ever, controversy exists as to whether the 8-0HDPAT-induced hyperphagia
is due to non-specific gnawing or to stimulation of appetite which may
counter a tonic 5-HT inhibitory influence on feeding (Fletcher, 1987;
Dourish et al., 1988).
Raphe 5-HT Neurons and Anxiety
The role of 5-HT in anxiety, and in the anxiolytic effects of the
benzodiazepines, has been extensively reviewed and contested in recent
years (Gardner, 1986; Johnston and File, 1986; Soubrie, 1986; Thiebot,
1986).

The midbrain raphe has been analyzed in terms of the effects of

benzodiazepine/GABA/5-HT

interactions

(Thiebot

et

al.,

1980,

1982,

1984; Sainati and Lorens, 1983; Nishikawa and Scatton, 1983; Green and
Hodges, 1986; Mendelson et al., 1987).
zodiazepine

inverse

agonist,

Intra-DR injections of the ben-

methyl-~-carboline-carboxylate

(~-CCM),

reduce social interaction in pairs of rats, suggesting an anxiogenictype of effect (File and Hyde, 1978; File et al., 1982; Guy and Gardner, 1985; Jones et al., 1986).
Clinically, interest in the role of 5-HT neurons in the control
of anxiety has been heightened by the recent Food and Drug Administra-
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tion approval (1987) of buspirone (BuSparR), a non-benzodiazepine azaspirodecanedione, approved for use in the treatment of anxiety (Tayler
et al., 1985). · Buspirone binds with a high affinity to 5-HT1A ·receptors (Peroutka, 1985), and decreases the activity of DR 5-HT neurons
(Vander Maelen et al., 1986).

Since buspirone also has been reported

to have DA binding properties (Riblet et al., 1982), an analogue of
buspirone, gepirone, which is devoid of DA binding properties, but has
a high affinity for 5-HT1A receptors (Yocca et al., 1986; see Blier and
de Montigny, 1987), has been studied.

Electrophysiologically, gepirone

also decreases the firing rate of 5-HT neurons (Blier and de Montigny,
1987), and is efficacious in the treatment of anxiety (Cott et al.,
1986; Csanalosi et al., 1987).

Furthermore, 8-0HDPAT has been reported

to have anxiolytic properties in rats (Carli and Samanin, 1988).

Thus,

the data indicate that 5-HT circuits play a role in anxiety, and in the
mechanism of action 5-HT1A anxiolytics, as well as the benzodiazepines.

B. Neurokinins
Since its discovery by von Euler and Gaddum (1931), the bioactive
peptide,

substance P (SP),

has been the

subject of a

considerable

amount of research (see reviews by Maggio, 1988; Nicoll et al., 1980;
Pernow, 1983).

Recent work, however, has focused upon the family of

peptides related to SP, called the "tachykinins."

These were so-named

because they have a characteristic fast onset of action on gut tissue,
in comparison to the much slower acting bradykinins.
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Nomenclature
As shown in Table I,

the tachykinins share a common carboxy-

terminal sequence -Phe-X-Gly-Leu-Ket-NH2,

where X can be an aromatic

or branched aliphatic amino acid (Erspamer, 1981, Harmar, 1984).

Three

of the tachykinins listed in Table I exist only in non-mammalian species.

These are eledoisin (Erspamer and Anastasi, 1962), physalaemin

(Erspamer et al.,

1964), and kassinin (Anastasi et al., 1977).

The

tachykinins found in mammals are referred to as neurokinins, and include SP, neurokinin A (NKA; formerly known as substance K and neurokinin a; Kimura et al., 1983, 1984), and neurokinin B (NKB; formerly
referred to as neuromedin K and neurokinin {3; Kangawa et al., 1983).
Another endogenous neurokinin, neuropeptide K (NPK; Tatemoto et al.,
1985), may or may not be an intermediate in NKA biosynthesis.
Molecular Biology
The

neurokinins,

like

other

neuropeptides,

are

derived

from

larger protein precursors which are synthesized in the neuronal cell
body.

Post-translational

modification

of

the

precursor

occurs as they are transported to the nerve terminal.
products are stored until released.

molecules

Here, the final

Studies have shown that two genes

contain codons for the three mammalian neurokinins:

the preprotachy-

kinin A gene encodes for SP and NKA; and, the preprotachykinin B gene
encodes for NKB (Kotani et al., 1986, Nawa et al., 1983, 1984).

The

preprotachykinin A gene produces three different preprotachykinin (PPT)
mRNAs: a, f3

and~·
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Table I: Tachykinin and Analogue Amino Acid Sequences
Amino acid sequence a

MW

Abbreviation

1348

SP

Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2

Neurokinin A 1133

NKA

His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2

Neurokinin B 1211

NKB

Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2

Physalaemin

1266

PHY

pGlu-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-Gly-Leu-Met-NH2

Eledoisin

1189

ELE

pGlu-Pro-Ser-Lys-Asp-Ala-Phe-Ile-Gly-Leu-Met-NH2

Kassinin

1335

KAS

Asp-Val-Pro-Lys-Ser-Asp-Gln-Phe-Val-Gly-Leu-Met-NH2

DiMe-C7

pGlu-Gln-Phe-MePhe-SarQ-Leu-Met-NH2

Tachykinin
substance

p

Dimethyl-C7

880

Senktide

842

Succinyl-Asp-Phe-MePhe-Gly-Leu-Met-NH2

a (common amino acids are underlined)
b Sar - N-methyl glycine

The a PPT encodes for SP only, while the
SP and NKA (Krause et al., 1987).

~

and 1 forms encode for both

Furthermore, it is now known

PPT also encodes for neuropeptide K (Tatemoto et al.,

that~-

1985), which

probably represents an elongated or pre-form of NKA (Martling et al.,
1987; Deacon and Conlon, 1987).

Precursor forms of SP (intermediates

in proteolytic processing) also have been detected in rat brain (Kream
et al., 1985).

The PPT mRNA and tachykinin precursors have been found

in human brain as well (Nyberg et al., 1985; Chesselet and Affolter,
1987).
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Release

Neurokinin release

from nerve

terminals may be mediated by a

calcium and potassium dependent mechanism (Lindefors et al., 1985 a).
This has been demonstrated in slice and synaptosomal preparations of
hypothalamus, ventral mesencephalon, and substantia nigra (Iversen et
al., 1976; Schenker et al., 1976; Jessel, 1978; Kronheim et al., 1980;
Torrens et al. , 1981).

Electrically-stimulated release also has been

demonstrated in brain and spinal cord (Otsuka and Konishi, 1976; Michelot et al., 1979; Akagi et al., 1980).
Degradation
The degradation and inactivation of tachykinins are important
considerations in the study of the pharmacology and physiology of these
peptides.

A number of peptidases have been postulated to be involved

in the enzymatic cleavage and degradation of SP.

These include: angio-

tensin-converting enzyme (Thiele et al., 1985), enkephalinase (endopeptidase 24.11; Matsas et al., 1984), dipeptidylaminopeptidase IV (Heymann and Mentlein, 1978), the so-called "substance P-degrading enzyme"
(Lee et al.,

1981;

Probert and Hanley,

1987),

"bacitracin-sensitive

enzyme" (Horsthemke et al., 1984), and calpain (Hatanaka et al., 1985).
Since many of these studies employed exogenous peptide,

it has been

suggested they may not accurately represent the activity of the peptidases in vivo (Mauborgne et al., 1987).
ations,

Using superfused slice prepar-

these authors have suggested that the endogenous SP released

from the substantia nigra is primarily inactivated by enkephalinase and
calpain (Mauborgne et al., 1987).

Others have suggested the involve-
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ment of enkephalinase in the physiological degradation of SP (Oblin et
al., 1988).

Indeed, recent studies indicate that enkephalinase hydro-

lyses NKA and NKB, as well as SP (Hooper and Turner, 1986; Turner and
Hooper, 1987).

However, the physiological relevance of these findings

has yet to be determined.

Neurokinin Antagonists

There

have

been a

number

of SP-related antagonists

developed

(Engberg et al., 1981; Folkers et al., 1981; Rosell and Folkers, 1982;
Regoli,

1985; Escher et al.,

1987; Regoli et al., 1987), and used to

classify neurokinin binding sites

et al.,

1984;

Jacoby et al., 1987; Murray et al., 1987; Vaught et al., 1987).

How-

ever,
have

several
local

studies

indicate

anesthetic

antagonist activities,

(see below;

Regoli

that these compounds are neurotoxic,

properties,

and actions not related to

their

thus making them unsuitable for use as in-vivo

competitive blockers (Hokfelt et al., 1981; Salt et al., 1982; Post et
al.,
Coote,

1985;

Freedman et

1987;

Dr.

Interestingly,
susceptible

to

Peter

recent
these

al.,

1986;

J.

Elliott,

studies

have

Lembeck et al.,
personal
revealed

non-specific neurotoxic

1987; Vaught and Scott, 1987).
stitution may underlie
Vaught and Scott, 1987).

1986;

Yusof and

communication,

that

rats

actions

are
(Post

1986).
uniquely
et

al. ,

It has been suggested that D-trp sub-

this neurotoxicity

(Post

and Paulsson,

1985;

The development of specific, non-neurotoxic,

non-anesthetic neurokinin antagonists is necessary.
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Localization Within the CNS

Using

immunocytochemical

procedures

directed against SP, Ljungdahl et al.

and

polyclonal

antisera

(1978 a,b) and Cuello and Kana-

zawa (1978), published the first major studies on the distribution of
SP-like cell bodies and fibers in the adult rat CNS.
lowed by

the

studies

of Inagaki

et al.

(1982)

These were fol-

and Sakanaka et al.

(1982) on the distribution of SP-like neurons in the pre-and post-natal
rat brain.

Although other reports preceded these (for example, Nilsson

et al., 1974; Hokfelt et al., 1975), the aforementioned studies represent the first detailed mapping of SP-containing perikarya and fibers
in the rat CNS.
have

been

accumbens,

Accordingly, SP-like immunoreactive (SPLI) cell bodies

localized

in many brain

the septal area,

including:

the basal forebrain,

nucleus of the stria terminal is,
amygdala,

regions,

zona

incerta,

gray,

interpeduncular nucleus,

the

caudate-putamen, bed

medial habenular nucleus,

hippocampus,

lateral

nucleus

thalamus,

hypothalamus,

dorsal raphe nucleus,

central

superior collic-

ulus, medullary raphe nuclei, medullary ventrolateral reticular formation,

and,

the spinal cord (Ljungdahl et al., 1978 a).

and terminals,

furthermore, have been observed in most regions of the

brain (Cuello and Kanazawa,
tantly,

SPLI fibers

1978; Ljungdahl et al.,

1978 a).

Impor-

SPLI has been discerned in the midbrain raphe nuclei

(Cuello

and Kanazawa, 1978; Ljungdahl et al., 1978 a; Shults et al., 1984).
Since the discovery of the other mammalian neurokinins, namely,
NKA and NKB,

no one has attempted to thoroughly map the neurokinin-

containing cell bodies within the CNS.

Most of the recent work has

focussed on discrete projection systems and specific areas.

Warden and
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Young (1988), however, recently mapped SP and NKB mRNAs in the rat CNS,
and found that these mRNAs have distinct patterns of distribution.
The antibodies originally used to detect SPLI have been found to
cross-react with the other neurokinins or their precursors (Dr. Tomas
Hokfelt,

personal communication,

1986;

Brodin et al.,

1986).

Thus,

with the demonstration that other neurokinins and their mRNAs exist in
the mammalian CNS, the specificity for SP-like immunoreactivity of the
early mapping studies has been questioned (Dr. Tomas Hokfelt, personal
communication, 1986).
Biochemical procedures, such as radioimmunoassay (RIA), and high
performance liquid chromatography (HPLC), have been used to examine the
distributions and concentration of the neurokinins in the CNS.

Since

these techniques employ tissue extractions, antisera can be developed
which recognize portions of the peptide strand inaccessible in vivo.
Hence,

the antibodies are more specific and less cross-reactive.

A

number of investigators have used these methods to determine the concentration of the neurokinins in distinct CNS structures (Brownstein et
al.,

1976; Minamino et al., 1984; Theordorsson-Norheim et al., 1984;

Lindefors et al., 1985, 1986; Shults et al., 1985 b; Arai and Emson,
1986; Brodin et al., 1986; Nagashima et al., 1987; Diez-Guerra et al.,
1988).
Binding Sites
Ligand-binding and in vitro bioassay studies have led to the
identification of three distinct neurokinin recognition sites:
(SP-preferring), NK-2

NK-1

(NKA-preferring), and NK-3 (NKB-preferring; Lee
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et al.,
1987).

1982,

1986; Regoli et al., 1984 a,b; Quirion,

1985; Henry,

An effort has been made to correlate binding affinity with bio-

logical activity (Dion et al., 1987).

In the discussion which follows,

the characterization of peripheral neurokinin binding sites will be
considered briefly,

followed by a more detailed discussion of their

properties in the CNS.
Peripheral Pharmacological Neurokinin Bioassays
The physiological properties of the neurokinins have been examined in various smooth muscle preparations, including the guinea pig
ileum,

trachea, and gallbladder; the rat vas deferens, duodenum, and

portal vein; the rabbit pulmonary artery, heart, and mesenteric vein;
the pig coronary artery;

the dog carotid artery;

and,

the isolated

human urinary bladder (Regoli et al., 1984 a,b,c; Mastrangelo et al.,
1986; Osakada et al., 1986; Shook and Burks, 1986; Dion et al., 1987;
Guard and Watson, 1987; Gulati et al., 1987;
Rovero and Pestellini 1987;
1988).

Munekata et al., 1987;

Tousignant et al.,

1987; Maggi et al.,

Some of the contractile effects of the neurokinins may be

mediated through the release of other transmitters,

such as acetyl-

choline (Holzer and Lembeck, 1980; Guard and Watson, 1987).
Based upon the relative potency of various agonists to contract
smooth muscle, and their blockade by competitive antagonists, different
muscles are thought to possess differing numbers or densities of neurokinin receptors.

For example, in the isolated pig coronary artery the

relative rank order of potency of the tachykinins is: SP - PHY> ELE >
KAS > NKA > NKB, with SP being 9 and 90 times more potent than NKA and
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NKB, respectively.

This smooth muscle preparation appears to contain a

high density of NK-1 sites, and can be used as an assay for NK-1 agonists (Gulati et al.,

1987).

The guinea pig ileum can be used as a

bioassay for the NK-2 binding site (Shook and Burks, 1986).

In this

smooth muscle preparation, the relative rank order of potency for the
force of contraction is: NKA > KAS > ELE >> PHY> SP, with NKA approximately 175 times more potent than SP.

The contraction of the detrusor

muscle of the human isolated urinary bladder also has been shown to be
mediated predominantly by NK-2 sites (Maggi et al., 1988).

The rat

isolated portal vein bioassay has been demonstrated to be most sensitive to NKB (Mastrangelo et al., 1986; Dion et al., 1987).

Recently,

there has been an effort to correlate the effects of neurokinins in in
vitro receptor bioassays with in vivo physiology (Kuwahara and Yanaihara, 1987; Maggi et al., 1987).
Characterization of CNS Neurokinin Binding Sites
The characteristics and localization of neurokinin binding sites
in the CNS have been reviewed recently (Glowinski et al., 1987; Saffroy
et al.,

1988).

The delineation of the neurokinin binding sites has

relied on the use of 125I-Bolton-Hunter (BH) and 3H-labeled peptides,
and analogues in membrane and synaptosomal preparations.

In rat corti-

cal synaptosomes, binding of 125I-BH-SP to NK-1 sites, and 125I-BH-ELE
to NK-3 sites
specific,

(Beaujouan et al.,

temperature-dependent,

1986; Bergstrom et al., 1987), is

saturable, and reversible, with Kd's

in the nanomolar range (Bergstrom et al., 1987; Viger et al., 1985).
These authors report that Scatchard and Hill plots for each indicate a
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single class of non-interacting binding sites.

Competitive studies

have revealed that SP and NKB inhibit binding of 125 1-BH-SP and 1251BH-ELE, respectively, in the nanomolar range (Glowinski et al., 1987).
It has been shown that the length of the peptide or analogue will
affect its binding.

For instance, longer fragments are more potent at

NK-1 sites than shorter C-terminal fragments and analogues,
DiMe-C7 and senktide

such as

(see Table 1), which are more potent at NK-3

binding sites (Cascieri and Liang, 1983; Torrens et al., 1984; Viger et
al., 1985).

3H-NKB and 1251-BH-ELE have been reported to label identi-

cal sites (Bergstrom et al., 1987).
NK-2 Binding Sites in the CNS
NK-2 binding sites have been distinguished from NK-1 and NK-3
sites in peripheral tissues (Buck et al., 1984, 1986; Burcher et al.,
1986).

Their presence in the CNS has been suggested, chiefly through

autoradiographic studies (Mantyh et al., 1984 b; Quirion and Dam, 1985;
Shults et al., 1985 a; Buck et al., 1986).

However, the presence of

NK-2 recognition sites in the CNS has been questioned.

Competition

studies using rat cortical synaptosomes have shown that 1251-BH-NKA has
a higher affinity than NKA for sites labeled with 1251-BH-ELE or 3HNKB, suggesting that NK-3 sites are being labeled (Bergstrom et al.,
1987; Glowinski et al., 1987; Saffroy et al., 1988).

Autoradiographic

analysis, furthermore, has indicated that the specific binding of 1251NKA and 3H-NKA is very low, and that they label sites identical to
those which bind 3H-SP or 1251-BH-SP.

Likewise, 1251-BH-NKA

'

3H-NKB

and 1251-BH-ELE appear to label the same recognition sites (Buck et
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al., 1986; Saffroy et al., 1988).

Thus, the presence of NK-2 binding

sites within the CNS needs to be examined more thoroughly.
Second-Messenger Coupling
There

is

some

evidence

that

the

neurokinins

can

stimulate

phosphotidylinositol breakdown in the periphery and in the CNS (Watson
and Downes, 1983; Mantyh et
1986).

~l.,

1984 c; Watson, 1984; Torrens et al.,

There also is evidence that SP receptors are coupled to guanine

nucleotide proteins (Sharma and Musacchio, 1987).

However, details of

events at the molecular level following neurokinin binding need to be
more thoroughly examined.
Conformational Studies
Recently, a number of studies have been aimed at determining the
three-dimensional structure of the neurokinins and related peptides and
how they interact with their respective binding sites (Chassaing et
al., 1986, 1987; Drapeau et al., 1987; Hashimoto et al., 1987; Ploux et
al., 1987; Rovero and Pestellini, 1987; Lavielle et al., 1988). Through
the construction of conformationally constrained analogues, it is hoped
that selective and stable analogues and/or antagonists will be found.
This approach has led to the development of a number of neurokinin
analogues including: DiMe-C7 [(pGluS, MePhe8, Sar9)SP(S-11)], originally developed as a metabolically stable analogue of SP (Sandberg et al.,
1982); septide [ (pGluS, Pro9)SP(6-ll)], a selective agonist for NK-1
binding sites
senktide

(Laufer et al.,

[ (succ-Asp6,

1986 a;

Wormser et al.,

1986),

and

MePhe8)SP(6-ll)], a selective agonist for NK-3
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sites (Laufer et al., 1986 b; Wormser et al., 1986).

It has been shown

that compounds with an N-methyl group at position 8, such as DiMe-C7
and senktide, are associated with a dramatic loss of potency at NK-1
sites and an increase in potency at NK-3 sites (Drapeau et al., 1987;
Lavielle et al., 1986; Plowe et al., 1987).

Ploux et al.

(1987) and

Lavielle et al. (1988) have suggested that the a helical core which the
neurokinins adopt when dissolved in methanol, may be related to their
bioactive conformation in vivo.
receptor,
However,

After these peptides bind to their

they appear to form similar three-dimensional structures.
the non-homologous

N-terminal sequences

may

influence

the

orientation of the C-terminal Gly-Leu-Met-NH2 trimer such that it binds
to its appropriate neurokinin receptor.
Distribution of CNS Neurokinin Binding Sites
The localization and distribution of neurokinin binding sites has
been extensively studied using autoradiography

(Wolf et al. , 1983;

Mantyh et al., 1984 a,b; Shults et al., 1984, 1985 a,b; Buck et al.,
1986;
1988).

Danks et al.,

1986;

Beauj ouan et al.,

1986;

Saffroy et al.,

These studies have indicated that neurokinin binding sites are

present, to varying degrees, throughout the CNS.
binding sites

tend to be rather ubiquitous,

distribution can be found.

Although neurokinin

certain differences in

For instance, high densities of NK-1 sites

have been found in the olfactory bulb; the prefrontal cortex; the hippocampus;

the anterior cortical nucleus of the amygdala;

the septal

area; the medial habenular nucleus; the dorsal raphe; the superior colliculus; cerebellar lobules 9 and 10; the dorsal tegmental nucleus of

~·-
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Gudden; the locus ceruleus; and, the dorsal motor nucleus of the vagus
(Mantyh et al., 1984 a; Beaujouan et al., 1986; Buck et al., 1986; Saffroy et al., 1988).

The density of NK-3 binding sites is highest in

the cerebral cortex; the basolateral amygdaloid nucleus (anterior); the
zona incerta;

magnocellular part of the paraventricular hypothalamic

nucleus;

perifornical

the

and

supraoptic

hypothalamic

nuclei;

the

interpeduncular nucleus; the ventral tegmental area; and, the nucleus
of the solitary tract (Beaujouan et al., 1986; Buck et al., 1986; Danks
et al., 1986; Saffroy et al., 1988).
With respect to the midbrain raphe, Saffroy et al. (1988) found a
greater number of NK-1 than NK-3 sites in the DR, but about the same
number (although less than in the DR) of both in the MR.
however,

have

found more 125r-BH-SP binding sites

Others,

than 125r-BH-ELE

sites in the MR (Buck et al., 1986).
Neurokinin Transmitter/Binding Site Mismatches
In certain brain regions, mismatches occur between the localization of a peptide and its receptor or binding site (Kuhar et al., 1985;
Herkenham, 1987).

For the neurokinins, the most illustrative and most

often cited example of a brain structure which displays this phenomenon
is the substantia nigra.

This area contains the highest concentrations

of SP and NKA in the brain (Kanazawa et al., 1984; Brodin et al., 1986)
with negligible amounts of NKB (Kanazawa et al., 1984; Arai and Emson,
1986).

Behavioral, electrophysiological, and biochemical effects have

been observed following SP and NKA injections into the pars compacta
and pars reticulata of the substantia nigra (Cheramy et al.,

1977;

!"'·
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Kelley and Iversen, 1978 a,b, 1979; Pinnock and Dray, 1982; Innis et
al., 1985).

However, NK-1 sites have not been localized in this region

(Mantyh et al., 1984 a; Shults et al., 1984; Beauj ouan et al.,· 1986;
Buck et al., 1986; Danks et al., 1986; Saffroy et al., 1988).

Only a

small number of NK-2 and NK-3 sites, furthermore, have been discerned
in the substantia nigra (Mantyh et al., 1984 b; Quirion and Dam, 1985;
Shults et al., 1985 a; Beaujouan et al., 1986; Buck et al., 1986; Danks
et al., 1986; Saffroy et al., 1988).
Explanations for the peptide concentration/receptor density mismatches include: 1) technical problems associated with autoradiographic
techniques;

2)

low affinity but physiologically functional binding

sites, which are not detectable autoradiographically; 3) internalization of receptors; and, 4) endogenous ligands occupying.the receptors
thus preventing the binding of radiolabeled compounds

(Herkenham et

Anatomical substance/receptor mismatch suggests that the

al., 1987).

substance has no function in that particular brain region, or that it
has some undetectable neurohumoral or maintenance function.
al,

electrophysiological,

Behavior-

and biochemical studies, nevertheless,

indicate a function, but the mechanism is unclear.

may

Neurokinin/binding

site mismatches in the substantia nigra remain an anomaly which, when
resolved, will surely add to our knowledge of neurotransmitter/receptor
interactions.
Recent Advances in Neurokinin Receptor Analysis
Some recent biochemical studies have led to the solubilization
and characterization of a specific SP binding protein (Nakata et al.,
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Molecular biologists have been able to successfully isolate

1988).

cDNA clones for bovine NKA and SP receptor mRNAs, and to express functional receptors in a Xenopus oocyte system (Masu et al., 1987; Buck et
al., 1988).

These unique and exciting approaches will allow the char-

acterization of neurokinin receptors, and provide models for examining
ligand-receptor coupling, second messenger systems, and receptor-membrane interactions.
Electrophysiology
The electrophysiology of the neurokinins has not been thoroughly
explored.

Until recently, most reports have dealt primarily with the

effects of SP.

A number of studies have reported that iontophoretic

application or micropressure
produce excitatory effects.

injection of SP and other neurokinins

For example, SP induces a slow depolariza-

tion probably by decreasing potassium conductance (Dun, 1985).

SP also

has an excitatory effect on neurons in the hypothalamic-preoptic area
(Shibota et al., 1988), locus ceruleus (Olpe et al., 1987 b), caudal
trigeminal nucleus
(Ramirez

(Salt and Hill,

and Chiappinelli,

1987),

1980),

chick sympathetic ganglia

dorsal root ganglia

Wright, 1981), and interpeduncular nucleus (Sastry, 1978).

(Roberts and
Both SP and

NKA have been shown to excite cells in the substantia nigra (Pinnock
and Dray, 1982; Innis et al., 1985) and spinal cord (Henry, 1976; Henry
and Salter, 1987).

Excitatory and inhibitory responses to SP have been

observed in the spinal cord (Belcher and Ryall, 1977) and dorsolateral
septum (Nayar et al., 1987).

SP-induced depression of neuronal activ-

ity in the rat olfactory bulb is thought to be mediated by GABA inter-
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neurons (Olpe et al., 1987 a).

Although the tachykinins excite spinal

cord neurons, physalaemin has been reported to enhance the depressant
effect of adenosine triphosphate (Salter and Henry, 1987).
Problems encountered in electrophysiological studies with tachykinins

include

their degradation within and adherence to the glass

micropipettes used for iontophoresis (Gozlan et al., 1977; Guyenet et
al., 1979; Lamour et al., 1983).

Micropressure application (Palmer et

al., 1986) does not require ejection or retaining currents, and may be
a more suitable method for the delivery of these peptides during electrophysiological experiments (Dray et al., 1983).
Behavioral Effects of Neurokinins
The majority of studies concerning the behavioral effects of the
neurokinins have been focused on the A9 and AlO DA cell groups in the
ventral mesencephalon.

SP has been shown to activate DA systems which

originate in this region (Davies and Dray, 1976; Cheramy et al., 1977).
The initial behavioral studies found that bilateral infusions of SP
into the ventral tegmental area (VTA) increased l.MA and enhanced exploratory behavior (Stinus et al., 1978).

These authors also reported

that the behavioral arousal induced by the systemic administration of
d-amphetamine was potentiated by a prior infusion of SP into the VTA.
Subsequent studies suggested that DA neurons mediate SP-induced behavioral arousal.

Infusions of haloperidol into and 6-hydroxydopamine (6-

0HDA) lesions of the nucleus accumbens block the hyperactivity produced
by intra-VTA SP (Kelley et al., 1979).
tia nigra

(SN)

SP infusions into the substan-

have been observed to stimulate l.MA and to produce
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grooming, stereotyped rearing, and sniffing (Kelley and Iversen, 1978
a b 1979), which could be blocked by 6-0HDA lesions in the caudate nu' '
Thus, SP infusions into the VTA
cleus (Kelley and Iversen, 1979).
markedly increase LMA and exploratory behavior, whereas SP infusions
into the SN produced stereotypic behaviors (Stinus et al., 1978; Kelley
and Iversen, 1979).

The behavioral effects elicited by repeated injec-

tions of SP into the VTA do not change in either their appearance or
intensity,

whereas

those

observed

following

repeated

SN

infusions

change from increased rearing to increased sniffing and grooming (Stinus et al., 1978; Kelley and Iversen, 1979).
Unilateral

intranigral SP

infusions

increase

the activity of

nigrostriatal DA neurons (Davies and Dray, 1976), increase DA turnover
in the

ipsilateral stria tum (Cheramy et al.,

1977;

Baruch et al.,

1987), and produce contralateral turning (James and Starr, 1977; Olpe
and Koella,

1977).

James and Starr (1979)

later demonstrated that

infusions of SP into the pars reticulata of the SN produce contralateral circling and increased DA turnover in the ipsilateral neostriatwn,
whereas infusions into the pars compacta induce ipsilateral circling,
decreased DA turnover, and increased 5-HT turnover in the ipsilateral
neostriatwn.
The behavioral effects observed after SP administration are short
lived (5-15 min).

DiMe-C7, which was developed as a metabolically

stable SP analogue (Sandberg et al., 1981), produces behavioral effects
of a greater duration (30-60 min; Eison et al., 1982 a,b).

Subsequent-

ly, NKA-immunoreactive fibers and receptors were demonstrated in the
VTA,

and intra-VTA NKA injections were shown to produce behavioral
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effects after doses approximately ten times lower than the minimally
effective SP dose (Kalivas et al., 1985).
Elliott

and

Iversen

(1986)

have

characterized the

behavioral

effects of the tachykinins after their bilateral administration into
the lateral ventricles and the VTA.

They reported that ELE and DiMe-C7

were more potent than SP at increasing LMA.

These authors also found

that the ability of the various peptides to produce wet dog shakes and
grooming varied as a function of the injection site.

DiMe-C7 and ELE

were more potent in producing wet dog shakes when administered into the
ventricles, whereas DiMe-C7 and SP were more potent when administered
into the VTA (Elliott and Iversen, 1986).

They found that grooming was

stimulated more effectively by SP and physalaemin by either route of
administration.

These studies illustrate the importance of employing

several different tachykinins in order to delineate the function of the
neurokinin receptors in a given brain region.
Behavioral Effects of Substance P Fragments
Stewart and colleagues have suggested that the N-terminal and Cterminal portions of the SP molecule produce different behavioral effects (Stewart et al., 1982; Hall and Stewart, 1983).
vanced this notion as well (Pinnock et al., 1983).
minal fragments
latencies,

Others have adThe N- and C-ter-

can produce opposite effects on grooming, hot plate

and stress-induced analgesia (Hall et al.,

1987).

These

differential effects may be due to the processing of the SP molecule
allowing the cleavage products to bind, perhaps, to different receptors
(Hall and Stewart, 1983).

These findings provide a means to explain
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the diversity of effects induced by SP.

On the other hand, as previ-

ously discussed, the short C-terminal fragments have a higher affinity
for the NK-3 binding site (Cascieri and Liang, 1983; Torrens e.t al.,
1984; Viger et al., 1985).

Thus,

the SP fragments many bind to the

different receptors and thereby produce different functional changes.
Conformational studies also suggest that the entire SP molecule is
necessary for biological activity (Ploux et al., 1987; Lavielle et al.,
1988).

More work is needed to elucidate the physiological role of SP

fragments in vivo.
Avoidance Learning
SP has been shown to induce an impairment in avoidance learning
by rats after its injection into the substantia nigra or amygdala, but
a facilitation in learning when injected into the lateral hypothalamus
(Huston and Staubli, 1978, 1979).

SP infusions into the nucleus basal-

is magnocellularis have been found to facilitate retention of a step-up
avoidance task (Kafetzopoulos et al., 1986).
of SP,

The N-terminal fragment

SPl-4, has been reported to enhance avoidance retention when

injected into

the lateral ventricles

(i.c.v.)

of mice,

but similar

infusions of SP or its C-terminal portion, SP7-ll, are without effect
(Pelleymounter et al., 1986).

SP also has been found to facilitate the

acquisition of an appetitively motivated learning task (Schlesinger et
al., 1986).
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Reinforcing Properties
Staubli and Huston (1985) have suggested that SP may be involved
in rewarding processes.

Infusions of SP into the lateral hypothalamus

(Ul) of rats produce positively reinforcing effects in a conditioned
place preference paradigm (Holzhauer-Oitzl et al., 1987).

The posi-

tively reinforcing properties of SP injected into the LH may be due to
a local vasodilatory action (Klugman et al., 1980).

Others have repor-

ted that intra-LH infusions of SP leads to a reduction in operant
responding for electrical stimulation of the LH (Goldstein and Malick,
1977), and that intra-cortical or intra-ventricular infusions of SP
decrease self-stimulation of the prefrontal cortex (Mora and Ferrer,
1984).

It also has been reported that injections of DiMe-C7 into the

lateral ventricles may produce aversive effects (Elliott and Iversen,
1983), whereas injections of DiMe-C7 into the MR may produce rewarding
effects (Lee, J. et al., 1987).

The reinforcing properties of SP and

DiMe-C7 need to be further examined in order to determine which neurokinin receptor and which site(s) is (are) involved.
Spinally-Mediated Behavioral Effects
The effects of intrathecally administered SP and other tachykinins on nociception (Yashpal and Henry 1982, 1983, 1984; Cridland and
Henry 1986, 1988; Henry and Salter, 1987; Sawynok and Nance, 1987) and
cardiovascular function

(Couture et al.,

1985,

1987,

1988;

Delbro,

1987; Hassessian et al., 1987; Helke et al., 1987) have been thoroughly
studied.

Behavioral responses following intrathecal and intracisternal

administration also have been observed.

In mice,

intrathecal ad-
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ministration of SP and ELE induces biting and scratching (Hylden and
Wilcox,

1981; Rackham et al.,

recently,

1981; Share and Rackham, 1981).

More

Stoessl and colleagues (1987 a, b) demonstrated that ·intra-

cisternal (or subcutaneous) administration of senktide induces wet dog
shakes and forepaw treading in both mice and rats,

presumably by a

serotonergic mechanism.
Sexual Behavior
SP also has been implicated in sexual behavior.

Infusions of SP

into the midbrain central gray has been observed to facilitate lordosis
(Dornan et al., 1987).

Anatomically, SP has been localized in the bed

nucleus of the stria terminalis, a region known for its role in sexually differentiated brain function (Valcourt and Sachs, 1979; Malsbury
and McKay, 1987).

Also, infusions of SP into the lateral ventricles

have been reported to inhibit ovulation in rats (Potargowicz and Traczyk, 1987).
Neurokinin - 5-HT Interactions in the CNS
The behavioral and neurochemical effects of neurokinin administration suggest that these neuropeptide and 5-HT systems interact.
Neurokinin/5-HT interactions have been deduced by observing the effects
of drugs which alter 5-HT transmission.

The intrathecal administration

of SP in mice induces hind limb scratching (similar to 5-HT), and the
effect of intrathecally administered 5-HT can be blocked by an SP antagonist (Fasmer and Post, 1983; Fasmer et al., 1983; Hylden and Wilcox, 1981).

Ogren et al. (1985) have suggested that SP may modulate 5-
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It has been demonstrated

hydroxytryptophan- induced head twitching.

that i.c.v. administration of 5,7-DHT potentiates the responses to intrathecally applied SP (Eide et al., 1988) and decreases SP content and
immunoreactivity in the medulla and spinal cord (Singer et al., 1979;
Towle et al., 1986; Pare et al., 1987).

Using mice and rats, Stoessl

and colleagues (1987 a,b) have demonstrated that the intracisternal or
subcutaneous

administration

of

senktide

induces

a

"5-HT

syndrome"

consisting of head twitches, forepaw treading, hind limb splaying, and
wet dog shakes, which can be blocked by 5-HT2 antagonists.

In addit-

ion, it has been shown that the dose-dependent hyperactivity produced
by intra-MR infusions of DiMe-C7 can be prevented by prior administration of PCPA or intra-MR 5,7-DHT administration (Paris and Lorens, 1987
a,b).

The 5-HT3 antagonist, GR38032F, furthermore, has been demonstra-

ted to attenuate both the locomotor hyperactivity and the increase in
DA turnover in the nucleus accumbens induced by intra-VTA administration of DiMe-C7 (Hagan et al., 1987).
Reisine et al.

(1982) have reported that SP applied to the sub-

stantia nigra in the cat releases 5-HT in the contralateral caudate
nucleus.

Similarly, SP infusions into the MR increase 5-HT turnover in

the hippocampus (Forchetti and Meek, 1982).

Recently,

it has been

demonstrated that both SP and NKB stimulate basal and potassium-evoked
5-HT release

in rat

frontal

cortex

slices,

presumably by distinct

receptors (Solti and Bartfai, 1987).
Chronic treatment with the antidepressant drugs,

imipramine and

zimelidine, increases SP concentration in the dorsal and ventral spinal
cord (Iverfeldt et al., 1986).

Imipramine, but not zimelidine, also
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increases potassium-stimulated SP release in a spinal cord-slice preparation.

This is thought to be mediated by 5-HT receptors (Iverfeldt

et al., 1986).

In contrast to imipramine, chronic treatment (14· days)

with the selective 5-HT reuptake inhibitors, zimelidine and alaprocolate, has been reported to increase SP-like immunoreactivity (SPLI) in
the ventral spinal cord, and both SPLI and NKA/NKB-like immunoreactivity in the periaqueductal gray (Brodin et al., 1985, 1987).

Repeated

administration of imipramine leads to decreases in SPLI and NKA/NKBlike immunoreactivity in the frontal cortex, whereas alaprocolate produces opposite effects (Brodin et al., 1987).

Cocaine has been report-

ed to increase SPLI in the DR and to decrease pontomedullary 5-HT concentrations (Pradhan et al., 1981).

5-Hydroxytryptophan administration

has been observed to decrease SPLI in the DR (Pradhan et al., 1981).
Thus, the interactions between 5-HT and the neurokinins are diverse and
clearly site-dependent.

One area which deserves more study is the

electrophysiological relationship between these two neurotransmitters.
Conclusions
Since von Euler and Gaddum's (1931) initial discovery of SP, a
great deal of information has been generated concerning the anatomy,
physiology, biochemistry, and molecular biology of the neurokinins in
both the CNS

and periphery.

Three distinct binding sites for

the

neurokinins have been identified which has led to the development of
metabolically stable selective agonists.

A variety of behavioral ef-

fects have been observed following neurokinin administration into the
CNS.

However, specific, non-toxic antagonists are required in order to
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better characterize
nition

sites.

A more

neurokinin effects
analysis

the

functions
thorough

in the

CNS

of the

distinct neurokinin recog-

electrophysiological

examination of

is necessary as well.

An anatomical

of the distribution of neurokinin cell bodies and neuronal

pathways likewise is needed.
This dissertation project was designed to elucidate the origin
and function of the neurokinin projections to the midbrain raphe.

The

objectives were: 1) the differentiation of the behavioral effects produced by the distinct neurokinin agonists; 2) to determine whether the
neurokinin-induced behavioral effects depended on the integrity of 5-HT
neurons;

3)

the raphe;

to determine the origin of the neurokinin innervation of
and, 4)

to demonstrate the functional significance of MR-

neurokinin-induced behavioral arousal.

CHAPTER III
METHODS
A. Behavioral Studies
Animals
Male Sprague-Dawley rats (Sasco-King, Orange, WI),
old and 27S-32S g at the time of surgery, were used.

90-120 days

The animals were

housed individually in an illumination (12 hr light-dark cycle, lights
on at 07: 00 h), temperature (22 ± 2°c), and humidity (SO ± S%) controlled facility.

Food and water were available ad libitum.

Following

their arrival, the animals were acclimated to their new environment for
at least one week prior to surgical intervention.
Cannula Implantation
The rats were anesthetized with sodium pentobarbital (60 mg/kg,
i.p.),

and treated with atropine sulfate

(0.4 mg/kg,

saline) and sodium ampicillin (SO mg/kg,

i.m.,

in 0.9%

i.m., in 0.9% saline).

The

rats were secured in a Kopf stereotaxic frame with the top of the
incisor bar positioned 3.3 mm below the interaural plane according to
the atlas of Paxinos and Watson (1986).

Thimersol (1:1000), an anti-

septic, was applied topically to the scalp.

An incision was made, the

skull exposed, and a craniotomy performed.

A sterile stainless steel

guide cannula

(0.46 mm,

o.d.

and 0.25 mm,
44

i.d.;

Plastic Products,
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Roanoke,
plane,

VA)

was

lowered at an angle 25° lateral to the midsagittal

3.2 mm lateral,

7.8 mm ventral and 7.5 mm caudal from bregma.

The guide cannula contained a sterile stainless steel stylet (0:23 mm,
o.d.) which extended 0.5 mm beyond its tip.

The cannula was secured to

the skull by means of acrylic cement and stainless steel screws.

The

wound margin was infiltrated with 2.0% lidocaine hydrochloride to minimize post-operative pain.
chloramphenicol ointment,
the wound.

The wound was closed with clips, and 1.0%
an antibiotic, was applied topically around

Post-operatively the rats were kept warm on a heating pad

until they regained their righting reflex.

All animals were allowed to

recover for at least one week prior to the initiation of behavioral
testing.

Neurotoxin Lesions

The rats were prepared for surgery as described above.
the

subjects were anesthetized with sodium pentobarbital

i. p.)

and pretreated with the norepinephrine

reuptake inhibitor, nomifensine maleate
i.p.),
(n -

(NE)

(60 mg/kg,

and dopamine

(DA)

(15 mg/kg/2.0 ml 0.9% saline,

30-40 min prior to the neurotoxin infusion.
11) was

Briefly,

One group of rats

first implanted with intra-MR cannulae.

They then re -

ceived an infusion of 5,7-DHT (8.0 µg, as the base, in 2.0 µl of 0.1%
ascorbate in 0.9% saline) directly through the cannula.
infused by a

microsyringe pump

(Model CMA/100,

Solna, Sweden) over 10 min (0.2 µl/min).

The drug was

Carnegie Medic in AB,

The internal cannula was left

in situ an additional 3-5 min to allow adequate spread of the solution
away from the tip.

The stylet then was replaced and the animal allowed
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to recover.

In addition,

two small burr holes were drilled in the

skull at the point of entry for the medial forebrain bundle

(MFB)

injections (see below).
The second group of rats (n
of 5,7-DHT (8.0 µg,

=

11) received a bilateral infusion

as the base, in 3.0 µl/side in the ascorbate ve-

hicle) into the MFB via 28 gauge stainless steel tubing.
(p)

Using bregma

as the reference point, the coordinates were: anteroposterior, P-

3.8 mm; mediolateral, p ± 1.7 mm; dorsoventral, p - 8.7 mm.
was infused over 10 min (0. 3 µl/min),

The drug

and the injection cannula was

left in situ an additional 3-5 min to allow adequate spread of drug.
Immediately following the infusion of 5,7-DHT, an intra-MR cannula was
implanted.
Two separate groups of control rats were prepared.

One group (n

- 5) was implanted with MR cannulae, then infused with 2.0 µl of ascorbate vehicle in a manner identical to the MR 5,7-DHT lesion group.
second group of controls

(n -

5)

The

received a bilateral infusion of

ascorbate vehicle (3.0 µl/side) into the MFB, as described above, prior
to MR cannula implantation.
Apparatus
Locomotor activity measures were obtained using darkened, enclosed, cylindrical photocell chambers (46 cm diam x 42 cm high; LVE Model
#PAC-001) with wire mesh floors (n - 10).

Activity counts were gener-

ated by interruption of any one of six photocell beams located at the
base of the chamber and recorded on a digital counter.

r

1
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Open field activity was observed using a plywood arena (100 x 100
cm) with 40 cm high unpainted walls.

wbulb

Illumination was provided by a 40

centered 1.0 m above the floor.

The floor was painted white and

divided by thin black lines into 25 equal squares (20 x 20 cm).
floor of the open field was elevated 7. 5 cm above
testing room.

Equidistantly spaced holes

The

the floor of the

(3. 5 cm diameter) were lo-

cated in the four corner squares of the central nine squares to permit
measurement of head pokes.

A head poke was defined as the lowering of

the animal's snout into a hole.

The space directly below the arena

(visible through the holes) was illuminated with a 25 cm, 20 W fluorescent tube.

Each animal's behavior was videotaped for subsequent anal-

ysis.

Handling and Habituation

The rats were handled daily beginning 7 -10 days after surgery.
After 2-3 days of handling, habituation to the photocell chambers was
initiated.

Each rat was placed individually into an apparatus.

Thirty

min later, the animal was removed, gently wrapped in a towel for 30-60
sec,

then returned to

the chamber

repeated for five consecutive days
rat to the injection procedure.
between

09:00-14:00 h,

for

30 min.

This procedure was

(Days 1-5) in order to adapt each

All behavioral testing was conducted

and each

rat was

always

tested

in the

same

photocell cage.
For

the

open

field

experiments,

beginning 7 -10 days after surgery.
ducted in a novel open field,

the

rats

were

handled daily

For the studies which were con-

the rats were removed from their home
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cage and adapted for 3 days to the injection procedures as described
above.

Later, on each of these 3 days, each rat was handled for 1-2

min to further accustom the animal to the experimenter.

The rats were

exposed to the open field only once, on the day of drug testing.

For

the studies which involved habituation to the open field chamber, each
rat was removed from its home cage, gently wrapped in a towel as described above, then placed in the center of the open field arena.

The

rat was allowed to explore the arena for 30 min, after which time it
was removed and returned to its home cage.
for five consecutive days.
day.

The chamber was

Drug effects were examined on the sixth

thoroughly cleaned with warm water and dried

after removal of each rat.
14:00.

This procedure was repeated

All testing was conducted between 09:00-

Each rat's behavior was videotaped for subsequent analysis.

The following

beha~iors

were quantified: the number of wall and center

squares entered, rears (rat stands on hind limbs and sniffs), and head
pokes.

Drug: Testing:

Drug testing for the LMA experiments began on the day (Day 6) immediately following the last day of habituation.

Vehicle or different

drug doses were administered every other day, in a randomized fashion.
The animals were placed in the chambers daily for 60 min, but no data
were collected on non-drug days.

Total activity counts for the 30 min

of post-drug testing were recorded.
The injection procedure consisted of removing the animal after
the 30 min pre-drug habituation period,

and gently wrapping it in a

...
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towel.

The stylet was removed and replaced with the internal cannula

which was connected, via polyethylene tubing, to a 25 µl Hamilton syringe driven by a microsyringe pump (Model CMA/100, Carnegie Medic.in AB,
solna, Sweden).
1.0 µl/min.

The drugs and vehicle were administered at a rate of

The volume of all infusions was 1.0 µl and the total time

for each infusion was 1.0 min.

Upon completion of the injection, the

internal cannula was left in situ for an additional 30 sec, after which
time it was removed and the stylet replaced.
For the open field studies, the rats were removed from their home
cages,

gently wrapped in a towel,

vehicle as described above.

and infused with a neurokinin or

Following completion of the drug infusion,

the rat was immediately placed in the center of the open field arena,
and its behavior videotaped for 24 or 30 min.

The rat then was re-

turned to its home cage.

DiMe-C7

[ (pGlu5,

MePhe8,

Sar9)substance P 5-11], neurokinin A

(NKA), substance P (SP), neurokinin B (NKB), eledoisin (ELE), kassinin
(KAS),

physalaemin (PHY)

(Peninsula Laboratories,

senktide [(succinyl-Asp6, MePhe8)substance P 6-11]

Belmont,

CA),

and

(Bachem, Torrance,

CA) were prepared according to the method of Stewart (1982).

The ly-

ophilized peptides were dissolved in 0.01 M acetic acid and diluted to
a stock concentration with phosphate buffered saline (PBS; pH 7. 4) .
The stock solutions (DiMe-C7: 6.0 µg/µl; NKA: 6.0 µg/µl; SP: 3.3 µg/µl;
senktide: 2.0 µg/µl;

ELE: 3.3 µg/µl;

KAS: 3.5 µg/µl;

then were aliquoted and kept frozen (-20°C).

PHY: 6.0 µg/µl)

On each drug day, an

so
aliquot was

thawed and diluted with vehicle

(PBS with 0.01 M acetic

acid added, pH 7.2).
NKB first was dissolved in 88% formic acid,
stock concentration (4.4 µg/µl)

with phosphate buffer (pH 11.8).

stock solution was aliquoted and kept frozen
day,

an aliquot was

then diluted to a
The

( - 20°C) .

On each drug

thawed and diluted with vehicle

(PBS with 88%

formic acid added, pH 3.8).
All peptide solutions were kept dark and cold until used.

Care

was taken throughout to avoid the use of glass or polystyrene which
will

bind

the

peptide

and

dramatically

alter

the

amount

delivered

(Stewart, 1982, 1983).
Peptide doses were calculated as moles/µl.

In order to account

for differences in purity which can affect the desired drug concentration (Stewart, 1982), analyses were obtained from each manufacturer for
each batch of peptide received.

These can be found in Appendix I.

The

purity of all peptides was greater than 80%.

The molar concentrations

used

the

took

into

consideration

the

purity of

solutions were appropriately prepared.

peptide,

and

stock

These calculations also can be

found in Appendix I.
Sodium pentobarbital was

obtained from

Butler

thimersol (MerthiolateR) from Eli Lilly (Indianapolis,

(Columbus,
IN);

OH);

lidocaine

hydrochloride (XylocaineR) from Astra (Worchester, MA); chloramphenicol
(ChloromycetinR
Plains,

NJ);

1.0%

atropine sulfate,

tryptamine-creatinine
MO).

ophthalmic

ointment)

from

Parke-Davis

sodium ampicillin

sulfate were

purchased

from

(Morris

and 5,7-dihydroxySigma

(St.

Louis,
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Neurochemical Measurements
The animals were sacrificed by decapitation,
moved, and dissected on a brass plate over ice.
campus,

hypothalamus,

medial

frontal

cortex,

their brains re-

The amygdala, hipponucleus

accumbens

and

striaturn were obtained using a modification of the method described by
Heffner et al., (1980).

The tissue was immediately frozen on dry ice,

then placed in microcentrifuge tubes and stored at

-80°C.

levels of 5-HT,

DA,

5-hydroxyindoleacetic acid

(5-HIAA),

Tissue

dihydroxy-

phenylacetic acid (DOPAC), norepinephrine (NE), and homovanillic acid
(HVA) were determined within 1-2 weeks in each of the brain areas by
high

performance

liquid

chromatography

(HPLC)

with

electrochemical

detection.
The frozen brain samples were weighed and sonicated in 0.1 N perchloric acid (PCA) containing 0 .1 mM ethylenediaminetetraacetic acid
(EDTA),

2. 0 mM sodium metabisulfite (an antioxidant),

50 ng of the

internal standard, N-methyl-5-hydroxytryptamine (NMS-HT), and/or 10 ng
of the internal standard,

3, 4-hydroxybenzylamine (DHBA).

The homog-

enate then was centrifuged at 15,000 x g for 10 min.
For brain regions which did not require concentration of the
amines and metabolites (nucleus accumbens and striaturn), the resulting
supernatant was aspirated, added to minivials, then placed into a Beckman 504 autosampler at room temperature.

The mobile phase consisted of

0.15 M monochloroacetic acid, 0.8 mM EDTA, 18% methanol and 100 mg/L of
octanylsulfonic acid (OSA).
were: DA,

The retention times for these conditions

5.2 min; DOPAC, 6.5 min; 5-HIAA, 9.9 min;

NMS-HT, 13.3 min; HVA, 15.2 min.

5-HT, 11.2 min;
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For brain regions which required concentration of the amines and
their metabolites (amygdala, hippocampus and medial frontal cortex), an
alumina extraction was performed.

The supernatant (100 µl)

from the

initial centrifugation was added to 50 mg activated alumina.

To this

suspension,

50 µl

of 3.0 M Tris-HCl

vigorously for 10 min.

(pH 8.4)

was

added and shaken

Then, 40 µl 0.1 N PCA was added and the suspen-

sion centrifuged for 2.0 min. The supernatant was aspirated, added to
mini vials,

and loaded into the autosampler at room temperature.

mobile phase consisted of 0.15 M monochloroacetic acid,
20% methanol, and 10 mg/L of OSA.

The

0.8 mM EDTA,

The retention times for the substan-

ces contained in the supernatant were: 5-HT, 5.7 min; NMS-HT, 6.9 min;
5-HIAA, 9.9 min.
The alumina pellet from the above extraction was washed twice in
200 µl

of

2.0 mM Tris-HCl

containing

vortexed, then centrifuged for 5.0 sec.

2.0 mM

sodium metabisulfite,

Following the second wash, 50

µl of 0. 2 N PCA containing 2. 0 mM sodium metabisulphite was added to
the alumina pellet.
trifuged for 5.0 sec.

The samples then were shaken vigorously and cenThe resulting supernatant was aspirated, added

to minivials and loaded into the autosampler.

The mobile phase consis-

ted of 0.15 M monochloroacetic acid, 0.8 mM EDTA, 15% methanol, and 750
mg/L of OSA.

The retention times for the substances contained in the

supernatant were: NE,

5.1 min; DOPAC, 6.4 min; DHBA, 8.6 min; and DA,

12.4 min.
All mobile phases were filtered (0.2 µm),

degassed under a vac-

uum, and delivered via a Beckman solvent delivery system (Model llOB).
The flow rate for all separations was 0.9 ml/min.

Aliquots of tissue
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samples or standards were injected (20 µl) onto a reverse-phase column
(S.0 µm 4.6 mm x 15 cm Beckman column. Rainin Co., Woburn, MA) equipped
with a guard column [Bioanalytical Systems (BAS), West Lafayette·, IN].
The effluent from the analytical column was passed through a BAS LC-4
electrochemical detector using a glassy carbon electrode with an applied potential of +0.74 V.

The electrical output was quantified using

a Beckman integrator (Model 427; Spectra-Physics, Santa Clara, CA).
Sacrifice
The animals used in the 5,7-DHT lesion study were sacrificed by
decapitation.

Rats used in all other experiments were injected with an

overdose of sodium pentobarbital (90 mg/kg, i.p.) and perfused transcardially with isotonic saline (100 ml) followed by 10% buffered formalin (100 ml).

The brain stems were stored in formalin for at least

two weeks prior to histological analysis.
Histology
Frozen coronal sections (50 µm)
were cut on a sliding microtome.

through the cannula placements

Every fourth section was float mount-

ed from cold phosphate buffered saline (PBS) onto gelatin-chrome alum
coated "subbed" slides,
acetate.
(p.62).

and subsequently stained with cresyl violet

A representative cannula placement is depicted in Fig.

1
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Statistical Analysis

All data were subjected to the appropriate analysis of variance
(ANOVA).
ple range

Post-hoc comparisons of means were made with Duncan's multitest

(Winer,

For the

1971).

repeated measures

analyses,

post-hoc comparisons were made only on the factors which were determined by the ANOVA to be significant at the 0. 05 probability level.
Data from the NKB injection study were analyzed with a Student's t-test
(two-tailed).
dent's

The neurochemical data were analyzed by ANOVA or Stu-

t-test where appropriate.

In order

to

compare

the

relative

potencies of the various tachykinins for eliciting hyperactivity,

the

data were analyzed by means of a regression analysis of the log-doses
of the peptide versus the total activity.

Tests for parallelism were

performed on the various regression lines (Kenakin, 1987; Tallarida and
Jacob,

1979) utilizing the computer programs of Tallarida and Murray

(1979).

B. Anatomical Studies

Animals

Rats were obtained and housed as described above (p. 44).

!"

'
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Retrograde Tracing
Iontophoresis
Glass micropipettes with a tip diameter of 15-20 µm were made
from glass tubing (100 µm outside diameter) using a Narashige electrode
puller.
The rats were anesthetized with sodium pentobarbital (60 mg/kg,
i.p.);

treated with sodium ampicillin (50 mg/kg,

i.m.) and atropine

sulfate (0.4 mg/kg, i.m.); and, placed in a Kopf stereotaxic apparatus.
An incision was made and a craniotomy performed.

Fluoro-Gold (FG) was

iontophoresed into the MR, with the aid of a dissecting microscope,
using the following coordinates: anteroposterior, bregma (p) - 7.5 mm;
mediolateral, p ± 3.4 mm; dorsoventral, p - 7.7 mm.

These were deter-

mined empirically by iontophoresing the dye, fast green.

A Midguard

constant current generator (Harvard Apparatus Inc., South Natick, MA)
supplied 7.0 sec pulses of a 6.0 µA positive current every 7.0 sec for
20 min.

The current was applied to the solution in the pipette by

means of a silver wire, and the circuit was completed by attaching an
alligator clip

to

the wound margin.

pipette was retracted from the brain,

Following iontophoresis,

the

the wound margin closed with

clips, and the animal placed on a heating pad until it recovered.

The

rats were sacrificed 7-14 days post-operatively.
Perfusion
The rats were administered an overdose of sodium pentobarbital
(90 mg/kg, i.p.) and perfused transcardially with 200 ml of phosphate
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buffered saline (0.1 M, pH 7.4, 700 ml/hat 4°C) followed by 400 ml of
4.0% paraformaldehyde in 0.1 M phosphate buffer (600 ml/h at 4°C).
Immediately prior to infusing the first solution, a bolus of heparin
sulfate (300 U in 300 ul) was administered through the aortic cannula.
Prior to the infusion of the fixative, the rat was placed on ice.

The

brain was removed, blocked and post-fixed for 60 min at room temperIn one rat (FLG-I3), the lower medulla and spinal cord also

ature.

were removed.

The brain then was transferred to a solution containing

20% sucrose and 0.01% bacitracin in 0.1 M phosphate buffer, and stored
for 1-7 days at 4°c.
Tissue Sectioning and Processing
The brains were frozen onto cryostat chucks with O.T.C embedding
mediwn

and sectioned in a

microtome-crytostat

(Hacker-Bright Model

5031, Fairfield, NJ) maintained at -20°c.

Coronal sections (18-25 µm)

were obtained and placed in ice-cold PBS.

Two series of adjacent sec-

tions were saved every 100 µm, and float-mounted onto gelatin-chromiwn
potassiwn sulfate-coated ("subbed") slides.

One series was processed

for the visualization of Fluoro-Gold labeling and counterstained with
0. 01% ethidiwn bromide (Schmued et al.,

1982), while the other was

stained with cresyl violet acetate.
Immunocytochemistry
Colchicine Pretreatment
In order to visualize neurokinin perikarya, colchicine pretreatment was used (Dahlstrom, 1971; Cuello et al., 1983; Skirboll and Hok-
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felt, 1983).

Bilateral intracerebroventricular (i.c.v.) injections of

colchicine (60 µg in 10 µl 0.9% saline) were made stereotaxically, under pentobarbital anesthesia (60 mg/kg, i.p.).
anteroposterior,

~

+ 1.0 mm· mediolateral,
'

In one rat,

- 4.3 mm.

~

The coordinates. were:

± 1.0 mm; dorsoventral,

~

an intrathecal injection of colchicine (100

µg/10 µl) was made via PE-10 tubing introduced through the dura at the
level of the first cervical vertebra, and gently lowered to the thoracic level.

Colchicine infusions were performed 24-48 h prior to

sacrifice.
Perfusion
The

rats

were

administered an overdose

of pentobarbital and

perfused transaortically with 200 ml of calcium-free Tyrodes solution
(700 ml/h at 4°C) followed by 400 ml of 4.0% paraformaldehyde in 0.1 M
phosphate buffer, containing 0. 4% saturated picric acid ( 600 ml/h at

4°c).
Antisera
The following primary antisera were used: rabbit anti-SP (Incstar, Inc., Stillwater, MN); rabbit anti-SP (SP2); and, rabbit anti-NKA
(NKA2).

The SP2 and NKA2 antisera were generously provided by Dr.

Ernst Brodin of the Karolinska Institute. (Sweden), and have been characterized with respect to their specificity and cross-reactivity (Brodin et al., 1986).

All lyophilized antisera were rehydrated in double-

distilled water, aliquoted, and stored at -80°C.

Thawed antisera were

diluted in PBS which contained 0.2-0.3% Triton-X-100 (a detergent which

r
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enhances antibody penetration into tissue) and 0. 01% bacitracin (as a
bacteriostat).

This solution served as the diluent for the secondary

antisera as well.

The concentrations of primary antisera which p"rovid-

ed the best staining were: SP-Incstar, 1:500; SP2 and NKA2, 1:100.
Two different secondary antisera were used.

One was a swine

anti-rabbit irnrnunoglobulin G (IgG) conjugated to fluorescein-isothiocyanate (FITC; Dakopatts, Sweden) diluted 1:10.

The other was a bio-

tinylated goat anti-rabbit IgG (Vector Labs, Burlingame, CA) diluted
1:200.

This latter antibody required the use of an avidin-FITC con-

jugate diluted 1:200 in 10 mM HEPES buffer in 0.9% saline (pH 8.6).
Tissue Sectioning and Processing
The tissue was placed in the cryostat at -20°C, and sectioned as
described above.

Coronal sections (20 µm) were placed into culture

dishes (3-4 per well) and processed free-floating.

The 10 µm sections

were thaw-mounted onto "subbed" slides prior to processing. The thawmounted sections were brought to room temperature and rehydrated in PBS
(10 min).

All sections first were incubated in the antibody diluent

(PBS with 0.2-0.3% Triton X-100 and 0.01% bacitracin) for 20-30 min.
When the avidin-biotin method was used, the diluent also included 5-10%
normal

goat

serum

in

order

to

block non-specific

avidin binding.

Following 3 x 10 min washes in PBS, the sections were incubated in the
primary antisera at the appropriate dilution for 24-48 h at 4°C.

The

sections then were washed in PBS (3 x 10 min) and incubated with the
secondary antibody at 37°C (FITC labeled swine anti-rabbit IgG) or room
temperature (biotinylated goat anti-rabbit IgG) for 60 min.

Following
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3 x

10 min washes

slides,

air

dried,

the

sections were mounted onto

to retard fluorescent fading (Dr. C.

University of Chicago, personal communication).

final washes,

"subbed"

and covers lipped with DePex mounting media which

~-mercaptoethanol

contained 2.0%
Saper,

in PBS,

Prior to the

the sections which had been processed with the biotin-

ylated secondary antibody were incubated with the FITC labeled-avidin
for 60 min at room temperature.

Microscopy

A Leitz Dialux 20 microscope equipped with a 35 mm camera was
used to visualize the FG, FITC, and ethidium bromide staining.

Photo-

micrographs were obtained using epi-illumination and Ploemoptics with
the appropriate

filter combination.

FG labeled cells were examined

using a "blue" filter combination (Leitz cube A; 340-380 nm excitation
and 430 nm barrier filters).

FITC positive material was observed using

a "green" filter combination (Leitz cube 12; 450-490 nm excitation and
515

nm barrier

filters).

Ethidium bromide

staining was visualized

using a "red" filter combination (Leitz N2 cube; 530-560 nm excitation
and

580

nm barrier

filters).

either black and white print
chrome; ASA 400;

Photomicrographs
(T-Max;

were

obtained with

ASA 400) or color slide (Ekta-

Eastman Kodak Co., Rochester, NY) film.

CHAPTER IV
RESULTS
A. Behavioral Studies
Experiment I: DiMe-C7 Dose-Response
Procedure
In the first experiment we replicated and extended our earlier
findings that intra-MR DiMe-C7 dose-dependently increases LMA (Paris
and Lorens, 1987 a,b), using a wider range of doses.

Following five

days of habituation to the apparatus, the rats (n - 10) received seven
intra-MR injections, each separated by 48 h.

Vehicle (1.0 µl) and six

doses (11.4, 34.2, 114, 342, 1140 and 3420 pmol) of DiMe-C7 were administered once according to a randomized design.
Results
The cannulae placements in the 10 rats used in this study are
shown schematically in Appendix II

(Fig A).

As we have discussed

previously (Paris and Lorens, 1987 a), the repeated drug administration
protocol used in the present studies (one injection every other day)
not only yields very reproducible behavioral effects with no apparent
tolerance development, but minimal glial scarring (Fig. 1).
In agreement with our previous reports (Paris and Lorens, 1987
a,b), intra-MR infusions of DiMe-C7 produce dose-dependent increases in
60
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LMA (Fig.

2).

An ANOVA revealed a significant drug treatment effect

[F(6,54) - 28.8, p < 0.001].

A post-hoc comparison of means indicated

that I.MA was significantly (p < 0.01) elevated following all doses of
DiMe-C7 except the 11. 4 pmol dose.

The effects of the two highest

doses, 1140 and 3420 pmol, were not significantly different from each
other, but were significantly greater than those of the lower doses.
In addition, the effects of the 342 pmol dose were significantly greater than those after the 34.2 pmol dose.
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Fig. 1. MR Cannula Placement: Photomicrograph (x25) of a 50 µm coronal
section (cresyl violet stain) showing a cannula tip (arrow)
which terminated in the ventral part of the median raphe nucleus (MR) in an animal from Experiment II. The cannula tracks
in all rats were associated with glial scarring which approximated 0.5 mm in diameter.
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Experiment II: Non-Mammalian Tachykinin Dose-Responses
Procedure
In this experiment, the non-mammalian tachykinins, ELE, KAS and
PHY, were tested.

Three separate groups of rats (n - 7 - 10 per group)

were used, one for each peptide tested.
A linear regression analysis of the results from the first experiment indicated that three doses of DiMe-C7 produced increases in
activity which were approximately 30, 50 and 90% of the maximal response.

These doses were: 30, 230 and 1140 pmol, respectively.

The same

three doses of the tachykinins were selected in order to compare their
effects on LMA.

In addition, all rats received an injection of a sub-

maximal dose of DiMe-C7 (230 pmol) for purpose of comparison.
Following the five day habituation period, the rats received five
intra-MR injections, each separated by 48 h.

Vehicle (1.0 µl), a test

dose of DiMe-C7 (230 pmol), and the three doses of the particular peptide

(30,

230 and 1140 pmol) were administered according to a ran-

domized design.
Results
The cannulae placements for the 24 rats used in this study are
depicted schematically in Appendix II (Fig. A).
Fig. 3 shows the effects of the non-mammalian tachykinins on LMA.
An initial analysis confirmed that there were no significant group
differences in the activity levels following the injections of vehicle
[F(2,21) -

2.23,

p > 0.10]

or DiMe-C7

[F(2,21) -

2.95, p > 0.10].
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Therefore, for the sake of simplicity, the vehicle and DiMe-C7 scores
were combined for all three groups for both statistical and graphical
purposes.
Further analysis of the 30 min post-drug activity scores indicated a significant group effect [F(2,21) - 23.48, p < 0.001] and a
significant effect of peptide dose [F(4,84) - 24.60, p < 0.001].

The

interaction between the group and dose factors also was significant
[F(S,84) - 2.19, p

0. 05].

All doses of ELE significantly elevated LMA.

The activity levels

observe.d following infusions of the 30 and 230 pmol doses were not
significantly different from each other, but were significantly less
than after infusions of the 1140 pmol dose.

The effect produced by

1140 pmol of ELE was equivalent to that produced by the 230 pmol test
dose of DiMe-C7.
A post-hoc comparison revealed that only the two highest doses of
KAS tested, 230 and 1140 pmol, significantly elevated LMA compared to
vehicle.

In addition, the activity levels following all doses tested

were significantly less than those induced by the DiMe-C7 test dose
(230 pmol).

Although only the two highest doses tested produced LMA

effects which were significantly different from those following the
vehicle injections (p < 0.05), the LMA effects after these three doses
of KAS did not significantly differ from each other.
For PHY, only the two highest doses, 230 and 1140 pmol, significantly elevated LMA in comparison to vehicle injections.

The LMA fol-

lowing infusions of all doses tested was significantly less (p < 0.05)
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than that produced by DiMe-C7 (230 pmol).

The effects of the three PHY

doses, furthermore, did not significantly differ from each other.
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Fig. 3. Tachykinin Dose-Response:
Total activity for 30 min postinjection of vehicle (Veh), DiMe-C7 and three doses of eledoisin (ELE), kassinin (KAS) and physalaemin (PHY) in separate
groups of rats (n - 7-9 per group). Data represent mean± SEM.
Significant difference from Veh: * p < 0.05 (ANOVA followed by
Duncan's multiple range test).
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Experiment III: Mammalian Neurokinin Dose-Responses
Procedure
This experiment was conducted identically to Experiment II except
for the peptides tested.

The mammalian tachykinins, neurokinin A and

substance P, and the neurokinin B agonist, senktide, were tested.
Results
The cannula placements for the 21 rats used in this study are
depicted schematically in Appendix II (Fig A).
An initial analysis of the 30 min post-drug total activity scores
following vehicle
0. 46, p > 0. 3]

[F(2,18) -

1.02, p > 0.3]

and DiMe-C7

[F(2,18) -

injections confirmed that there were no significant

differences between the three groups of rats.

Therefore, both the

vehicle and DiMe-C7 scores for all three groups were combined for
statistical and graphical purposes.
Fig. 4 shows that all three of the neurokinins increased LMA.

An

ANOVA indicated that there was a significant effect of the dose of the
particular peptide [F(4,72)

=

26.14, p < 0.001], as well as a signif-

icant difference between the three groups [F(2,18) - 9.60, p < 0.001].
The interaction between dose and group also was significant [F(8,72) 8.59, p < 0.01].
For the senktide group, all three doses (30, 230, and 1140 pmol),
significantly increased LMA compared to the effects of both vehicle and
DiMe-C7.

Further analysis indicated that the LMA increases produced by

the 230 pmol dose was significantly greater than that produced by 30
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pmol dose, and that the hyperactivity produced by the 1140 pmol dose
was

significantly greater than that following

the

30 and 230 pmol

doses.
All three doses of NKA significantly elevated I11A compared to
vehicle.

The hyperactivity produced by 1140 pmol was significantly

greater than that induced by the 30 and 230 pmol doses, as well as the
DiMe-C7 test-dose (230 pmol).

The increases in I11A produced by the 30

and 230 pmol doses of NKA did not differ significantly from each other,
or from those observed following DiMe-C7 (230 pmol) administration.
For the SP group, only the highest dose tested (1140 pmol) significantly increased I11A compared to vehicle.

The increase in I11A pro-

duced by the 1140 pmol dose was significantly greater than that observed following the 30 pmol SP dose, but did not differ from the
increase in activity produced by the DiMe-C7 test-dose.
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Experiment IV: NKA Low Dose-Response Study
Procedure
Following the five day habituation period,
experiment)
days.

the rats (n

=

7 per

received five intra-MR injections each separated by two

Vehicle (1.0 µl) and four doses (1.0, 3.0, 10 and 30 pmol) of

NKA were administered according to a
sacrifice and histological analysis,

randomized design.

Prior to

some of the rats were used in

Experiment VI.
Results
The cannulae placements for the eight rats used in this study are
shown schematically in Appendix II (Fig. A).
Fig. 5 shows that NKA dose-dependently increased LMA.

An ANOVA

indicated that there was a significant effect of NKA on LMA [F(4,28)
13. 8' p < 0. 001] .

~

A post-hoc comparison of means revealed that only

the 30 pmol dose significantly elevated LMA compared to the vehicle
injections.

The increase in LMA produced by the 30 pmol NKA dose was

equivalent to that observed in Experiment III (Fig.4).

As seen in Fig.

5, injections of 1.0 and 3.0 pmol of NKA decreased LMA, however, this
was not statistically significant (0.05 < p < 0.10).
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Experiment V: Senktide Low Dose-Response Study
Procedure
This experiment was conducted identically to Experiment IV except
for the peptide studied.

Senktide was tested at the same four doses

used in the previous experiment.
Results
The cannulae placements for the 8 rats used in this study are
schematically represented in Appendix II (Fig. A).
Fig.

6 shows that senktide dose-dependently increased l.MA.

An

ANOVA indicated that there was a significant effect of senktide on l.MA
[F(4,28) - 16.5, p < 0.001].

Post-hoc comparisons of means showed that

all of the senktide doses tested, except 1.0 pmol, significantly elevated l.MA.

The increase in l.MA produced by the 30 pmol dose was equiv-

alent to that observed in Experiment III (Fig. 4).

Further analysis

showed that the increasing doses of senktide each produced significantly greater effects on l.MA than the immediately lower dose.

Thus, the

l.MA effect of the 30 pmol dose was significantly greater (p < 0. 05)
than that following 10 pmol, which was greater than that following 3.0
pmol, which was greater than that following the 1. 0 pmol dose, which
was equal to that following vehicle injections.
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Re&ression Analysis
Fig.

7 shows the regression analysis performed for the .tachy-

kinins and analogues studied.

An initial analysis of activity follow-

ing vehicle infusions showed that there were no significant differences
between the groups of rats [F(8,62) - 2.02; p > 0.05].

± SEM for all the vehicle scores was 624 ± 24.
test

scores

also

did not reveal

[F(5,39) - 1.95; p > 0.10].

The grand mean

Analysis of the DiMe-C7

any significant group differences

The grand mean± SEM for all DiMe-C7 test

scores was 1220 ± 43.
Tests for parallelism indicated that the senktide and DiMe-C7
regression lines were not significantly different (t - 0.56, df - 8; p

> 0.05). *

Both the senktide and DiMe-C7 slopes, however, were signif-

icantly different from the SP and NKA lines.

The SP and NKA regression

lines, moreover, did not differ significantly (t - 1.54, df - 2; p >
0.05).

The relative positions of the lines indicate that senktide was

more potent than DiMe-C7, and NKA was more potent than SP.
Analysis of the regression lines for the non-mammalian tachykinins indicated that they were parallel, and that their slopes were
significantly different from those of senktide and NKA, but not SP.

It

should be noted, however, that the slopes for the non-mammalian compounds were relatively flat indicating a lack of dose-dependent effects
within the range of doses tested.

* For the sake of clarity, only the most relevant t-values are
given.
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Fig. 7. Regression Analysis: Regression lines of total activity for 30
min post-injection versus tachykinins dose in pmol (log scale).
Regression lines:

senktide: y - 585(x) +
DiMe-C7: y - 622(x) +
NKA:
y - 345(x) +
SP:
y - 128(x) +
ELE:
y = 87(x) +
KAS:
y - 22(x) +
PHY:
y = 89(x) +

608
138
393
578
781
751
566

Veh = grand mean of vehicle activity scores; DiMe-C7 (230 pmol)
- grand mean of test dose activity scores.
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Experiment VI: Intra-MR NKB Injections
Procedure
Rats from Experiments IV (n

=

4) and V (n

=

5), as well as two

naive rats, were habituated to the testing apparatus for five days.

On

the sixth day the rats received an injection of either the formic acid
vehicle (1.0 µl) or NKB (3.0 pmol).

They were sacrificed by decapita-

tion immediately following removal from the testing chamber.
Results
The cannulae placements in the rats which received injections of
either the formic acid vehicle or NKB are included in Appendix II (Fig.
A).

The cannulae placements for the two additional rats (not shown)

were comparable.
Fig. 8 shows the 30 min total activity following either formic
acid vehicle or NKB (3.0 pmol) injections.

LMA (t

=

3.31, df

=

9, p < 0.01).

NKB significantly elevated

For the purpose of comparison, the

activity levels obtained in Experiment V following injections of vehicle or senktide (3.0 pmol) are presented in Fig. 8.

NKB elevated Ll1A

to a level equivalent to that seen with an equimolar dose of senktide
(t

1.94, df - 11, p > 0.05).
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Experiment VII: 5.7-Dihydroxytryptamine (5.7-DHT) Lesions

Procedure

Beginning 14 days

post-operatively,

and following

two

days

of

handling, the animals were habituated to the testing apparatus for five
days,

60 min per day.

The day immediately following the last day of

habituation, drug testing was begun.
32)

received intra-MR injections

At 48 h intervals, each rat (n -

of vehicle

pmol), NKA (230 pmol) and senktide (30 pmol).

(1.0 µl),

DiMe-C7

(1140

These doses were selec-

ted on the basis of our previous dose-response analysis which showed
that

they produced sub-maximal but equivalent increases

Fig.

2 and 3).

in LMA (see

Each drug was administered only once, according to a

randomized design.

Results

The cannulae placements in the 21 rats used in this study are
shown schematically in Appendix II (Fig. B).
The 5,7-DHT injections into the MR produced some cell loss (presumably 5-HT neurons) with minimal glial scarring in the region surrounding
observed.

the

cannula tip.

No extensive scarring or cavitation was

Analysis of the MFB injection sites revealed that the 5,7-

DHT and vehicle infusions did not cause any destruction of perikarya in
the region, or any cavitation at the tip of the injection needle.

No

evidence of retrograde degeneration in the MR was obtained.
An initial analysis of the data (not shown)

indicated that the

two groups of control animals did not differ either in their response
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to the neurokinin infusions or neurochemically,

therefore their data

were combined for subsequent analysis.
Fig. 9 shows the total activity counts for the 30 min following
the inj ec ti on of DiMe - C7,
rats.

NKA and senktide for the three groups of

An ANOVA revealed significant lesion [F(2,24) - 6.18; p < 0.01]

and drug [F(3,72) - 24.91; p < 0.001] effects.

The lesion x drug in-

teraction also was significant [F(6,72) - 4.63; p < 0.001].

A post-hoc

analysis indicated that for the control group, administration of all
three peptides significantly elevated LMA compared to vehicle, but that
the activity levels produced by these infusions did not significantly
differ from each other.

Further analysis indicated that the LMA fol-

lowing vehicle infusions was equivalent for all three groups.

The

activity levels produced by infusions of senktide and DiMe-C7 were
equivalent between the control and MFB lesion groups.
The MR 5, 7-DHT lesions completely blocked the LMA produced by
infusions of DiMe-C7, NKA and senktide.

In contrast, the MFB 5,7-DHT

lesions did not affect the locomotor hyperactivity produced by intra-MR
administration of DiMe-C7 and senktide, but appeared to attenuate the
effects of NKA.

The hyperactivity produced by infusions of NKA was

significantly lower than that produced by both senktide and DiMe-C7 in
rats with MFB lesions.

In addition,

the hyperactivity produced by

infusions of NKA in the MFB lesion group was intermediate to that
produced by similar infusions in the control and MR lesion groups.
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The MR 5,7-DHT injections significantly reduced the 5-HT and 5HIAA concentrations in all five brain regions assayed (Table II).

The

MFB 5, 7-DHT injections produced virtual depletion of 5-HT and 5-HIAA
concentrations in all the brain regions.

In all cases, the MFB lesions

produced reductions greater than 86% from control levels.
Table III shows the effects of the MR and MFB 5,7-DHT lesions on
forebrain DA,

NE and metabolite levels.

The MFB lesions produced

significant reductions in NE levels in both the MFC and hippocampus.
These lesions also produced significant reductions in DA levels in all
brain regions analyzed, except the amygdala.

DOPAC levels were af-

fected by the MFB lesions only in the striatwn and nucleus accwnbens.
HVA

concentrations

were

significantly

reduced only

in the

nucleus

accwnbens of rats with MFB lesions.
The only effect of the MR lesions on DA levels was an increase in
the amygdala.

Similarly, DOPAC levels were significantly increased in

both the amygdala and MFC in rats with MR 5,7-DHT lesions.
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Table II:
EFFECTS OF INTRA-MEDIAN RAPHE (MR) AND MEDIAL FOREBRAIN BUNDLE (MFB)
5.7-DIHYDROXYTRYPTAMINE LESIONS ON FOREBRAIN
SEROTONIN LEVELS
Region
Group

5-HIAA
(ng/g)

5-HT
(ng/g)

Amygdala
Control
MR-Lesion
MFB-Lesion

1114 ± 58
292 ± 74 (-74%)
60 ± 29 (-95%)

+

255 ± 17
89 ± 19 (-65%)
N.D. (- >96%)

*
*

792 ± 44
222 ± 71 (-72%)
42 ± 16 (-95%)

*

192 ± 11
49 ± 17 (-74%)
N.D. (- >97%)

*

794 ± 47
429 ± 68 (-46%)
114 ± 8 (-86%)

*

319 ± 23
158 ± 32 (-50%)
N. D. ( - >94%)

1157 ± 83
652 ± 155 (-44%)
N.D. (- >98%)

*

327 ± 18
167 ± 38 (-49%)
N. D. ( - >94%)

*
*

Medial Frontal Cortex
Control
MR-Lesion
MFB-Lesion
Stria tum
Control
MR-Lesion
MFB-Lesion

*

Nucleus Accumbens
Control
MR-Lesion
MFB-Lesion

+

Hippocampus
Control
MR-Lesion
MFB-Lesion

*
*

583 ± 37
67 ± 13 (-89%)
53 ± 16 (-91%)

*
*

278 ± 17
61 ± 9 (-78%)
30 ± 9 (-89%)

--m-=------

N - 7-9 per group; data represent mean ± SEM; numbers in parenthesis - % change from corresponding Control; significant
difference from corresponding Control: + - p < 0. 05; * - p <
0.01.
N.D. - Not detectable; less than limits of sensitivity: amygdala, < 10 ng/g; medial frontal cortex, < 5 ng/g; striatum, <
20 ng/g; and nucleus accurnbens, < 20 ng/g wet weight of tissue.

F··~-

Table Ill:
EFFECTS OF INTRA-MEDIAN RAPHE {MR) AND MEDIAL FOREBRAIN BUNDLE CMFB)
5.7-DIHYDROXYTRYPTAMINE LESIONS ON FOREBRAIN DOPAMINE AND
NOREPINEPHRINE LEVELS

Region
Group

NE

HVA

DO PAC

DA
(ng/g)

Amygdala
597 ± 34
659 ± 36
476 ± 22

Control
MR-Lesion
MFB-Lesion

381 ± 42
503 ± 21 (+32%)
299 ± 22

30 ± 3
43 ± 4 (+43%)
29 ± 2

105 ±

9

18 ±

130 ±

11

*
*
-------------------------------------------------------------------------------------------Medial Frontal Cortex
Control
MR-Lesion
MFB-Lesion

*

353 ± 17
351 ± 18
268 ± 16 (-24%)

*

1

9 (-21%)

29 ± 3 (+61%)
16 ± 2

7678 ± 346
7543 ± 358
5737 ± 406 (-25%)

887 ± 67
1003 ± 29
* 533 ± 60 (-40%)

*

83 ±

Stria tum
Control
MR-Lesion
MFB-Lesion

*

352 ± 26
412 ± 26
264 ± 40

00
\J1
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Table III (cont'd)

Nucleus Accumbens

-------

Control
MR-Lesion
MFB-Lesion

*

7222 ± 332
6251 ± 371
5682 ± 141 (-21%)

1109 ± 49
1088 ± 101
* 760 ± 78 (-31%)

*

378 ± 27
372 ± 45
231 ± 31
(-39%)

Hippocampus
Control
MR-Lesion
MFB-Lesion

*

808 ± 31
831 ± 53
590 ± 45 (-27%)

N - 7-9 per group; data represent mean ± SEM; numbers in parenthesis - % change from corresponding control; significant difference from corresponding control: * - p < 0.01.
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Experiment VIII: DiMe-C7 Dose-Response in a Novel Open Field
Procedure
Rats (n

30 from Experiment II) were handled daily for 3 days.

=

They then were tested (10 rats per day for three days) following an
infusion of either vehicle (1.0 µl) or three doses of DiMe-C7 (30, 230,
and 1140 pmol).

Each animal was injected with drug or vehicle and im-

mediately placed in the center of the arena.

The behavior of the an-

imal was videotaped for 30 min for subsequent analysis.

Following the

testing period, each rat was removed, transported to another room and
swiftly decapitated.

The brain was removed and placed in buffered

formalin for subsequent histological analysis.
Results
The effects of DiMe-C7 on behavior in a novel open field are
shown in Fig.

10.

An analysis of the total activity (wall squares

entered + center squares entered + rears + head pokes) indicated that
DiMe-C7 did not affect activity in a novel open field [F(3,21)
p > 0.3].

=

0.55;

Further analysis of each component behavior (Fig. 11) demon-

strated no significant effects of DiMe-C7: wall squares entered [F(3,
20) -

0.07;

0.05];

rears

0.74;

p > 0.3];
[F(3,20) -

p > 0.3].

center squares entered [F(3,20) 2. 78, p > 0.05];

and head pokes

There were significant effects of time

1.32; p >
[F(3,20) (Fig.

11)

within the chamber for wall squares entered [F(9,27) - 3.72; p < 0.01],
center squares entered [F(9,180) - 3.65; p <
[F(9,180) - 5.53; p < 0.01].

0.05], and head pokes

The only significant drug x time inter-
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actions were
[F(27,180) -

for rears

[F(27,180) -

2.08; p < 0.01].

1.58;

p -

0.05]

and head pokes

Analysis of the time effects indicated

that the greatest contribution came from the highest dose of DiMe-C7
(1140 pmol).

There was a general increase in activity over the 30 min

testing period.
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200

10.

DiMe-C7 Novel Open Field: Total Activity:
Total activity
(wall squares + center squares + rears + head pokes) for 30 min
following infusion of varying doses of DiMe-C7.
N - 7/9 rats
per dose; data represent mean ± SEM. No significant differences from vehicle infusions were observed.
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Experiment IX: Neurokinin Effects on Novel Open Field Behavior

Procedure

Rats

(n

=

30 from Experiment III) were handled daily for three

days beginning eight days following the completion of Experiment III.
This experiment was conducted identically to Experiment VII, except for
the drugs

In this study,

tested.

each rat was

infused with either

vehicle (1.0 µl), NKA (230 pmol) or senktide (30 pmol).

Following the

completion of the experiment, all rats received an overdose of sodium
pentobarbital

and

were

transcardially

followed by buffered formalin.

perfused

with

normal

saline

The brain stems were removed and stored

in formalin for at least one week prior to histological analysis.

Results

The effects of NKA (230 pmol),

senktide

(30 pmol)

and vehicle

(1.0 µl) on behavior in a novel open field are shown in Fig. 12 and 13.
An

analysis

of

the

total

activity

(wall

entered +

squares

center

squares entered + rears + head pokes) indicated that there was a significant drug effect [F(2,18) -

8.71; p < 0.01].

A post-hoc analysis

indicated that the activity levels of the animals injected with senktide were significantly greater than that following infusion of vehicle
and NKA.

Analysis of each component behavior (Fig.

13) demonstrated

significant drug effects for wall squares entered [F(2,18) 0.05] and center squares entered [F(2,18) -

6.49; p <

5.40; p < 0.01].

Signif-

icant time effects also were observed for wall squares entered [F(9,
162) -

14.5; p< 0.01], center squares entered [F(9,162) -

3.45;

92
p

< 0.01], head pokes [F(9,162) - 3.49; p < 0.01), and rears [F(9,162)

- 8.79; p < 0.01).
Post-hoc analysis showed that the significant effects on component behaviors were due to the increases on these measures among the
rats which had received infusions of senktide.
13,

the

senktide

treated group was more

groups for the entire 30 min period.
hicle

and

NKA

infused

rats

which

As can be seen in Fig.

active

than the other

two

This is in contrast to the veshowed significant

reductions

squares entered during the last 12-15 min of the testing period.

in
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Fig.

12.
Neurokinin Effects in a Novel Open Field: Total Activity:
Total activity (wall squares + center squares + rears + head
pokes) for 30 min following infusion of vehicle, NKA (230 pmol)
or senktide (30 pmol).
N - 7/9 rats per dose; data represent
group means ± SEM.
* - significant difference from vehicle
infusions, p < 0.05 (ANOVA +Duncan's multiple range test).
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Experiment X: Neurokinin-Habituated Open Field
Procedure
In order to test the effects of habituation on a rat's behavioral
response to an intra-MR neurokinin infusion,

rats were tested in an

open field arena to which they had been adapted.
implanted with intra-MR cannulae.

Rats (n - 19) were

Following 7 days recovery, the rats

were adapted to the injection procedure and placed in the open field
apparatus for 30 min a day for 5 consecutive days.

On the sixth day,

each rat was removed from its home cage, infused with either vehicle
(1.0 µl), NKA (230 pmol) or senktide (30 pmol), and immediately placed
in the open field arena for 30 min.

The experiment was conducted over

a two week time period with approximately half the rats from each group
tested during each week.

Following completion of the experiment, the

rats were perfused with saline and formalin and their brain stems
removed for histological analysis.
Results
The cannulae placements are shown schematically in Appendix II
(Fig. C).

An initial analysis comparing the activity measured on the

first and last days of habituation indicated a significant reduction in
total activity [F(l,15)

=

37.6; p < 0.001], wall squares entered [F(l,

15) - 32.5; p < 0.001], center squares entered [F(l,15) -

31.2; p <

0.001], rears [F(l,15) - 15.2; p < 0.001], and head pokes [F(l,15)
8.63; p < 0.01].

This reduction in activity indicates that the animals
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habituated to the open field chamber during the five days of adaptation.
The

total

activity

following

administration of either vehicle

(1.0 µl), NKA (230 pmol) or senktide (30 pmol) is shown in Fig. 14.

An

analysis of the total activity on the test day indicated a significant
effect of the neurokinins
parisons

showed

that

both

[F(2,16) NKA

and

activity compared to vehicle infusions.

4.41; p
senktide

< 0.05].

Post-hoc com-

significantly

elevated
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Fig. 14. Neurokinin Effects in an Habituated Open Field: Total Activity:
Total activity (wall squares entered + center squares entered + rears + head pokes) for 30 min following infusion of
vehicle, NKA (230 pmol) or senktide (30 pmol). N = 7/9 rats per
dose; data represent group means ± SEM. * = significant difference from vehicle infusions, p < 0.05 (ANOVA + Duncan's multiple
range test).
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The

effects

of vehicle,

NKA and

senktide

on wall

squares entered, rears and head pokes are shown in Fig. 15.

and center
An ANOVA

revealed a significant drug effect on wall squares entered [F(2,15) 10.5; p < 0.001],
and rears

center squares entered [F(2,15)

[F(2,15) -

6.52; p < 0.01].

8.38; p < 0.01],

Significant time effects and

drug x time interactions also were noted for the number of wall squares
entered

[F(7,105) -

11.8;

p < 0.01 and F(l4,105) -

2.82;

p < 0.01,

respectively].
The animals which had been infused with either NKA or senktide
entered a

significantly greater number

of squares

treated group during the first 15-18 min (Fig.

15).

than the vehicle
Interestingly,

further analysis indicated that the rats infused with NKA entered more
center squares and emitted more rears than the other two groups.
contrast,

animals

injected with

senktide

tended to

In

enter more wall

squares than those injected with NKA over the 24 min test period.
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Neurokinin Effects in an Habituated Open Field: Component
Behaviors:
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head pokes per 3 min block for 30 min following infusion of
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for clarity.
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B. Anatomical Studies
Experiment I: Retrograde Tracing of MR Afferents
The Fluoro-Gold (FG) injection sites are shown in Fig. 16.

All

were localized within the MR and were approximately 1.0 mm in diameter.
The center of each injection site was associated with a small glial
scar (approximately 0. 25 mm in diameter) which is characteristic of
iontophoretic FG administration (Schmued and Fallon, 1986).

The number

and extent of FG retrogradely-labeled cell bodies were virtually identical in all animals.

Fig. 17 schematically portrays the loci of the

FG labeled cell bodies observed in a representative animal (FLG-I2).
The injection site in case FLG-I2 is pictured in Fig. 18f.

Photomicro-

graphs of labeled perikarya in different brain regions are shown in
Fig. 18.

The description which follows summarizes the results which

were consistently obtained in the six rats.

Certain exceptions to the

labeling pattern will be pointed out.
Telencephalon
Retrogradely labeled neurons were found in the following telencephalic areas:

frontal and cingulate cortices,

pallidurn, and the magnocellular preoptic area.

septal area, ventral
No labeled cells were

observed in the caudate-putamen, the nucleus accurnbens, the hippocampal
formation, or the amygdaloid complex at any anteroposterior level.
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Cortex

As shown in Fig. 17a-g and 18a, a high density of labeled

n~urons

was found throughout the medial aspects of the frontal and cingulate
cortices.

In two

rats

(FLG-H3

and I1),

a

few retrogradely labeled

cells (not shown in Fig. 17) were found in the insular cortex.

Labeled

neurons were not observed in other cortical regions.

Septal Area

The septal area

(Fig.

17d-f) was found to contain a number of

retrogradely labeled neurons.

Most notable in this region was the high

density of labeled neurons in the nucleus of the horizontal limb of the
diagonal band (Fig.

18b).

Fewer labeled cells were observed in the

vertical limb and in the medial septal nucleus.
countered within

the

lateral

septal

nuclei,

mediate division than in the dorsolateral

Cells also were en-

more within the

septum.

inter-

Adjacent to

the

septal area, a few labeled neurons were observed in the bed nucleus of
the stria terminalis (Fig. 17f).

Ventral Pallidum. Preoptic Area. and the Substantia Innominata

The ventral pallidum and substantia innominata (Fig. 17e,f) were
found to contain a number of retrogradely labeled cells.

A large num-

ber of FG-labeled cells were observed within the magnocellular preoptic
area (Fig.

17f) spread over its medial and lateral subdivisions.

It

also should be noted that the cells which were found in the horizontal
limb of the diagonal band and those found within the ventral pallidum
tended to form a continuous band of perikarya.
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ABBREVIATIONS
3
4

3V
4V

7

7n
12
aca
Acb
AHC

Amy
AOP
APT
Arc

ATg
BSTM
Cg
CG

CLi
CnF

oculomotor nucleus
trochlear nucleus
third ventricle
fourth ventricle
facial nucleus
facial nerve
hypoglossal nucleus

f
fi
fmi

anterior commissure,
anterior part
nucleus accumbens
central anterior hypothalamic area
amygdala
anterior
olfactory
nucleus, posterior
anterior pretectal
nucleus
arcuate nucleus
anterior
tegmental
nucleus

g7

bed nucleus stria terminalis (medial part)
cingulate cortex
central gray
caudal
linear
nucleus
cuneiform nucleus

raphe

fr

FR

Gi

GP
HDB
HiF
ic

IC

IO
IPN
LC
LDTg

LH
LHb
11

LPB
cp
CPu
ctg

cerebral peduncle
caudate putamen
central tegmental tract

Dk

nucleus
of
Darkschewitsch
dorsomedial hypothalamic
nucleus
dorsomedial
tegmental
area
deep
mesencephalic
nucleus
dorsal raphe nucleus
dorsal tegmental bundle
dorsal tegmental nucleus
of Gudden

LPGi

LPO
DMH
DMTg
DpMe

DR
dtb
DTG

EW

Edinger-Westphal nucleus

LS
LSI
LV
LVe

mS

ME
Med

fornix
fimbria
forceps minor of the
corpus callosum
fasciculus
retroflexus
frontal cortex
genu
of
the
facial
nerve
gigantocellular reticular nucleus
globus pallidus
horizontal limb of the
diagonal band of Broca
hippocampal formation
internal capsule
inferior colliculus
inferior olive
interpeduncular nucleus
locus ceruleus
laterodorsal tegmental
nucleus
lateral hypothalamus
lateral
habenular
nucleus
lateral lemniscus
lateral
parabrachial
nucleus
lateral
paragigantocellular nucleus
lateral preoptic
nucleus
lateral septa! nucleus
lateral septa! nucleus
(intermediate part)
lateral ventricle
lateral
vestibular
nucleus
motor root of the trigeminal nerve
median eminence
medial
(fastigial)
cerebellar nucleus
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MG

MHb
MiTg
ml
mlf
MM

MoS
MPO
MR

mt

MVe
MVeV

medial geniculate nucleus
medial habenular nucleus
microcellular tegmental
nucleus
medial lemniscus
medial
longitudinal
fasciculus
medial mammillary
nucleus
motor trigeminal nucleus
medial preoptic nucleus
median raphe nucleus
mammillothalamic tract
medial vestibular nucleus
medial vestibular nucleus (ventral part)

RPn

RRF
RtTg

RVL
sS

Su
st

sensory root of the
trigeminal nerve
superior
cerebellar
peduncle
septofimbrial nucleus
substantia innominata
stria medullaris
substantia nigra (pars
compacta)
substantia nigra (pars
reticulata)
nucleus of the solitary
tract
spinal trigeminal tract
spinal
trigeminal
nucleus (oral part)
subpeduncular tegmental
nucleus
superior colliculus
stria terminalis

Tu
Tz

olfactory tubercle
trapezoid nucleus

VDB

vertical limb of the
diagonal band of Broca
ventral nucleus of the
lateral lemniscus
ventromedial
thalamic
nucleus
ventromedial hypothalamic nucleus
ventral pallidum
ventral tegmental area
ventral tegmental nucleus of Gudden

scp
SFi

SI
sm
SNc
SNr
Sol

ox

optic chiasm

pc

posterior commissure
posterior hypothalamic
area
piriform cortex
premammillary nucleus
(ventral part)
pontine nuclei
pontine reticular nucleus (caudal part)
pontine reticular nucleus (oral part)
pedunculopontine tegmental nucleus
prerubral field
principal sensory trigeminal nucleus
(dorsomedial part)
principal sensory
trigeminal nucleus
(ventrolateral part)
prepositus hypoglossal
nucleus
paraventricular nucleus
pyramidal tract

PH
Pir

PMV
PN
PnC
PnO
PPTg
PR

PrSDM
PrSVL
PrH
PVN

PY
R

RLi
RMg
ROb
RPa

red nucleus
rostral
linear
raphe
nucleus
nucleus raphe magnus
nucleus raphe obscurus
nucleus raphe pallidus

nucleus raphe pontis
retrorubral field
reticulotegmental pontine nucleus
rostroventrolateral
reticular nucleus

spS
Sp SO
SPTg

VLL
VM
VMH

VP
VTA
VTG

xscp

decussation
of
the
superior
cerebellar
peduncle

ZI

zona incerta
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Fig. 16. Fluoro-Gold Injection Sites: Fluoro-Gold injection sites in
the six rats used in this study.
Drawings of coronal sections
(designated a-f in upper left of schematic) are adapted from Paxinos and Watson (1986).
Numbers at lower left of each drawing
indicate distance in mm from the interaural plane.
Colchicinetreated rats are indicated below with an asterisk.
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Fig.

17.
Localization of Retrogradely Labeled Cells Following MR
Fluoro-Gold Infusions:
The loci of neurons which were labeled
bilaterally following an FG injection into the MR in rat FLG-12
(colchicine treated) are plotted on drawings of coronal sections
(designated a-t in upper left of schematic) are adapted from Paxinos and 'Watson (1986).
Numbers at lower left of each drawing
indicate distance in mm from the interaural plane. The injection
site is indicated by the blackened area in the MR (see sections
m-o) and illustrated in Fig. 16 c-e and 18 f.
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llO

Fig. 18.
Representative Photographs of Fluoro-Gold Labeled Neurons:
Photomicrographs (x250; except in f where magnification was xl60)
of: a) medial frontal cortex; b) horizontal limb of the diagonal
band of Broca; c) lateral habenular nucleus; d) laterodorsal
tegmental nucleus; e) medial nucleus of the cerebellum; and, f)
injection site. Representative Fluoro-Gold labeled cells in each
section are indicated with arrows. Drawings of coronal sections
are adapted from Paxinos and Watson (1986).
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Diencephalon
Fluoro-Gold labeled neurons were found be distributed discretely
within the following diencephalic regions:

the lateral habenular nu-

cleus, the ventromedial thalamic nucleus, and the hypothalamus.

Epithalamus

The diencephalic region which contained the greatest number of
retrogradely

filled

17h,i; Fig. 18c).

cells

was

the

lateral

habenular

nucleus

(Fig.

No FG-labeled neurons were observed in the adjacent

medial habenular nucleus.

An occasional labeled cell was found em-

bedded within the stria medullaris, just dorsal to the habenular complex.

Dorsal Thalamus

The ventromedial nucleus was

the only dorsal

found to contain retrogradely labeled neurons
these

cells were

(Fig.

thalamic nucleus
17h-j).

Most of

clustered around the mammillothalamic tract.

This

group of labeled neurons also seemed to be continuous with those found
more posteriorly in the prerubral fields.

Sub thalamus

A number

of FG- labeled cells were encountered within the zona

incerta (Fig. 17g-j) and the area immediately surrounding the mammillothalamic tract.
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Hypothalamus
A number of areas within the hypothalamus (Fig. 17g-j) were. found
to contain retrogradely labeled neurons.
lateral,
nuclei.

ventromedial,

dorsomedial,

These included the anterior,

paraventricular,

and mamrnillary

The densest number of labeled cells were localized throughout

the lateral hypothalamic area and the mammillary region.

A number of

cells were found surrounding the fornix.
Mesencephalon
FG filled neurons were observed in the region just dorsal and
lateral to the posterior commissure (Fig. 17j).

Cells were observed

ventral to the posterior commissure, immediately lateral to the third
ventricle and dorsal to the nucleus of Darkschewitsch.

This latter

nucleus also was found to contain a few labeled neurons (Fig. 17k).
The ventral tegmental area (Fig.17j-l) contained a large number
of labeled cells.

A few FG-filled neurons also were found in the

substantia nigra, pars compacta (Fig. 17j,k).
A large number of retrogradely labeled cells were found more
caudally in the midbrain (Fig. 17i-o), especially in the central gray,
the superior colliculus, the deep mesencephalic nucleus lateral to the
red nucleus, and the interpeduncular nucleus.

A few labeled cells also

were found in the medial geniculate, the anterior pretectal nuclei, and
the inferior colliculus.
The rostral rubral field contained FG filled neurons, as did the
rostral and caudal linear raphe nuclei.

The dorsal raphe (DR) nucleus

contained FG-labeled neurons as did all portions of the MR surrounding
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the

A few labeled cells were seen in the

injection site.

ventral

tegmental nucleus of Gudden.

Metencephalon

At pontine levels a large number of retrogradely labeled cells
were found in the nucleus raphe pontis, and in both the oral and caudal
Scattered cells

parts of the pontine reticular nucleus (Fig. 17m-q).

could be seen in the ventral nucleus of the lateral lemniscus, and in
the reticulopontine tegmental, and subpedunculotegmental nuclei.

Some

FG-filled neurons were found in the cuneiform nucleus and in the pedunculopontine and adjacent microcellular tegmental nuclei.
More

caudally,

the

laterodorsal

tegmental

tained a prominent number of FG-filled cells
Labelled cells also were found in the motor,
notably,

nucleus

(Fig.

(LDTg)

17p,q;

con-

Fig 18d).

motor nucleus, and most

in the principal sensory nucleus (ventrolateral part) of the

trigeminal complex
labeled neurons

(Fig.

were

17p,q).

observed

to

In colchicine treated rats,
send dendri tic

processes

these

into

the

adjacent dorsal tegmental nucleus of Gudden and trigeminal nuclei.

Cerebellum

A number of retrogradely labeled cells were detected within the
medial nucleus of the cerebellum (Fig.

17s; Fig. 18e).

only cerebellar region found to contain FG-filled cells.

This was the
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Myelencephalon
At medullary levels

(Fig.

17q-t),

scattered FG-filled

~eurons

were detected in the nucleus raphe magnus, pallidus, and obscurus; the
medial and lateral vestibular nuclei; and the prepositus hypoglossal
nucleus.

Within the medullary reticular formation, labeled cells were

found in the gigantocellular and lateral paragigantocellular nuclei.
Lower Medulla and Spinal Cord
FG-labeling in the lower medulla and spinal cord was investigated
in only one rat (FLG-13).

A few (1-3/nucleus) labeled cells were found

in: the rostroventrolateral reticular nucleus; the dorsal and ventral
medullary reticular field; the nucleus of the solitary tract (bordering
the dorsal motor nucleus of the vagus); the dorsal and paramedian reticular nuclei; the lateral reticular nucleus; layers 3, 5, 7, 8 of the
cervical cord;

the central cervical nucleus;

layers 2 and 8 of the

thoracic cord; and, along the border of layers 4 and 10 of the lumbar
spinal cord.
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. Experiment II: Neurokinin Fiber Staining

Representative sections depicting immunocytochemical staining for
neurokinin fibers are shown in Fig.

19.

SP- and neurokinin-like im-

munoreactivity (SPLI and NKLI, respectively) were found within the MR,
the DR,

the interpeduncular nucleus, and within the principal sensory

trigeminal nucleus.

Results with the anti-SP and anti-NKA antisera

were virtually identical.

Controls

In order to test the specificity of the primary antibodies used,
sections

through

the

interpeduncular nucleus,

dense neurokinin fiber network,

which contains a

very

were incubated with primary antibody

and with primary antibody which had been preabsorbed with the respective antigen
shows

the

(SP and NKA;

100 µg/ml

immunocytochemical

of diluted antibody).

staining

obtained

with

the

Fig.

20

unabsorbed

antisera (a) and the absence of staining with the preabsorbed primary
antisera (b).
Previous cross-absorption studies with the SP2 and NKA2 primary
antibodies

indicated

that

the

immunoreactivity

was

still

observed

following preabsorption of the SP2 antiserum with NKA or NK.B.

Pre-

absorption of the NKA2 antibody with SP did not affect the fiber labeling, but preabsorption with NK.B did eliminate it (Brodin et al., 1986).
Cross-absorption studies with the commercially obtained anti-SP antibody indicated a 5-10% cross-reactivity with NKA and no apparent crossreactivity with NKB (Dr. Mary Frick,
cation,

1988).

Incstar,

Inc., personal communi-

Substitution of the primary antibodies with diluent

(omit controls), eliminated all staining.
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Fig.

19.
Neurokinin-Like Immunoreactive Fibers:
Photomicrographs
(x250) of sections through a) the median raphe nucleus (MR), and,
b) the principal sensory trigeminal nucleus (PrSVL). The MR section was incubated with the rabbit anti-NKA primary antibody,
whereas the PrSVL section was incubated with the rabbit anti-SP
antiserum.

b
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Fig.

20.
Preabsorbed Control:
Photomicrographs (x250) of sections
through the interpeduncular nucleus (IPN) stained with a rabbit
anti-SP antibody without preabsorption (a), and following absorption overnight with SP.
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Experiment III: Neurokinin Perikarya Staining
In order to determine whether our immunocytochemical proeedures
would enable us to visualize neurokinin immunoreactive cell bodies,
sections through the rat dorsal root ganglia were processed for study.
Ganglia were obtained from an untreated and an intrathecally colchicine
pretreated rat.

Fig. 21 shows the localization of both SPLI and NKLI

within the dorsal root ganglia.
The results of the immunocytochemical staining of neurokinin cell
bodies in the CNS are shown in Fig. 22.

SPLI and NKLI-perikarya were

observed in a number of regions previously reported to contain SP or NK
reactive perikarya.

The best staining was found in the following re-

gions: the rostral central gray, the interpeduncular nucleus, the dorsal raphe nucleus, and the laterodorsal tegmental nucleus.

Fig. 22

shows immunoreactive cells in the medial habenular nucleus, interpeduncular nucleus, the rostral central gray, and the laterodorsal tegmental
nucleus.

Occasional SPLI and NKLI cells also were encountered within

the septum,

the paraventricular nucleus, the caudate-putamen, and the

lateral hypothalamus.
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Fig.

21.
Neurokinin-Like Immunoreactivity in Dorsal Root Gan~lia:
Photomicrographs (x250) of SP-immunoreactive cells and fibers in
the dorsal root ganglia following incubation with the rabbit anti-SP antibody in a colchicine-treated (a), and an untreated rat
(b).
Photomicrograph (x250) of an NKA-immunoreactive cell following incubation with the rabbit anti-NKA antiserum is shown in
(c).
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a

b

c
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Fig.

22 (a-d).
Neurokinin-Like Immunoreactive Perikarya :
Photomicrographs (xl60 in a and b; x250 in c and d) of SP-immunoreactive
cells, from colchicine-treated rats, following incubation of the
tissue sections with the rabbit anti-SP antibody.
Sections are
through: a) the medial habenular nucleus (MHb); b) the interpeduncular nucleus (IPN); c) the rostral central gray (CG); and,
d) the laterodorsal tegmental nucleus (LDTg) .
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a

b
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Combined Fluoro-Gold and Neurokinin Immunocytochemistry

The brains
into the MR,

from two rats which had received an infusion of FG

and colchicine treatment one week later, were processed

for immunocytochemistry.
been

found

to

give

medial

habenular

raphe,

the

cleus.

Sections were saved through regions which had

adequate

nucleus,

staining for neurokinin perikarya:

the

rostral central gray,

With the

interpeduncular

nucleus,

the

exception of the medial habenular nucleus,

the appropriate filter combination,

cases

viewing of a

all of
By using

separate populations of either FG

or FITC labeled cells could be discerned in each region.
cut

dorsal

and the laterodorsal tegmental nu-

these regions were found to be the source of MR afferents.

clear

the

of doubled-labeled neurons.

In one

There were no
case,

initial

section through the laterodorsal tegmental nucleus sug-

gested the possibility of a doubled-labeled cell which was not verified
upon subsequent viewing.

Although it is possible that the fluorescence

may have faded, staining of the laterodorsal tegmentum in another animal did not reveal any double-labeled neurons.

Fig. 22 (e,f) shows a

section through the dorsal raphe photographed using the filter combinations for visualization of FG and FITC.
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Fig. 22 (e,f). Combined Retrograde Labeling and Neurokinin Irnrnunocytochemistry:
Section through the dorsal raphe (DR) showing SPirnrnunoreactive and FG-filled neurons.
Section was photographed
(x250) to visualize FITC (e) and FG-labeled cells (f). Note that
the FG-labeled cells (black arrows in f) are not visible in e.
Although some "bleed-through" of the fluorescence can be seen,
the FITC labeled cells (white arrows in e) are not visible in f.

CHAPTER V
DISCUSSION
The purpose of this dissertation project was to investigate the
functional relationships between neurokinin and 5-HT neuronal processes
within the median raphe nucleus (MR) of the rat midbrain.

The first

series of experiments studied the behavioral effects following tachykinin injections into the MR.

It was found that activation of two dif-

ferent neurokinin receptors (NK-2 and NK-3) could elicit locomotor hyperactivity, and that agonists (NKB and senktide) selective for the NK-3
site were ten times more potent than agonists (NKA) selective for the
NK-2 site.

Lesions made with 5,7-DHT confirmed that the hyperactivity

produced by neurokinin injections into the MR depend on the integrity
of MR 5-HT neurons.

The hyperkinesis produced by activation of NK-2,

but not NK-3, sites may be mediated, at least in part, by 5-HT projections to the forebrain.

Analyses of animals' behavior in an open field

suggested, furthermore, that the behavioral changes elicited by MR injections of the neurokinins depend on the degree of familiarity or
novelty of the environment.
Using a retrograde tracing technique and immunocytochemistry, the
second series of experiments examined the origin of the neurokinin
innervation to the MR.

The MR was found to receive afferent projec-

tions from many discretely localized brain structures.

Immunocytochem-

ical studies confirmed that the MR contains SP-like and neurokinin-like
132
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immunoreactive fibers.

Analyses of the combined immunocytochemical and

retrograde labeling data suggested, furthermore, that the forebrain is
the source of the neurokinin innervation to the MR.

A. Behavioral Studies
Dose-Response Analysis of Intra-MR Neurokinin Infusions
The
determine

first

series

of experiments were undertaken in order to

the relative rank order of potency for intra-MR injected

tachykinins

to

induce

locomotor

hyperactivity.

The

dose-response

analyses suggest that hyperkinesis can be elicited by activation of two
different neurokinin receptors.

At the NK-2 site, NKA was more potent

than SP and the non-mammalian tachykinins,
senktide was more potent than DiMe-C7.

while at the NK-3 site,

Importantly, the hyperactivity

produced by intra-raphe infusions of neurokinin B (3.0 pmol) was equivalent to that produced by an equimolar dose of senktide.

The results

suggest that activation of NK-2 and NK-3 receptors in the MR lead to
elevations in the level of behavioral arousal.

Intra-MR neurokinin-

induced hyperactivity, moreover, may provide a novel in-vivo model for
studying NK-2

and NK-3

receptor activation

in the central nervous

system of the rat.
Stoessl et al. (1987 a,b) have reported that peripheral or intracisternal infusions of senktide produce the classical "serotonin-syndrome" (head twitching, forepaw treading, hind limb splaying) in both
rats and mice.

The experimental procedure used for measuring LMA in

the present study (a darkened photocell chamber) does not permit one to
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differentiate photocell breaks produced by locomotion from those produced by stereotypic movements.

However, the analyses of the rats' be-

havior in an open field following the intra-MR injection of DiMe-C7,
NKA and senktide indicated that the animals were not engaged in any of
these
trast,

"serotonin-mediated"

or other

types of stereotypies.

In con-

the animals exhibited an increase in a variety of exploratory

behaviors, such as walking, rearing, sniffing, and head poking.
The non-mammalian tachykinins,

ELE,

KAS,

and PHY,

all produced

increases in LMA, although ELE was the most potent and the most efficacious.

Binding studies indicate that radiolabeled ELE labels NK-3

binding sites in rat brain (Bergstrom et al., 1987; Glowinski et al.,
1987).

Isolated peripheral tissue preparations, such as the rat portal

vein, are sensitive to low doses of both
1987; Mastrangelo et al., 1986).

NKB and ELE (Drapeau et al.,

However, this assay also is sensitive

to KAS, suggesting that this in-vitro preparation does not necessarily
reflect binding potencies or pharmacodynamic interactions within the
CNS.
Senktide was the most potent (minimum effective dose:

3.0 pmol)

and the most efficacious neurokinin analogue to elicit hyperactivity.
The relative

potencies of the neurokinin agonists were:

NKB) > DiMe-C7, and NKA >>SP.

senktide

(-

Radiolabeled senktide was developed as

a selective NKB agonist (Laufer et al., 1986a; Wormser et al., 1986),
and binds to NK-3 sites in rat brain.

Thus, the data suggest that the

intra-raphe effects of senktide on LMA are mediated by NK-3 receptors.
Infusions of 3.0 pmol

NKB, equimolar to the lowest dose of senk-

tide which produced a significant increase in LMA,

induced locomotor
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hyperactivity which was equivalent to that of senktide.

Since it was

necessary to dissolve NKB in a formic acid vehicle, the experiment was
limited to a single injection.

The morphology of the cells immediately

surrounding the cannula tips in rats which received either the formic
acid vehicle or NKB infusions was identical to that seen in rats infused with other compounds.

However, in a few instances, a thin "halo"

(approximately 0. 2 mm thick) , devoid of perikarya, was observed surrounding

the

cannula

tips.

Nevertheless,

the

infusions alone did not affect I.MA (see Fig. 8).

formic acid vehicle
These results cor-

roborate those obtained with senktide.
Activation of an.NK-2 or NK-3 receptor in the MR of the rat leads
to an increase in behavioral arousal.

Neurokinin-like fibers (but not

cell bodies) and receptors have been observed in the MR.

The effects

of the neurokinins, in contrast to those of intra-MR infused muscimol,
depend upon intact 5-HT neurons (Paris and Lorens, 1987 a,b; and present study).

This suggests that NKA and NKB projections to the raphe

modulate 5-HT neuronal activity.
Although MR NK-2 receptor activation leads to locomotor hyperactivity, it should be noted that the presence of NK-2 receptors in the
CNS has been questioned (Glowinski et al., 1987; Saffroy et al., 1988).
It must be emphasized, furthermore,

that without the availability of

non-neurotoxic neurokinin antagonists, one can only utilize the relative potencies of the various agonists to identify the possible receptor(s) involved.
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MR and Medial Forebrain Bundle 5.7-DHT Lesions
Infusion of the SP analogue, DiMe-C7, into the MR produces dosedependent increases in LMA which can be blocked by pretreatment with
~

the tryptophan hydroxylase inhibitor, PCPA, and by MR 5,7-DHT lesions
(Paris and Lorens,

1987 a,b).

One of the objectives of the present

study was to determine if 5, 7-DHT lesions of the MR would similarly

r

t:~·

block the effects of intra-raphe infusions of senktide and NKA.

Doses

which previously were determined to produce equivalent increases in LMA
(see Fig. 4), were administered to rats two weeks following 5, 7-DHT
lesions of the MR.

t- ..

1
,,

These lesions completely blocked the hyperactivity

produced by the intra-raphe neurokinin infusions.

In order to test

whether 5-HT projections to the forebrain mediate the LMA effects of
intra-MR infused neurokinins, 5,7-DHT was injected bilaterally into the
medial forebrain bundle (MFB), anterior to the DA cell bodies of the
rostroventral midbrain tegmentum.

These lesions, in contrast to the

5,7-DHT lesions of the MR, did not block the hyperactivity produced by
the

intra-raphe

injections

of

senktide

and DiMe-C7,

appeared to attenuate the hyperactivity produced by NKA.

although

they

These results

indicate that intra-raphe neurokinin induced hyperactivity produced by
activation of NK-3 receptors depends on the integrity of 5-HT neurons
in the MR, but not on the 5-HT fibers which ascend through the MFB to
innervate the forebrain.
hyperactivity may

On the other hand, NK-2 receptor mediated

depend in part upon 5-HT fibers which innervate

forebrain regions.
Since the MFB 5, 7-DHT lesions were placed in the lateral hypothalamus, rostral to the DA cell bodies in the ventral tegmental area
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(VTA) and substantia nigra (SN), it is possible that 5-HT projections
to these structures are critical for intra-MR neurokinin induced effects on LMA.

The DA neurons in the substantia nigra (A9) and rostro-

ventromedial mesencephalon (AlO), and the forebrain regions they innervate, have been implicated in the regulation of motor function (Le Moal
et al., 1975; Koob et al., 1981; Bannon and Roth, 1983; Oades et al.,
1986; Oades and Halliday, 1987).

The DA neurons in the VTA, futher-

more, are innervated by neurons of the MR, and have been shown by electron microscopy to receive synaptic contacts from 5-HT axon terminals
(Herve et al., 1987; Oades and Halliday, 1987).

Thus, a neurokinin---

5-HT---DA circuit which mediates behavioral arousal can be postulated.
In fact, we have unpublished data which shows that a low dose of the DA
antagonist, haloperidol (200 µg/kg, i.p.), can block the LMA effects of
intra-MR DiMe-C7.
This system is distinct from the direct neurokinin-VTA projection
which modulates LMA (Stinus et al., 1978; Kelley et al., 1979, 1985;
Kalivas et al., 1985; Elliott and Iversen, 1986).

Since the hyperac-

tivity produced by intra-raphe infusions of neurokinins can be blocked
by ibotenic acid lesions of the MR, the neurokinin-raphe induced increases LMA is not due to diffusion of the neurokinins to the adjacent
VTA.

In order to determine whether a MR-5-HT---VTA-DA link is critical

for intra-MR neurokinin induced hyperactivity, it would be necessary to
perform lesions of the VTA with the catecholamine neurotoxin, 6-hydroxydopamine (60HDA).
Alternatively,

These studies are in progress.
it is possible

that the intra-raphe neurokinin

induced increase in LMA is mediated by a descending 5-HT projection.
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The MR has been shown to send 5-HT as well as non-5-HT projections to
the nucleus raphe magnus and obscurus in the rat, and the reticular
formation and raphe pallidus
Bobillier et al.,

1975;

in the cat (Brodal et al.,

1960 a, b;

Gallager and Pert, 1978; Beitz, 1982).

direct spinal projections from the MR have been observed,

No

although

projections to cervical levels originating in the reticular formation,
just lateral to the MR, have been reported (Bowker et al., 1981).
The MR 5, 7-DHT lesions led to increases in amygdaloid DA and
DOPAC levels and to increased DOPAC levels in the medial frontal cortex
(Table III).

No changes in DA or DOPAC levels were found in the nucle-

us accumbens or neostriatum.

These observations suggest that damage to

MR 5-HT neurons results in enhanced DA utilization in select forebrain
regions and support the view that 5-HT fibers modulate the activity of
mesencephalic DA neurons.

The increases in DOPAC levels in the medial

frontal cortex are in contrast to those observed following electrolytic
lesions of the MR (Herve et al., 1981).

This discrepancy, however, may

be due to the non-specificity of electrolytic lesions as a technique to
deplete 5-HT concentrations (Lorens, 1978).

Although 5-HT neurons are

known to innervate the basal ganglia, the MR 5, 7 -DHT lesions did not
affect the DA and DOPAC levels in the neostriatum.
in

agreement

with

results

obtained

(Dray, 1981; Soubrie et al., 1984).

following

This observation is
electrolytic

lesions

In fact, only electrolytic lesions

of both the dorsal and median raphe nuclei have been observed to produce transient changes in striatal DOPAC levels (Juorio and Greenshaw,
1986).
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The 5,7-DHT injections into the MFB, following pretreatment with
the NE and DA reuptake inhibitor, nomifensine, produced falls in the
DA, DOPAC, and NE levels in all the areas assayed, except the amygdala,
suggesting incomplete protection of catecholamine neurons.

The de-

creases in catecholamine parameters were between 20-40% and not nearly
as great as those for 5-HT and 5-HIAA.

The decreases in catecholamine

levels, however, were not as extensive as that observed with MFB lesions with no pretreatment (Waddington and Crow, 1979).
al.

Baumgarten et

(1981) have suggested that a combination of nomifensine and des-

methylimipramine may provide optimal selectivity of 5, 7-DHT for 5-HT
neurons.

However, it is important to point out that although the MFB

lesions did produce 20-40% falls in forebrain catecholamine and metabolite levels,

these lesions did not block the I.MA effects of intra-

raphe infusions of the neurokinins.
The data from the present study indicate that raphe NK-2 and NK-3
receptor mediated hyperactivity depends upon 5-HT neurons.

The results

suggest that a 5-HT projection to the DA cell bodies of the ventral
tegmental area may be important.

Alternatively, a 5-HT projection to

other brain stem sites cannot be ruled out.
tivity,

on the other hand, may depend,

NK-2 mediated hyperac-

in part, upon ascending 5-HT

fibers.

B. Anatomical Studies
The present series of experiments were undertaken in order to
thoroughly examine

the origin of the afferents to the MR with the

eventual goal of determining the source of its neurokinin innervation.
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The optimal method for accomplishing these goals
gradely transported fluorescent dye,
immunofluorescence method of Coons
berg,

is to use a retro-

in combination with the indirect

(1950, 1958; Bjorklund and Skager-

1979; van der Kooy and Steinbusch,

1980;

Skirboll and Hokfelt,

1983; Skirboll et al., 1984; Shiosaka and Tohyama, 1986).

Fluorescent

tracers have been shown to provide the most sensitive method for visualizing retrogradely

labeled neurons

(Skirboll et al.,

1984).

The

fluorescent dye chosen to study the afferent projections to the MR was
Fluoro-Gold

(FG).

excitation,

is

This

dye can be visualized following ultraviolet

intensely fluorescent,

has a high signal-to-noise ratio,
excellent dendritic

filling,

extremely resistant to fading,

does not leak from cells,

produces

and can be readily combined with other

fluorescent dyes and tracing methods

(Schmued and Fallon, 1986; Wes-

sendorf et al., 1987; Reep et al., 1988).

Initially, we dissolved FG

in double-distilled water and injected small (25-75 nl) volumes using
30 gauge tubing and a microsyringe pump.

Despite the small volumes

infused, this method resulted in extensive diffusion of the dye out of
the MR and along the injection tubing.
cation adopted was

Therefore, the method of appli-

to iontophorese the FG solution.

produced very small,

well demarcated injection sites

This procedure
(see Fig.

17f)

with no diffusion along the micropipette track or into adjacent structures.
FG can be taken up and retrogradely transported by cut or damaged
neuronal processes but not by intact fibers (Schmued and Fallon, 1986).
Since fiber systems pass through and just lateral to the MR, it is possible

that

the

FG may have been taken up by fibers

damaged by the
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However,

micropipette.
very minimal

because

this type of non-specific uptake was probably

the

concentration of

the

FG

solution was

low

(2.0%) and the injection sites were very discrete (Schmued and Fallon,
Nevertheless,

1986).

the sources of the afferent projections to MR

observed in the present study should be corroborated by employing an
anterograde tracer, such as Phaseolus vulgaris leucoagglutinin (PHA-L).
Little attention has been focussed on the afferent inputs to the
In fact,

MR in the rat.

only one systematic retrograde tracing study

has been reported (Aghajanian and Wang, 1977).

This was the first and

only attempt we are aware of to document the source of the afferents to
the midbrain raphe nuclei.
the afferents
formation.
Wang

However, this study qualitatively compared

to the MR with those to the DR and pontine reticular

The present study differs from the work of Aghajanian and

(1977)

retrograde

marker

(Schmued and

1986)

used

semi-quantitative

and

We employed a more sensitive

in a number of respects.

a

fallon,

1986;

approach

Shiosaka and Tohyama,
to

map

the

perikaryal

origins

of MR afferents

in coronal sections obtained throughout the

brain.

The density of the various projections was inferred from the

number of labeled cells found within a given structure.

The data are

diagrammed in Fig. 17 and are discussed below by region.
The regions found to contain to greatest numbers of retrogradely
labeled cells included: the medial frontal and cingulate cortices, the
septal area,

the ventral pallidum/substantia innominata,

the lateral

habenular nucleus, the zona incerta, the lateral habenular nucleus, the
lateral hypothalamus,

the

interpeduncular nucleus,

and the laterodorsal tegmental nucleus.

the central gray,

Retrogradely labeled neurons
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were conspicuously absent from a number of major forebrain structures,
including:

the caudate-putamen,

the nucleus accumbens,

the amygdaloid

complex, the hippocampal formation, and entorhinal cortex.

Cortical Afferents

The

only

FG-labeled

cells

found

located in the medial frontal cortex,

in

the

cerebral

cortex were

and in the medial wall of the

Projections from these areas to the raphe have been

cingulate gyrus.

described previously (Leonard, 1969; Aghajanian and Wang, 1977; Dr. E.

J. Neafsey, personal communication, 1988).

Pre-frontal cortical stimu-

lation also has been reported to affect the firing rate of raphe neurons (Hardy and Haigler, 1985).

Since an aspartatergic projection from

the frontal cortex to the ventral tegmental area has been suggested
(Christie et al., 1985), it is possible that the corticoraphe projection also may be aspartatergic.

Al though the MR has been shown to

project extensively to other areas of the cerebral cortex,

including

the parietal and occipital regions, only the medial frontal and cingulate cortices were found to send fibers back to the MR (O'Hearn and
Molliver,

1984;

Parnavelas

et

al.,

1985;

Waterhouse

Kosofsky and Molliver, 1987; Molliver, 1987).

Notably,

et

al.,

the number of

FG-labeled cells in these regions was very large (see Fig 17a-g).
possible

function

of

cortical-raphe

below (see pp. 179-180).

interactions

will

1986;

be

The

discussed
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Septal Afferents

FG filled cells were found in the dorsal and intermediate parts
of the lateral septal area, in the medial septal nucleus,

in the vert-

ical and horizontal limbs of the diagonal band of Broca, and in the bed
nucleus of the stria terminalis.

These observations confirm previous

reports of efferents from these structures to the MR as demonstrated by
the retrograde transport of the fluorescent tracer true blue,

and by

the anterograde transport of PHA-L and [3H]leucine (Swanson and Cowan,
1979; Swanson, 1982; Tomimoto et al., 1987).

In the present study, the

largest number of labeled cells observed in the septa! region were localized in the horizontal limb of the diagonal band, with minor contributions from the remaining septa! nuclei.
disagree

with

the

results

obtained by

This observation appears to
Aghajanian

and Wang

(1977).

These authors reported a minor projection from the diagonal band to the
MR, and an apparently insignificant projection from the bed nucleus.

Basal Forebrain

The results indicate that afferents to the MR originate in the
ventral pallidum, lateral preoptic area, and the rostral portion of the
Afferents to the MR from this portion of the

substantia innominata.
rat

forebrain have been observed by some but not all authors.

instance,

Swanson et al.

medial preoptic area.

For

(1987) reported afferents to the MR from the

However, their PHA-L injection included parts of

the nucleus of the diagonal band and lateral pre-optic area which may
have confounded their results (Swanson et al., 1987).
PHA-L confined to the substantia innominata,

An injection of

as well as an injection
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into the caudal portion of the lateral preoptic area resulted in labeled fibers
1984).

and terminals

in the region of the MR (Swanson et al. ,

These observations have been confirmed by several other labor-

atories (Aghajanian and Wang, 1977; Tomimoto et al., 1987).

A projec-

tion to the MR which originates in the ventral pallidal region also has
been described by Haber et al.
of tritiated amino acids.
along

the

reticular

outermost
formation

(1985) using the anterograde transport

These authors also observed a few fibers

lateral border

of

the

MR

following an injection of

and

adjacent

tritiated amino acids

into the globus pallidus (dorsal pallidum; Haber et al., 1985).
gradely labelled neurons
present study,

in these

regions

pontine

Retro-

were not observed in the

perhaps due to the discrete FG infusions into the MR.

The lack of retrogradely labelled neurons in the globus pallidus also
has been noted by others (Aghajanian and Wang, 1977).

Habenular Complex

The results confirmed that a large number of cells in the lateral
habenular nucleus project to the MR.
a portion of the
1982),

reach

These projections, which comprise

dorsal diencephalic

conduction system

the midbrain via the fasciculus

retroflexus

(Sutherland,
(Akagi and

Powell, 1968; Pasquier et al., 1976; Aghajanian and Wang, 1977; Herkenham and Nauta, 1979).

These habenuloraphe fibers may pass through or

around the interpeduncular nucleus
and Nauta,

1979).

(Akagi and Powell, 1968; Herkenham

The principal target for medial habenular nucleus

efferents is the interpeduncular nucleus (Herkenham and Nauta, 1979).
Following

an

injection

of

tritiated

amino

acids

into

the

medial
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habenular nucleus,

Herkenham and Nau ta

terminals within the MR.

( 1979)

also found fibers

and

This observation is in disagreement with the

present and other studies (Pasquier et al., 1976; Aghajanian and Wang,
1977).

It should be noted, however, that in the present study, in all

cases, one or two weakly labelled cells were found in the very dorsolateral

portion

lateral nucleus.

of

the

medial

Therefore,

habenular

nucleus,

bordering

on

the

it is possible that a few neurons in the

medial habenular nucleus project to the MR as suggested by Herkenham
and Nauta (1979), but not to the extent to which they describe.

Dorsal Thalamus

The only dorsal thalamic region found to project to the MR was
the ventromedial nucleus.

Although earlier studies have reported a

projection from the DR to the ventromedial thalamic nucleus (Herkenham,
1979), there are no reports of any connections between this nucleus and
the

MR.

afferents

Shammah-Lagnado
to

the pontine

and

colleagues

reticular

(1987),

formation

however,

from a

group

observed
of cells

bordering the zona incerta and the ventromedial thalamic nucleus.

Zona Incerta

A significant projection from
identified.

Although efferents

the

zona

incerta to

from the midbrain raphe

the MR was
to

the zona

incerta have been described (Shammah-Lagnado et al., 1985), efferents
from this

region to the raphe have not been observed,

except for a

projection to the nucleus raphe magnus (Carlton et al., 1983).

,
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Hypothalamus

In the present study,
following hypothalamic
lateral nucleus;

FG-filled neurons were visualized in the

regions:

the

anterior hypothalamic

area;

the

the paraventricular nucleus; the dorsomedial nucleus;

the ventromedial nucleus;
mammillary complex.

the posterior hypothalamic

Aghajanian and Wang

(1977)

area;

and,

the

described afferents

which originate in the anterior hypothalamic nuclei and terminate in
the

midbrain

reticular

formation but not

in

the

MR.

Hypothalamic

afferents to the pontine reticular formation also have been reported by
other

investigators

(Shammah-Lagnado et al.,

1987).

Saper and col-

leagues (1979) demonstrated lateral hypothalamic projections to the MR
in the rat.

Labeled fibers have been observed in the MR following the

injection of tri tiated amino acids

into the dorsomedial hypothalamus

and into the premammillary region (Krieger et al.,
al.,

1984).

Tritiated amino

acid injections

1979;

into

Swanson et

the ventromedial

hypothalamus labeled fibers in the DR but not in the MR (Krieger et al,
1979).

Projections from the paraventricular nucleus to the brain stem

also have been reported

(Armstrong et

al.,

1980;

Conrad and Pfaff,

1976), but paraventriculoraphe connections have not.
FG-labeled perikarya were visualized throughout
complex.

Following the

the mammillary

injection of tritiated amino acids

into the

mammillary nuclei, Cruce (1977) observed labeled fibers in the lateral
border of the MR, as well as in the ventral and dorsal nuclei of Gudden, but found no evidence for synaptic terminals.
projections appear to be reciprocated (Shibata, 1987).

These mammillary
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Substantia Nigra and Ventral Tegmental Area
A projection to the MR from the pars compacta of the substantia
nigra, which contains the A9 DA cell group (Dahlstrom and Fuxe, 1964),
was identified in the present study.

Nigroraphe connections have been

reported previously (Pasquier et al., 1977; Fallon and Loughlin, 1985).
In comparison to its projection to the DR, however, the nigral projection to the MR appears to originate in only a few cells (see Fig.
17j,k).
In contrast to the substantia nigra, the ventral tegmental area,
which contains the AlO DA cell group (Dahlstrom and Fuxe, 1964), was
found to send a significant projection to the MR.

Ventral tegmental DA

and non-DA projections to the MR have been reported by others (as reviewed in Oades and Halliday, 1987).
The retrorubral field, which includes the AS DA cell group (Dahlstrom and Fuxe, 1964), the rostral and caudal linear nuclei, and the
interfascicular nucleus also are the source of afferents to the MR.
These projections have been observed previously and most likely are DA
and non-DAergic in nature (Fallon and Loughlin, 1985).
Central Gray and Cuneiform Nucleus
Projections from the periaqueductal gray and adjacent cuneiform
nucleus were noted in the present study.

Although these regions have

been reported to receive projections from the midbrain raphe, reciprocal connections have not been observed (Conrad et al., 1974; Andrezik
and Beitz, 1985).

However, both of these regions appear to project to

the nucleus raphe magnus (Beitz, 1982; Carlton et al., 1983; Lakos and
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Basbaum, 1988).
1982).

Some of these fibers may contain neurotensin (Beitz,

Since the midbrain raphe contains neurotensin fibers and bind-

ing sites (Kessler et al., 1987; Shipley et al., 1987), it is possible
that afferents to the MR which originate in the central gray are neurotensinergic.
Interpeduncular Nucleus
The interpeduncular nucleus (IPN) is a major source of afferent
fibers to the MR.

Recently, Groenewegen and colleagues (1986) detailed

the cytoarchitecture and fiber connections of the IPN.
that the MR is one of the major targets for IPN efferents.

They reported
These raphe

projections originate in distinct IPN subnuclei (Groenewegen et al. ,
1986).

In the present study, retrogradely labeled neurons were found

throughout the IPN.

There also is some evidence that the projection

from the IPN to the MR is excitatory (Maciewiez et al., 1981).
Gudden's Tegmental Nuclei
In the present study, numerous FG-labeled perikarya were found in
the ventral tegmental nucleus of Gudden (VTG).

This observation is in

agreement with reports which describe reciprocal connections between
the MR and the VTG (Morest, 1961; Petrovicky, 1973, 1985 a,b).

Al-

though the dorsal tegmental nucleus of Gudden (DTG) has been reported
to project to the MR (Morest,

1961; Petrovicky, 1973), we failed to

observe any retrogradely labeled neurons

in the DTG.

However,

as

described below, the adjacent laterodorsal tegmental nucleus does send
a massive projection to the MR.

The DTG and VTG, however, both project
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to

the

adjacent pontine reticular formation

(Petrovicky,

1985 a,b;

Shammah-Lagnado et al., 1987).
Reticulotegmental Nucleus
Based on

the number of labeled cells discerned,

the pontine

reticulotegmental nucleus (RTg) is the source of a minor projection to
the MR (see Fig. 17m-o).

The major target of RTg efferents is the

cerebellum (Flumerfelt and Hrycyshyn, 1985).

RTg projections to the MR

have not been described previously.
Pedunculopontine and Microcellular Tegmental Nuclei
The pedunculopontine tegmental nucleus (PPTg) was found to send
projections

to the MR.

The PPTg is located in the "mesencephalic

locomotor region" (Skinner and Garcia-Rill, 1984; Garcia-Rill et al.,
1987).

Although it has been reported to project to other mesencephalic

structures, such as the ventral tegmental area, the substantia nigra,
the superior colliculus, and periaqueductal gray (Steeves and Jordan,
1984; Garcia Rill et al., 1987), PPTg projections to the MR have not
been previously described.
innervate

The PPTg contains cholinergic neurons which

the substantia nigra as well as the IPN (Armstrong et al.,

1983; Woolf and Butcher, 1985, 1986; Paxinos and Butcher, 1985; Clarke
et al., 1987; Beninato and Spencer, 1987; Jones and Beaudet, 1987; Rye
et al., 1987).

It thus is possible that the PPTg may be a source of a

cholinergic projection to the MR.
The microcellular tegmental nucleus (Paxinos and Butcher, 1985),
which lies dorsolateral to the PPTg, also was found to project to the
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MR (see Fig.

l 7m, n).

Although this nucleus is intensely stained by

acetylcholinesterase histochemistry, and evidences SP-like immunoreactivity, relatively little is known about its connectivity or physiology
(Paxinos and Butcher, 1985).
Laterodorsal Tegmental Nucleus
Another major source of afferent projections to the MR is the
laterodorsal tegmental nucleus.

This nucleus contains a large number

of cholinergic neurons, and is the origin of an ascending cholinergic
system, the dorsal tegmental pathway (Armstrong et al., 1983; Shute and
Lewis, 1967).

Using the PHA-L anterograde tracing technique, Satoh and

Fibiger (1986) were the first to demonstrate a projection from this
region to the MR.

These authors suggest that this projection may be

cholinergic because of the high levels of choline acetyltransferase
activity in the MR (Kobayashi et al.,

1975).

However,

it is also

possible that this pathway may contain SP or one of the other neurokinins, since SP-like immunoreactive perikarya have been discerned in
the laterodorsal tegmental nucleus (Sakanaka et al., 1982; Vincent et
al., 1983).
Raphe Nuclei
MR afferents from the dorsal (DR) and pontine raphe nuclei, and

from the nucleus raphe magnus and obscurus, were observed.

A projec-

tion to the MR from the DR, but not from the other raphe nuclei, has
been reported (Bobillier et al., 1975).

These findings suggest that

raphe-raphe connections may provide a means for 5-HT neurons in the MR
to be regulated by 5-HT neurons in other raphe nuclei.
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Medial Nucleus of the Cerebellum
The medial cerebellar nucleus,

the rat equivalent of the fas-

tigial nucleus (Beitz and Chan-Palay, 1979 a,b), was found to project
..-

to the MR.

The only previous report of a cerebellar input to the

midbrain raphe was based on the

degree of retrograde degeneration

observed following lesions of the fastigial nucleus in the cat (Brodal
et al., 1960b).

In the present study, retrogradely labeled neurons in

the medial nucleus were detected in all rats (see Fig. 17s and Fig.
18e.).

No other cerebellar regions were found to contain FG-filled

cells.
Visual System Afferents
Afferents

to the MR were found to originate in the superior

colliculus and anterior pretectal nucleus.

Both of these regions are

involved in the processing of visual information.

It should be noted

that MR afferents from the lateral geniculate body and occipital cortex
were not observed.

Although the midbrain raphe sends 5-HT and non-5-HT

fibers to various components of the visual system, including the superior colliculus,

lateral geniculate body,

and retina (Beitz et al.,

1986; Dolabela de Lima and Singer, 1987; Villar et al., 1987), these
areas have not been reported to innervate the raphe (for a review, see
Sefton and Dreher, 1985).

However, fibers emanating from these areas

descend just lateral to the MR in the tectospinal tract (Papez and
Freeman, 1930; Waldron and Gwyn, 1969).

It is possible that collateral

branches from this system synapse upon cells within the raphe.

Alter-

natively, it is possible that FG may have been taken up by fibers in
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the tectospinal tract which may have been damaged by the glass microAn anterograde tracing study utilizing PHA-L iontophoresed

pipette.

into the superior colliculus and pretectal nucleus would help clarify
this issue.
Trigeminal Nuclei
Two nuclei in the trigeminal complex were found to project to the
MR: the principal sensory nucleus, and the motor nucleus of the trigeminal nerve.

The trigeminal region may receive 5-HT and enkephalinergic

projections

from

the midbrain raphe

(Travers,

1985;

Beitz et al.,

1987), but trigemino-MR projections have not been described [see Travers (1985) and Tracey (1985) for reviews].

Ascending and decussating

fibers emanating from the trigeminal complex pass immediately dorsolateral to the MR.

It thus is possible that some synapse upon cells in

the raphe (Huerta et al., 1983; Smith, 1973).

Alternatively, it is

possible that these trigeminal cells were labeled because of uptake of
FG by fibers damaged by the micropipette.
Auditory Afferents
The present study localized afferents to the MR which originated
in areas that make up part of the auditory system in the rat (Webster,
1985) :

the medial geniculate nucleus,

inferior colliculus,

ventral and lateral nuclei of the lateral lemniscus.

and the

Interconnections

between these areas and the MR have not been reported previously.

1S3
Vestibular Inputs
Three nuclei associated with the vestibular system in the rat
(Mehler and Ruberstone, 198S) were found to project to the raphe: the
lateral and medial vestibular nuclei, and the prepositus hypoglossal
nucleus.

Connections between the vestibular complex and the MR have

not been previously described.
Noradrenergic Afferents
Projections to the MR were observed to originate in areas containing norepinephrine (NE) cell groups: A4 and A6 of the locus ceruleus, and AS and A7 of the lateral brain stem reticular formation (Dahlstrom and Fuxe, 1964).

Previous reports have indicated that the MR re-

ceives its primary noradrenergic innervation from the lateral tegmental
system which arises in the Al, AS and A7 cell groups.

The DR and MR

appear to receive only a minor contribution from the locus ceruleus (A4
and A6; Levitt and Moore, 1979).

WGA-HRP injections into the region of

the AS-NE containing cells did not result in labeled fibers in the DR
or MR

(Byrum

and Guyenet,

1987).

However,

dopamine-P-hydroxylase

immunocytochemistry has confirmed the presence of noradrenergic fibers
and terminals in the mesencephalic raphe (Swanson and Hartman, 197S).
Regions adjacent to the MR, including the dorsal tegmental nucleus of
Gudden, the VTA, and the pontine reticular formation receive afferents
from the LC (Levitt and Moore, 1979; Shammah and Lagnado et al., 1987).
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Reticular Formation
A number of reticular structures were found to send efferent
projections to the MR including the deep mesencephalic nucleus,
oral and caudal parts of the pontine reticular formation,
gigantocellular and lateral gigantocellular reticular nuclei.

the

and the
These

regions have been shown to receive projections from the MR (see review
by Steinbusch and Niewenhuys,

1983) ,

but have not been previously

reported to send efferents to the MR.

Interconnections between the

reticular formation and the raphe are not surprising in light of the
similarity of their afferent and efferent connections
Beitz, 1985; Shammah-Lagnado et al., 1985).

(Andrezik and

In fact, in their original

description, Taber et al. (1960) considered the raphe nuclei as forming
the medial extension of the reticular formation.

C. Immunocytochemical Findings
Localization of Neurokinin-like Immunoreactivity in the
Midbrain Raphe and Surrounding Regions
The first step in determining the neurokinin innervation of the
MR was to characterize the SP-like (SPLI) and neurokinin-like (NKLI)
immunoreactivity.

This was accomplished utilizing antibodies directed

against SP and NKA/NKB (antisera SP2 and NKA2; Brodin et al., 1986), as
well as anti-SP antisera obtained commercially (< 10% cross-reactivity
with NKA and NKB; Dr. Mary Frick, Incstar, Inc, personal communication,
1988).

These antibodies produced SPLI and NKLI staining which was

similar in distribution (see Fig. 19).

These observations are consis-
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tent with those of other investigators who found SPLI in the MR and the
trigeminal complex

(Ljungdahl et al.,

1978; Shults et al., 1984).

1978 a;

Cuello and Kanazawa,

Because of the cross-reactivity of the

NKA/NKB antisera employed, and because of the similar distribution and
probable co-localization of NKA and SP in the CNS, the immunoreactive
methods used were unable to distinguish between SPLI and NKLI.
In order to confirm the presence of the neurokinins in the midbrain raphe, a collaborative study was undertaken with Dr. Ernst Brodin
(Karolinska Institute, Stockholm).

In brief, adult male Sprague-Dawley

rats were sacrificed, and tissue punches (1.5 mm in diameter and 1.0 mm
thick; average weight - 3 .4 mg/punch) were obtained from the MR, DR,
IPN and rostral central gray.

The tissue was frozen on dry ice, pooled

into three samples for each area (one sample -

4-5 punches),

then

stored at -40°c until analyzed by reverse-phase HPLC and radioimmunoassay (Brodin et al. , 1986) .

The samples were assayed for SP with

antisera SP2 (cross-reactivity with NKA/NKB and NPK, negligible) and
for NKA/NKB with antisera NKA5 and E7 (which cross react with NKB, 90
and 240%, respectively; and, with NPK, 54 and 93%, respectively; Brodin
et al., 1986; Lindefors et al., 1985 b; Dr. E. Brodin, personal communication, 1988).

The SP-like and NKA-like concentrations, as well as

the NKA/NKB and NKA/NPK ratios in each brain area are presented in
Table IV.
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Table IV: HPLC-RIA ANALYSIS OF MIDBRAIN TISSUE PUNCHES
NKALI

SPLI

B.egion

NKA
NKB

NKA
. NPK

NKA5
E7
(fmol/sample)

Antisera SP2
(fmol/sample)

----------------------

--------------------------- ----------------2679
± 388)

2337
± 331)

4.3

9.0

1904
± 418

2503
±567

2666
± 413

4.4

8.2

CG

5630
± 2430

3784
± 572

4350
± 922

5.4

6.4

IPN

2518
± 1591

3526
± 809

4343
± 1044

1. 9

5.0

MR

1971
± 324

DR

--

Data represent mean ± SEM for three samples.
Each sample represents
punches from 4-5 animals.
Cross-reactivities of the antisera were
accounted for in the calculation of the ratios.

These data confirm that each of the four brain regions contain
SP, NKA, NKB, as well as small amounts of NPK.

It would appear that

the three neurokinins exist within the raphe in roughly equal concentrations.

These

results,

furthermore,

underscore

the need for

utilizing biochemical methods in order to substantiate immunocytochemical findings.
Problems Associated With Peptide Immunocytochemistry
One of the objectives of the dissertation project was to determine the origin of the neurokinin innervation of the MR.
this goal,

To accomplish

retrograde tracing using the fluorescent dye, Fluoro-Gold

(FG), was combined with immunocytochemical techniques to localize the
neurokinins.

This method is recognized as a sensitive and useful
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procedure for visualization of neurotransmitter-specific afferents to a
particular brain region (van der Kooy and Steinbusch, 1980; Hokfelt et
al.,

1983;

Skirboll and Hokfelt,

1983;

Skirboll et al., 1984):

The

first step in this procedure is to identify perikarya which accumulate
the dye by retrograde transport.

The second step involves the visual-

ization of neurons which contain the neurotransmitter.

The final step

involves the successful combination of the two.
Visualization of a particular transmitter can be accomplished by
immunocytochemistry (Coons, 1950, 1958; Sternberger, 1979; Shiosaka and
The immunocytochemical demonstration of a substance,

Tohyama, 1986).

however, is associated with a number of problems.

These include: the

sensitivity and specificity of the primary antisera; modification or
loss of antigenic binding sites due to fixation or sectioning; lack of
antibody penetration;
antibody binding;

choice of buffers; steric hindrance preventing

and the so-called "Bigbee" effect (Bigbee et al.,

in which high concentrations of antigen and primary antibody

1977),

prevent the binding of the secondary antibody (Larsson,
reniew,
source

1983;

of

Van Leeuwen, 1986).

false-negative/positive

1983;

Sof-

All of these factors can be the
results,

and must be

eliminated

during the development of a staining procedure for a given substance.
Peptide immunocytochemistry,
obstacles which must be overcome.

furthermore,

involves some unique

Since neuropeptides are synthesized

from large precursor molecules which originate in the soma and are
transported and processed enroute to the nerve terminal, the concentration of the peptide in the cell body is typically very low (Hokfelt
et al. , 1980).

In order to visualize peptide-containing perikarya,

158
animals usually must be pretreated with colchicine so that the peptide
accumulates within the soma
r.arsson, 1983).

(Dahlstrom,

1971; Cuello et al.,

1983;

The charge of the peptide during the processing ·steps,

determined by the pH of the buffer system employed, also is critical to
the success of the staining procedure (Van Leeuwen, 1986).
Another problem associated with peptide immunocytochemistry is
that the antibodies employed may cross-react with the precursor or
similar molecules which contain the antigenic site against which the
antibodies are directed (Larsson, 1983; Hokfelt et al., 1980; Block and
Hoffman, 1987).

Thus, the antibodies may enable the visualization of a

particular group of immunoreactive cells, but subsequent studies utilizing more specific antisera may give conflicting results.

This has

been the case for somatostatin as well as the opioid neuropeptides
(Hokfelt et al., 1980).

Because of the similarity in the structure of

members of a related group of peptides,
significant problem.

cross-reactivity can be a

In fact, the high cross-reactivity of the anti-

bodies utilized in some of the first SPLI mapping studies has precluded
a definitive localization of SP-specific neurons and processes (Dr. Tomas Hokfelt, personal communication, 1986).

Another problem associated

with peptide immunocytochemistry is that antisera directed against a
particular antigenic site may not always be recognized in tissue sections because of the three-dimensional structure of the peptide in-vivo
(Larsson, 1983), or because of its membrane binding properties.

This

particular problem is not typically encountered with other techniques,
such as radioimmunoassay or HPLC (Brodin et al., 1986; Larsson, 1983).
Since these procedures are performed on peptides extracted from tissue,
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more of the molecule is accessible to the antibody,

thus allowing a

better opportunity for binding, and increased specificity for antisera
directed against the unique portions of the peptide chain (Larsson,
1983; Brodin et al., 1986).
Neurokinin Immunoreactivity in Dorsal Root Ganglia
In order to control for the ability of our procedures to localize
SPLI and NKLI cell bodies, SPLI and NKLI were first demonstrated in
spinal dorsal root ganglia (DRG), a tissue known to be rich in neurokinin cell bodies (Hokfelt et al., 1975; Dalsgaard et al., 1982, 1985;
Fuxe et al., 1983; Leach et al 1985; Gibbins et al., 1987).

Sections

through the DRG from both intrathecally colchicine-treated and untreated rats were processed as described in Chapter III, Methods.
this procedure,

Using

we were able to visualize both SPLI and NKLI cell

bodies and fibers in the DRG.

Although intrathecal administration of

colchicine was used to arrest axonal transport and increase the cellular concentration of the peptides (Dahlstrom, 1971; Cuello et al.,
1983;

Dalsgaard et al.,

1985),

contrary to our expectations,

more

perikarya were stained in the untreated rat (Fig. 20), whereas better
fiber staining was seen in the colchicine-treated rat.
that the accumulation of material

It is possible

in the soma following colchicine

treatment causes swelling and distention which hinders the binding of
the antibody to the peptides.

This physical disruption also could lead

to better antibody penetration of individual fibers and hence better
axonal staining.
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Localization of Neurokinin Cell Bodies in the CNS
The mapping of SP-like immunoreactive cell bodies in the adult
rat CNS was first reported in the seminal studies of Ljungdahl et al.
(1978 a,b) and Cuello and Kanazawa (1978) and subsequently by Shults et
al.

(1984).

Their findings, as well as those obtained in the present

study, are summarized in Table V.

As can be seen, the results overall

are in general agreement.
Although

neurokinin-like

cell

body

staining was

obtained

in

sections through the dorsal root ganglia (see Fig. 20), CNS perikaryal
staining following colchicine pretreatment was not observed consistently in every brain region examined.

In general, the best cell body

staining was obtained in the brain stem, particularly in the central
gray, IPN, DR and laterodorsal tegmental nucleus.

With the exception

of the IPN, this might be explained by the proximity of these regions
to the ventricular system and, thus, their accessibility to the colchicine administered into the lateral ventricles (Ljungdahl et al., 1978
a).

SPLI cell bodies in the IPN can be easily visualized in untreated

rats (Cuello and Kanazawa, 1978; Ljungdahl et al., 1978 a; Artymyshyn
and Murray, 1985; Contestable et al., 1987).
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Table V: SUBSTANCE P-LIKE IMMUNOREACTIVE CELL BODIES IN THE CNS

B,egion

Ljungdahll

Shults2 Cuello3 Present4

Rhinencephalon
-;,lfactory tubercle

+

Telencephalon
nucleus accumbens

++

++

+++
++++
+++

+++
++++
++

+++
++

+

++++

++

septal nuclei
medial
lateral
diagonal band of Broca
caudate-putamen
medial forebrain bundle areas
interstitial nucleus of the
anterior commissure
globus pallidus
bed nucleus of the stria
terminal is
amygdala
preoptic area, medial
hypothalamus
suprachiasmatic nucleus
anterior hypothalamic nucleus
paraventricular nucleus
ventromedial nucleus
dorsomedial nucleus
lateral hypothalamic
premammillary nucleus
posterior hypothalamic nucleus
Diencephalon
subthalamic nucleus
medial habenular nucleus
zona incerta
Mesencephalon
central gray
nucleus of Darkschewitsch
interpeduncular nucleus
mesencephalic reticular
formation
superior colliculus
laterodorsal tegmental nucleus
dorsal raphe
pontine reticular formation,
caudal

+
+

+

+

+
++++
+++
++++

++++
++
+++

++

+

+
+

+++
+++
+++
++++
++++

++++
+++
++++
++++
+++

+

+
++++
++

++++

++++
+++
++++

++++
++++

+

+++

+++
++

++++

++
+++

+

+++

+++

+++

++

+

+

+

+
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Table V (cont')
Mesencephalon (cont')
cuneiform nucleus
dorsal parabrachial nucleus6
raphe pontis
Myelencephalon
raphe magnus
raphe obscurus
raphe pallidus
medullary reticular formation
spinal vestibular nucleus
nucleus of the solitary tract
spinal trigeminal nucleus
caudal trigeminal nucleus
lateral cuneate nucleus

+++
++
++

++++
+++
+++
++++
+
+
+

++++
+
+
++++
+
+
+
+

+++

+

+

1

Adapted from Ljungdahl et al. (1978): + - l; ++ - 2-5; +++ - 6-20;
++++ - > 20 SP-immunoreactive cell bodies.

2

Adapted from Shults et al. (1984): + - "low"; ++ - "moderate"; +++
- "high"; ++++ - "highest" number of SP-immunoreactive cells bodies.

3

Adapted from Cuello and Kanazawa (1978). Since these authors were
primarily interested in immunoreactive fibers and terminals, they
did not use colchicine pretreatment and did not attempt to quantify
the number of immunoreactive cell bodies encountered.

4

Present study: the rating scheme of Shults et al. (1984) was used.

5

The "magnocellular preoptic nucleus" of Paxinos and Watson (1986).

6

The "lateral parabrachial nucleus" of Paxinos and Watson (1986).
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In the present study,
septum,

diagonal

SPLI cell bodies were observed in the

band of Broca,

nucleus, but not in every rat.

hypothalamus,

and medial habenular

Ljungdahl et al.

(1978 a) also were

unable to discern SPLI perikarya in a given area in every rat studied.
!hey reported, furthermore, that intracerebral infusions of colchicine
were necessary in order to visualize SPLI perikarya in certain areas
(Ljungdahl et al., 1978 a).

In addition, SPLI cell bodies were more

easily seen and in some cases, exclusively,
rats

(Ljungdahl et al.,

1978 a).

in young (1-3 week old)

These observations emphasize the

importance of using optimal conditions for each brain region under
study.
The problems (reviewed above pp. 156-159) encountered with neurokinin staining probably explain why most immunocytochemical studies of
this family of peptides have focussed upon individual brain regions.
Table VI provides a list of reports

in which neurokinin- like cell

bodies have been visualized in the CNS.
The lack of perikaryal neurokinin-like staining in certain CNS
regions could be due to the low concentration of the peptide in the
soma, even after colchicine pretreatment.

This may be especially true

for neurons with long and/or highly collateralized axons.
is the striatonigral neurokinin system.

An example

This is probably the most

extensively studied neurokinin system in the CNS (Jessel et al., 1978;
Kanazawa et al., 1980; Bolam et al., 1983, 1986; Gerfen, 1985; Ritter,
1985; Arai et al., 1987; Bannon et al., 1987; Chesselet et al., 1987;
Kawai et al., 1987; Li et al., 1987; Nylander and Terenius, 1987; Sivam
et al., 1987; Voorn et al., 1987; Diez-Guerra et al., 1988).
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Table VI: SUBSTANCE P-LIKE IMMUNOREACTIVITY IN SELECTED AREAS

-

Visualization
Method2

Regionl

nucleus accumbens
(cat and ferret)
(cat)

caudate

arcuate nucleus &
median eminence
tuberomammillary nucleus
medial habenular &
interpeduncular nuclei
hippocampus

Source

PAP

Pickel et al., 1988

PAP
PAP
PAP
PAP

Izzo et al., 1987
Beckstead, 1987
Penny et al., 1986
Bolam et al.,1983

PAP and
colloidal gold

Tsuruo

et

al. ,

FITC and
PAP

Kohler et al.,

PAP

Contestabile,
1987

PAP
(SP and NKA)

1987

1985

et

al.,

Shults et al., 1987

FITC and
PAP
FITC

Davies and Kohler,
1985
Del Fiacco et al.,
1987

dorsal raphe

PAP

Magoul et al., 1986

interpeduncular nucleus

PAP

Groenewegen et al.,
1986
Vu and Hamill, 1988
Barr et al., 1987
Artymyshyn and
Murray, 1985
Huitinga et al., 1985

(human)

PAP
PAP
PAP
FITC
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Table VI (cont')

parabrachial nuclei

PAP

Block
and
1987

nucleus of the solitary tract
(monkey)

FITC
PAP

Thor and Helke, 1987
Maley et al., 1987

medullary raphe &
reticular formation

PAP
PAP

Menetry and
1987
Hancock, 1984

brain stem (human)

PAP

Nomura et al. , 1987

ventrolateral medulla
(cat)

FITC
PAP

Pilowsky et al., 1986
Ciriello et al., 1988

Hoffman,

Basbaum,

1

Species used is the rat, unless otherwise noted.

2

Method of visualization: PAP - peroxidase antiperoxidase (light
microscopy); FITC - fluorescein isothiocyanate (fluorescence microscopy)
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Some investigators have had difficulty visualizing SP-like immunoreactive cell bodies in caudate nucleus (Ljungdahl et al., 1978 a; Bolam et
al, 1983), while others presumably have had no difficulty, even without
colchicine pretreatment (Cuello and Kanazawa, 1978).

In contrast to

the caudate nucleus, the IPN, with its relatively shorter projections
and high concentrations of SP, is a structure in which SPLI cell bodies
are readily stained under a variety of conditions.
Alternatively, it is possible that there is differential processing and expression of neurokinins in distinct pathways.

The density

and distribution of SP binding sites, cell bodies and fibers fluctuates
during the pre-and post-natal period (Inagaki et al., 1982; Sakanaka et
al., 1982; Quirion and Dam, 1986).

This could explain why cell bodies

in some brain regions are only visualized in very young (l-3 week old)
rats (Ljungdahl et al., 1978 a).
It is worth noting that a number of recent studies have utilized
the PAP or avidin-biotin-PAP technique for visualizing neurokinin cell
bodies.

These methods do not require specialized fluorescence micros-

copy and may be more sensitive because of the low concentrations of
primary antibody which can be used (Hsu et al., 1981; Larsson, 1983;
Vandersande, 1983; Van Leeuwen, 1986).

A fluorescence immunocytochem-

ical technique was used in the present study because of the sensitivity
of the retrogradely transported fluorescent dyes which are available
(Hokfelt et al., 1983; van der Kooy and Steinbusch, 1980; Skirboll and
Hokfelt., 1983; Skirboll et al., 1984).
ers,

such as horseradish-peroxidase

Although other neuronal trac-

(HRP)

and wheat-germ agglutinin

(WGA), are available (Schwab et al., 1978; Leehan et al., 1981; Mesu-
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lam, 1982), these suffer from the disadvantages of being taken up by
fibers

of passage

labeling

and producing anterograde

(Leehan et al.,

1982;

as well as

retrograde

reviewed by Hokfelt et al., ·1983).

Improvements in specificity have come through conjugation of WGA with
HRP and gold complexes,

and their careful iontophoretic application

into the brain (Gonatas et al., 1979; Baker and Spencer, 1980; Basbaum
and Mentery, 1987).
require a

A disadvantage, however, is that these techniques

special development step not needed with the fluorescent

tracers (Hokfelt et al., 1983).
Combined MR Fluoro-Gold Injections with Neurokinin Immunocytochemistry
Neurokinin-like staining of selected brain regions was attempted
using two rats which had received FG injections into the MR 10 days
earlier.

Since our best SPLI and NKLI staining was observed in brain

stem areas, these regions were concentrated on for the combined retrograde tracing and immunocytochemical studies.

Both FG and FITC labeled

neurons were discerned in several brain structures, but especially in
the rostral central gray, the DR, the IPN, and the laterodorsal tegmental nucleus.
case,

Double-labeled cells, however, were not observed.

In one

there may have been one or two double- labeled neurons in the

laterodorsal tegmental nucleus, but on re-examination, the fluorophore
appeared to have faded.

Fig. 22e,f shows FITC and FG but not double-

labeled cells in the same DR-section.

Therefore, the neurokinin inner-

vation of the MR probably does not originate in these brain regions.
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,EYture Considerations for Determining the Neurokinin Afferents to the MR
Because of the inability to observe PG- labeling in neuro_kininlike perikarya, the origin of the neurokinin innervation of the MR was
not demonstrated.

Thus, alternative approaches should be adopted.

One

approach would be to concentrate on the brain regions which have been
shown to send fibers to the MR.

Neurokinin-like staining then could be

optimized for those regions and eventually combined with retrograde
labeling.

For instance, it might be necessary to utilize intracerebral

injections of colchicine in order to bring out neurokinin-like perikarya staining (Ljungdahl et al., 1978 a; Bolam et al., 1983; Groenewegen et al., 1986).

Alternatively, as suggested in recent articles

(see Table VI), it may be necessary to utilize the PAP or avidin-biotin
method of Hsu and colleagues (Hsu et al., 1981; Hsu and Reine, 1981),
rather than fluorescent methods.
Another approach would be to place lesions in putative neurokinin-labeled nuclei

or pathways which may

innervate

the MR,

then

analyze tissue punches of the raphe nuclei for neurokinin immunoreactivity.

This method has been used extensively to study the striato-

nigral neurokinin system (Jessel et al., 1978; Kanazawa et al., 1980;
Arai et al., 1987; Sivam et al., 1987; Voorn et al., 1987).

A bio-

chemical approach using HPLC coupled with RIA has been used successfully to determine the amount of neurokinin immunoreactivity in the MR
and various other brain regions (see Table IV; Brodin et al., 1986;
Lindefors et al., 1985).

This approach has the advantage of being able

to produce quantitative data concerning the neurokinin input to the
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raphe and is being used in our collaborative study with Dr. Brodin's
laboratory.
In situ hybridization histochemistry has been recently employed
to study neurokinin distribution in the CNS (Chesselet et al., 1987;
warden and Young, 1988).

This technique uses 3 5 s-labeled probes spec-

ific for neurokinin mRNA transcripts.

Although the probes are highly

sensitive and avoid many of the problems encountered with immunocytochemistry, at present the technique appears to suffer from a lack of
resolution.

For example, Warden's and Young's (1988) recent report,

which compares the distribution of the mRNAs for SP and NKB in the rat
CNS, localizes SP transcripts in regions not previously shown to contain SP-like cell bodies.

This would suggest that either there is a

technical problem with their methods, or that some neurons in the CNS
are inefficient with respect to gene transcription.
not try to reconcile these discrepancies.
offer great potential for

The authors did

Al though these techniques

localizing neuronal neurokinin processes,

Warden's and Young's results must be interpreted carefully.

D. Function of Neurokinin-Induced Hyperkinesis
The results from the present study raise some important questions.

What is the functional relevance of the behavioral arousal

produced by neurokinin infusions into the MR?

Is the animal exploring,

searching for food, seeking a means of escape, or simply locomoting?
What anatomical circuits mediate intra-MR neurokinin induced activation?

The following discussion will address these questions.
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What is the Function of Intra-MR Induced Hyperkinesis?
Open Field Studies
Measurement of LMA in enclosed photocell chambers does not permit
~-

an analysis of the animal's behavior.

The animal could generate activ-

ity counts (photobeam breaks) by rotating, grooming, rearing, or biting
(Dourish, 1987).

Likewise, drug induced increases in activity could be

manifested in several ways.

For example, infusions of tachykinins into

the ventral tegmental area induce increases in LMA as measured in photocell chambers, but when observed in an open field, the rat may be engaging in grooming, rearing or scratching (Elliott and Iversen, 1986).
Peripheral and intracisternal injections of senktide, furthermore, have
been reported to produce stereotypic movements in rats (Stoessl et al.,
1987 a,b).

Thus, we observed rats in an open field following neuro-

kinin infusions into the MR.
It is generally accepted that exposure of an animal to a novel
environment elicits both fear (neophobia) and curiosity.

Immediately

after placement in the center of the open field, a normal rat will move
cautiously but directly to the wall and "freeze," defecate and urinate.
The animal then will ambulate along the wall of the compartment seeking
a means to escape .
explore the apparatus.

As the animal's fear attenuates,

it begins to

Eventually, the animal habituates to the cham-

ber, and tends to sit or lie quietly near the wall, occasionally sauntering to another part of the arena.

A number of factors affect an

animal's response to a novel open field.

These include the intensity

and type of illumination and background noise;

the degree of food
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and/or water deprivation, the strain and sex of the rat; time of day
and year; handling and prior experience; the presentation of reinforcing stimuli, such as electric shock, highly palatable foods, or. small
furry objects; and, how the animals are normally housed (Gray, 1972,
1982; Frankova et al., 1987).

Although not well understood, pheromones

also may play a role, especially when rats are tested sequentially in
the same chamber. The open field used in the present study (see Methods, Chapter III) was designed to provide a mildly fearful environment
with holes in the floor which could elicit exploratory responses.

In

addition, the animals were handled frequently and were well adapted to
the injection procedure.
The results of the first two open field experiments showed that
vehicle treated rats exhibited high levels of activity, and that much
of their time was spent exploring the chamber.

This was evidenced by

the high incidence of rearing, head pokes, and center squares entered
(see Fig. 10 and 11).

Intra-MR infusions of DiMe-C7 and NKA did not

lead to further increases in activity.

In contrast, senktide, as well

as muscimol (unpublished observations), produced increases in LMA.
In order to control for the effects of novelty on the behavioral
arousal produced by neurokinin injections into the MR, the rats in the
third open field experiment were adapted to the chamber prior to drugtesting.

Not surprisingly, the vehicle treated rats exhibited a much

lower level of activity than similarly treated rats exposed to the
novel chamber (compare Fig. 12 and Fig. 14).

MR infusions of both NKA

and senktide produced increases in activity in rats which had been
adapted to the open field arena.

The increases in activity were mani-
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fested predominantly as increases in wall squares entered during the
first 15 minutes in the chamber.

However, it is interesting to note

that although both NKA and senktide produced significant increases in
activity,

NKA tended to increase exploratory behaviors:

pokes, and center squares entered.
lar effects (Gray,

1982).

rears,

head

Anxiolytic compounds produce simi-

In contrast, senktide induced locomotion

primarily along the periphery of the chamber.

These observations

suggest that the binding of senktide to an NK-3 receptor in the MR
results in increased locomotion,
receptor

leads

whereas binding of NKA to an NK-2

to enhanced exploration.

receptors on 5-HT neurons

Thus,

activation of NK-2

in the MR may produce a mild anxiolytic

effect.
Punished Drinking
The potential "anxiolytic" effects of intra-MR infusions of senktide were examined using a punished drinking paradigm (unpublished observations).
ing (File,

Anti-anxiety drugs increase the rate of punished respond1987; Treit, 1985).

punished or unpunished drinking.

Senktide (0-30 pmol) did not affect
Thus, activation of a MR NK-3 recep-

tor does not appear to produce an anxiolytic effect.

We are planning

to examine the effects of NKA and the NK-1 agonist, septide, using this
paradigm.
Effects on Food and Water Intake
To further investigate the functional significance of neurokinin
induced LMA, we observed the effects of the peptides on food and water
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MR infusions of muscimol and the S-HT1A agonist,

intake.

8-0HDPAT,

have been demonstrated to increase locomotion and to induce increases
in food and water intake in non-deprived rats

(Dourish et al.,

a,b,c, 1986; Klitenick and Wirtshafter, 1986, 1987).
kinins also increase LMA,
ingestive behaviors

as

1985

Since the neuro-

it is possible that they could stimulate-

well.

Studies conducted in our

laboratory,

however, have revealed that senktide infusions into the MR or DR produce decreases in both food and water consumption in non-deprived rats.
No effects were observed in deprived animals.
tide on food intake are novel.

These effects of senk-

Infusion of pmol doses of tachykinins

into the lateral ventricles has been reported to produce an antidipsogenic effect

in rats

(Massi et al.,

1986;

De Caro et al.,

1987).

Thus, it is possible that the tachykinins may regulate water intake via
the MR.
found

It is interesting in this regard that Lorens et al.

that

electrolytic

midbrain

raphe

lesions

produced

(1971)

transient

increases in water consumption.

Effects on Reinforcement Processes and Pituitary-Adrenal Axis

Preliminary

studies

in

our

laboratory,

using

the

conditioned

place preference paradigm, suggest that intra-MR infusions of muscimol
induce aversive effects, whereas DiMe-C7 injections may produce rewarding effects (Lee, J. et al., 1987).
furthermore,
plasma

levels

were

found

of ACTH

to

produce

Infusions of muscimol into the MR,
dose - dependent

and corticosterone.

These

increases

in

the

pituitary-adrenal

hormones are secreted as a result of an animal's exposure to aversive
or stressful stimuli (Bassett et al., 1973; File and Peet, 1980; Natel-
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son et al., 1987).

In contrast, MR infusions of DiMe-C7 do not alter

the plasma levels of these hormones.
Neurochemical Effects
Muscimol has been shown to produce several behavioral effects
when infused into the midbrain raphe,

including hyperkinesis, hyper-

phagia, and hyperdipsia, as well as endocrine and electrophysiological
changes.

It has been reported that raphe-GABAergic neurons modulate

forebrain 5-HT and DA turnover (Forchetti and Meek, 1981; Nishikawa and
Scatton, 1985 a,b; Nishikawa et al., 1986).
The effects of intra-MR infusions of the neurokinins on 5-HT
turnover have not been thoroughly examined.

One study has reported

that intra-MR administration of high doses of SP (4.0 and 10 µg) produces an increase in 5-HT turnover in the hippocampus, measured as an
increase

in 5-HIAA concentration (Forchetti and Meek,

1982).

This

study, as well as preliminary evidence obtained in our laboratory using
DiMe-C7, supports the view that the neurokinins modulate the activity
of 5-HT neurons.
Neuroanatomical Considerations
Locomotion is composed of a complex series of neuronal events
which involve spinal and brain stem signals which are monitored by
cortical and diencephalic messages.

Spinal feedback, as well as sen-

sory input, can modulate any component of the circuit.

Although the

basic locomotor pattern generator involves a hard-wired spinal circuit,
locomotion is dependent upon supraspinal influences (Carew, 1985; Arm-

r
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strong, 1986).

Some of the major supraspinal messages come from the

mesencephalic and subthalamic locomotor regions, the nigrostriatal and
mesoaccumbens DA systems, the pontomedullary locomotor sites, the red
nucleus and rubrospinal tract, and the cerebellum (Armstrong, 1986) .
.To implicate the MR in a complex series of neuronal connections, such
as those involved in locomotion,

requires anatomical documentation.

The anatomical findings obtained in the present study will be discussed
in relation to known locomotor circuits.
Mesencephalic Locomotor Region
A "mesencephalic
posterior midbrain.

locomotor region" has been localized in the
Electrical stimulation of this region induces

locomotion in cerveau isole cats (Grillner and Shik, 1973).

The anat-

omy and physiology of this region had been studied extensively by Garcia-Rill and colleagues

(Garcia-Rill et al. , 1983 a, b;

1983; Garcia-Rill and Skinner, 1987 a,b).

Garcia-Rill,

An homologous region, pri-

marily involving the pedunculopontine nucleus (PPTg), has been demonstrated in the rat (Skinner and Garcia-Rill, 1984; Garcia-Rill et al.,
1987).

GABA neurons appear to play an important role in the modulation

of locomotor movements by

this

area

(Imperato and DiChiara,

Childs and Gale, 1983; Garcia-Rill et al., 1985).

1981;

The mesencephalic

locomotor area, furthermore, is reciprocally connected with the nucleus
accumbens,

entopeduncular nucleus,

and motor cortex (Garcia-Rill et

al., 1981, 1983, 1985; Saper and Lowey, 1982; Brudzynski and Mogenson,
1985; Brudzynski et al., 1986; Yang and Mogenson, 1987; Swerdlow and
Koob, 1987; Scarnati et al., 1987).

The mesencephalic locomotor area

r

t
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and basal ganglia also appear to be functionally interconnected (Garcia-Rill, 1986).
There have been no reports,

to our knowledge,

relationship between the MR and the PPTg in the rat.
anatomical study represents
between the PPTg and the MR.

concerning the
The present

the first observation of a direct link
Previous studies have indicated that a

number of cells in the PPTg contain choline acetyltransferase (Sofroniew,

1985 a, b) and NADPH-diphorase (a marker reputably specific for

cholinergic neurons in the PPTg; Goldsmith and van der Kooy, 1988),
suggesting that the PPTg may be the source of a cholinergic projection
to the MR.

Additional electrophysiological and lesion experiments are

needed to verify the functional relationship between these brain stem
nuclei.
Subthalamic Locomotor Region Connections
Another region which has been implicated in locomotion is the
"subthalamic locomotor area" (Armstrong, 1986).

This diencephalic area

comprises the fields of Forel, the subthalamic nucleus, zona incerta,
lateral hypothalamus, and the mammillary nuclei (see Armstrong, 1986).
These structures have been shown anatomically and physiologically to
project to and modulate neuronal activity within the PPTg (Swanson et
al., 1984, 1987; Mogenson et al., 1985; Mogenson and Wu, 1986).

As

discussed previously (p. 143), several components of the subthalamic
locomotor area have reciprocal connections with the MR, including the
zona incerta,

the lateral hypothalamus,

and the mammillary nuclei.
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Therefore,

connectivity with the subthalamic locomotor area provides

another means for MR neurons to communicate with motor circuits.

Lateral Hypothalamic Locomotor Connections

Electrical stimulation of the lateral hypothalamus has been shown
to affect locomotion (Gross and Sinnamon, 1986; Sinnamon and Stopford,
1987; Sinnamon et al.,
and

the

1987).

The relationships between this region

ventromedial midbrain have

1987; Sinnamon and Stopford,

1987).

been examined

(Sinnamon et al. ,

It would appear that the MR and

adjacent structures may be involved in the locomotion induced by electrical stimulation of the lateral hypothalamus.
midbrain,
lMA

including the PPTg,

(Sinnamon and Stopford,

Lesions of the dorsal

did not affect electrically stimulated
1987).

Sinnamon and colleagues

(1987)

present evidence that electrical stimulation of the midbrain raphe can
produce a variety of locomotor effects,
inhibition when

observed

hypothalamically-induced

in

the

ranging from facilitation to

presence

locomotion

or

(Sinnamon

absence
et

al.,

of

concurrent

1987).

Two

caveats apply to this type of research: 1) the effects were observed in
anesthetized preparations and thus may not necessarily reflect locomotion in awake animals; and,

2) electrical stimulation produces both

antidromic and orthodromic activation of fibers of passage, as well as
stimulation of interstitial cell bodies.
experiments can be quite difficult.

Thus, interpretation of these

r

r

-
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Association with the Mesotelencephalic DA Systems
The mesotelencephalic DA system is composed of the mesostriatal
and mesolimbocortical DA systems,

originating in the A8-10 DA cell

groups (Bjorklund and Lindvall, 1984).
accumulated

in

recent

years

A vast amount of literature has

implicating the mesencephalic DA cell

groups and their terminal regions in locomotion.
tigators also have

A number of inves-

implicated MR-5-HT neurons in the regulation of

these pathways (Chase, 1974; Jacobs, 1974; Dray et al 1976; Hery et
al., 1980; Lee and Geyer, 1984 a,b; DiSimoni et al., 1987; Herve et al,
1987; Lee, E.H.Y. et al., 1987; Mori et al., 1987).
DA regions are reciprocally connected with the MR.
inating in the ventral tegmental area,
fields,

The mesencephalic
MR afferents orig-

substantia nigra, retrorubral

and rostral and caudal linear nuclei were observed in the

present study.

The dopaminergic nature of these afferents remain to be

elucidated.
The

dependence

of

the MR-neurokinin

induced hyperactivity on

ascending mesotelencephalic DA systems has yet to be evaluated.
ever,

How-

the behavioral evidence obtained in the present study suggests

that the hyperactivity elicited is mediated by 5-HT--DA interactions in
one of these systems.

First, the hyperactivity produced by activation

of an NK-3 receptor was not affected by destruction of ascending 5-HT
fibers rostral to the mesencephalon, but was blocked by destruction of
5-HT neurons within the MR.
ventral

tegmental

Therefore, a 5-HT projection to either the

area or substantia nigra may mediate

neurokinin induced LMA.

intra-raphe

Secondly, pretreatment with the DA antagonist,

haloperidol, can block the effects of DiMe-C7.

The 5-HT innervation of

-
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the substantia nigra has been proposed to originate in the MR (Dray et
al., 1976, van der Kooy and Hattari, 1980; Mori et al., 1987).

How-

ever, recent anatomical evidence suggests that the DR is the primary
source of nigral 5-HT afferents

(Wirtshafter et al.,

1987 b).

The

available anatomical evidence indicates that 5-HT neurons innervate the
VTA (Herve et al.,

1987; Oades and Halliday, 1987).

Therefore, MR

neurokinin-induced hyperactivity may be mediated by a 5-HT projection
to the ventral tegmental area.

In order to test this hypothesis, one

could use 6-0HDA to selectively destroy DA cell bodies of the ventral
tegmental area,

and substantia nigra,

intra-MR neurokinins.

then evaluate the effects of

Such studies are in progress.

Medial Frontal Cortical Projections and LMA
The medial aspects of the prefrontal cortex have been implicated
in a

number

of psychological processes,

including spatial problem

solving, drive inhibition, and the temporal sequencing of appropriate
behaviors (Brutkowski, 1965; Kolb 1974, 1984; Fuster, 1985; Herrmann et
al., 1985; Vives et al.,

1986).

This region, furthermore, has been

associated with visceral motor function (Terrebery and Neafsey, 1983).
Although lesion data suggest that the medial frontal cortex modulates
LMA (Kolb,

1974),

it would appear that this region probably is not

involved in locomotion per se.
integrating

spatial,

temporal

Rather, it appears to be critical for
and environmental

stimuli

(see Kolb,

1984; Brutkowski, 1965; Herrmann et al., 1985; Fuster, 1985).

Since

the medial frontal cortex provides a rather substantial projection to
the MR (this study and Leonard, 1965), it is possible that this cort-
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ical region plays an important role

in the processing of external

stimuli during physiological and drug-induced locomotion.
The involvement of the medial frontal cortex in the regulation of
an organism's response to significant environmental stimuli is further
suggested by the widely reported, but little understood, stress-induced
increases in frontal cortical DA metabolism (Thierry et al., 1976; Lavielle et al., 1978; Blanc et al., 1980; Bannon and Roth, 1980; Reinhard
et al., 1982; Herman et al., 19.82; Claustre et al., 1986; D' Angio et
al., 1987).

The neurokinins have been shown to regulate frontal corti-

cal DA turnover via their modulation of DA neurons in the rostromedioventral mesencephalon

1986).

(Bannon et

al.,

1983,

1986;

Elliott et al.,

These changes in DA turnover are not due to locomotion per se,

since rats trained to run in a wheel exhibit increases in DA metabolism
in the neostriatum but not in the frontal cortex (Speciale et al. ,

1986).

As the LMA effects of intra-raphe neurokinin administration may

be mediated by DA neurons within the ventral tegmental area, it is possible that intra-MR neurokinin administration will affect DA metabolism
in the frontal cortex as well.
Conclusions
Anatomically, the MR is in a position both to modulate and to be
modulated by a number of regions involved in the regulation of motor
function.

The heterogeneity of the locomotor responses observed in the

present study reflects the complexity and diversity of the afferent
modulation of MR neurons and their projections.

SUMMARY
The overall objective of the dissertation project was to investigate the origin and functional role of the neurokinin innervation of
the median raphe nucleus (MR) in the rat.

The neurokinins (SP, NKA,

and NKB) are found in mammals and are members of a family of structurally related bioactive peptides called tachykinins.

The non-mam-

malian tachykinins include eledoisin, kassinin, and physalaemin.

The

neurokinins have a distinct distribution of binding sites (NK-1, NK-2,
NK-3) in the CNS.

The neurokinins and their recognition sites, fur-

thermore, have been localized within the midbrain raphe nuclei.
specific aims

of the project were to determine:

1)

The

the behavioral

effects of direct injection of the neurokinins into the MR; 2) which
neurokinin(s) is (are) involved; 3) if the behavioral effects depend on
the integrity of raphe 5-HT neurons; and, 4) the origin of the neurokinin innervation of the MR.
Our laboratory was the first to show that intra-raphe injections
of a neurokinin agonist, the metabolically stable SP analogue, DiMe-C7,
produce dose-dependent increases in locomotor activity which are dependent upon intact midbrain 5-HT neurons.

This neurokinin induced be-

havioral activation can be blocked by administration of the dopamine
(DA) antagonist, haloperidol.

In the present study, the dose-dependent

behavioral effects of the mammalian and non-manunalian tachykinins and
the neurokinin B agonists, DiMe-C7 and senktide, were compared.

Unfor-

tunately, non-neurotoxic antagonists currently are not available so
181
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that

the

neurokinin

recognition

site(s)

involved

could be

further

characterized.
The dose-response analyses suggested that behavioral arousal can
be induced by activation of MR NK-3 sites with senktide and DiMe-C7,
and by activation of MR NK-2 sites with NKA.

lntra-raphe injections of

the serotonergic neurotoxin, 5,7-DHT, prevented the hyperactivity produced by infusions of DiMe-C7, NKA and senktide into the MR.

In con-

trast, previous studies demonstrated that similar lesions did not block
the hyperactivity induced by intra-raphe administration of the GABAA
agonist, muscimol.
the

median

5,7-DHT lesions of the 5-HT fibers which ascend in

forebrain

groups, however,

rostral

to

the

mesencephalic

DA cell

did not block the increases in activity produced by

senktide or DiMe-C7,
NKA.

bundle,

but did attenuate the hyperactivity produced by

These results suggest that the increases in locomotor activity

induced by senktide may be mediated by a 5-HT projection to the ventral
tegmental area and/or the substantia nigra, while the effects produced
by NKA may be mediated,
forebrain.

Additional

in part, by 5-HT fibers which innervate the
studies

are needed in order

to confirm this

hypothesis.
Analysis of the animals' behavior in an open field arena led to a
further differentiation of the effects of senktide and NKA following
their

injection

into

the

MR.

Senktide

produced elevated activity

levels when the animals were placed in a novel environment, while NKA
induced an
Thus,

increase

in exploration only in a

familiar

environment.

it is possible that neurokinin--5-HT interactions in the MR may

regulate emotional

tone and motivational processes.

The behavioral
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arousal induced by intra-raphe muscimol administration is associated
with feeding behavior and increases in plasma ACTH and corticosterone
levels which are not dependent on intact 5-HT neurons.

In contrast,

the behavioral activation produced by infusions of either DiMe-C7 or
senktide into the MR are not accompanied by either feeding or changes
in plasma hormone concentrations.

It remains to be seen if intra-raphe

injections of NKA, or a specific NK-1 agonist, such as septide, would
affect ingestive behaviors or pituitary-adrenal function.
Retrograde tracing studies (utilizing the fluorescent dye,
Fluoro-Gold) were performed in order to determine the origins of the
afferent projections to the MR.

Several of the brain regions found to

project to the MR have been implicated in the regulation of motor function.

Although further studies are necessary, these data provide an

anatomical basis for the possible role of the MR in the initiation,
sequencing, and maintenance of distinct behavioral patterns.
Fluorescence immunocytochemistry and HPLC-RIA confirmed previous
reports that fibers containing neurokinin-like substances are located
within the midbrain raphe.

However,

combined neurokinin immunocyto-

chemistry with Fluoro-Gold retrograde tracing did not reveal the origin(s)

of the neurokinin input to the MR.

Brain stem regions were

found which contained both retrogradely labeled cells and neurokinin
immunoreactive neurons, namely,
peduncular nucleus,
tegmental nucleus.

the dorsal raphe nucleus, the inter-

the rostral central gray,

and the

laterodorsal

Unfortunately, clear-cut evidence for double label-

ing in these structures was not obtained.

The neurokinin neurons which

project to the MR remain to be demonstrated.
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The imrnunocytochemical studies indicated, furthermore,

the need

to refine the approach used to visualize neurokinin cell bodies in various CNS regions.

Further studies should include the use of intra-

cerebral injections of colchicine to arrest axonal transport, and the
development of histochemical techniques which would optimize the staining of neurokinin-like substances in distinct brain regions.
Future studies also should examine the electrophysiological effects of the neurokinins on 5-HT and non--5-HT neuronal activity in the
midbrain raphe.

This would allow a more complete understanding of the

physiology of raphe neurokinin/5-HT interactions.
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Peptide Analysis and Preparation
Documentation concerning the purity and content of each peptide
was supplied. Most of the batches contained > 84% of the peptide. In
these cases, no corrections were made for determination of molar concentrations. One batch of neurokinin A, however, had a peptide content
of only 76%.
A correction was made to obtain the proper stock solution, as noted below.
1.)

Vehicle:

2.)

Preparation of Stock Solutions:

0 .1 M phosphate buffered saline (PBS) with 0. 01 M
acetic acid added, pH 7. 2 (350 ml PBS and 150 ml
0.01 M acetic acid)

DiMe-C7 (MW 880.13):
5.0 mg lyopholyzed peptide is dissolved in 250 µl 0.01 M acetic
acid. Once dissolved, 585 µl PBS is added.
Stock concentration - 6.0 ug/ul - 7.0 nmol/ul
Senktide (MW 842.1):
1.0 mg lyopholyzed peptide dissolved in 400 µl 0.01 M
acetic acid, followed by 100 µl PBS.
OR:
5. 0 mg dissolved in 2000 µl acetic acid followed by
500 µl PBS.
Stock concentration - 2.0 ug/ul - 2.4 nmol/ul
Neurokinin A (MW 1133.48):
Batch 1: 5.0 mg lyopholyzed peptide dissolved in 300 µl
M acetic acid, followed by 535 µl PBS.
Batch 2:

0.01

Since the biochemical analysis provided by the
manufacturer indicated< 80% purity (see below), a
correction was made:
5.0 mg supplied (0.76) - 3.8 mg actual, dissolved in
200 µl 0.01 M acetic acid followed by 435 µl PBS.
Stock concentration - 6.0 ug/ul - 5.3 nmol/ul
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Substance P (MW 1347.80):
5. 0 mg lyopholyzed peptide was dissolved in 1000 µl 0. 01 M
acetic acid, followed by 500 µl PBS.
Stock concentration - 3.3 ug/ul - 2.4 nmol/ul
Eledoisin (MW 1188.57):
5.0 mg lyopholyzed peptide dissolved in 1300 µl 0.01 M acetic
acid, followed by 235 µl PBS.
Stock concentration - 3.3 ug/ul - 2.8 nmol/ul
Kassinin (MW 1334.74):
5.0 mg lyopholyzed peptide dissolved in 1200 µl 0.01 M acetic
acid, followed by 235 µl PBS.
Stock concentration - 3.5 ug/ul - 3.1 nmol/ul
Physalaemin (MW 1265.61):
5. 0 mg lyopholyzed peptide was dissolved in 250 µl
acetic acid, followed by 535 µl PBS.

0. 01 M

Stock concentration - 6.0 ug/ul - 4.7 nmol/ul
Neurokinin B (MW 1210.58):
4. 0 mg lyopholyzed peptide dissolved in 100 µl, 88% formic
acid, followed by 800 µl 9.8 mM PBS, pH 11.0 (final pH 3.8).
Stock concentration - 4.4 ug/ul - 3.6 nmol/ul
Vehicle:

Note:

10 ml 88% formic acid and 80 ml PBS (pH 11.0).
Final pH - 3.8.

Peptide stock solutions were divided into aliquots and
stored in polyethylene tubes frozen at o0 c.
On a drug
day, the peptides were thawed, and appropriate molar
dilutions made.
All solutions were kept cool and dark
until used.
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3.)

Manufacturers Purification and Content Analysis:
DiMe-C7 (Peninsula Laboratories, Belmont CA):
All DiMe-C? used
was from the same lot number, although purchased separately.
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PENINSULA LABORATORIES, INC.

QUALITY CONTROL RECORD
PENINSULA LABORATORIES, INC.

i

I

I ::::g ~:~lu~:::_Phe 8 , J
~"u' p0>•-0>•-"•-<,,._,...,_,.,_._.._..,_,.,

l,-.. .

Sar 9

Dale: September 29, 1986

Substance P (5-11)

Lot No.: 011045

M. W.: 880.13

,.'.· LOT ANALYSIS:

,

: _: _:
_

:::c~YER CHROMATOGRAPHY
F

_!:~· Result.s:

L.
!"i:
!·

Results:

I
!

Fm (nBuOH:Pyr:H(!Ac:H 0, 15: 15: 3: 12)
2

o-tolidine

Single spot running Yith the standard. Rf • 0.67

ELECTROPHORESIS

j.. l.'hatman
f

o-tol1dine

Single spot running Yith the nandard. Rf • 0. 67_

Silica .
j;;~
..
~:;t
!,,

(nBuOH:Pyr:H0Ac:H o, 15:10_:3:12)
2

Results:

3 MM; pH 1.9(HCOOH:Acet); 1000 V, 1 hr.; o-tolidine

Single spot traveling Yith the standard toYard the cathode.
Rf • 0.07 Yith reference to Arginine.

AMINO ACID ANAI.YSIS
Chromatogram I

63-1402

92. 6 : peptide
Theory

Found

NH

2
2

1. 81
l. 94

Met
Leu
Phe
Sar
N!':e-Phe

I
I
I

Cl~

1
I

l.00

0.99
1. 06
0.71

*

* The value of NHe-Phe is not determined by Amino Acid Analysis.
Note:

Certified by·

c. 4~

p./$'0/

I

Ouahty Control Manager

All peptides should be stored in
a cool & dry place until in use.
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Senktide (Bachem, Torrance, CA):
All Senktide used was from the
same lot number, although purchased separately.

BACHEM1NC.
FINE CHEMICALS

Certificate of Analysis
PRODUCT:

Senktide

LOT NUMBER:
STRUCTURE:

RELEASE DATE:

655C

December 1986

Succinyl-Asp-Phe-N-MePhe-Gly-Leu-Met-NH 2

MOLECULAR WEIGHT:
APPEARANCE:

842.l

White powder

AMINO ACID ANALYSIS:
Asx
Glx
Ala
Met
'Tyr

0.95

Thr

Ser

Pro

Gly
Val
Leu
His

Cys
Ile
Phe

LOO

0.97•

Arg
Lys
•N-MePhe • Present, but not quantitated

l
i
l

!e

!I

PEPTIDE CONTENT:
PEPTIDE PURITY:

LOO
LOO

Trp

83.8\ (~3\)
>99\ (See attached HPLC trace)
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(Peninsula and Bachem):

Neurokinin A

1~
•ft
!

QUALITY CONTROL RECORD
PENINSULA LABORATORIES, INC.

Calalog No.

7359

Date:June 17, 1986

Name:

a-Neurokinin (Neuromedin L, Substance K)

Lot No.:

010251

M. W.:

1133. 48

His-Lys-Thr-Asp-Ser-Phe-Val-Cly-Leu-Het-NH

\ Sequence:
I

2

I

LOT ANALYSIS:
Thin Layer Chroll"1tographv:
Cellulose

Ninhydrin

F: nBuOH:Pyr:H0Ac:H 0 15:10:3:12
2

Silica

nBuOH:Et0Ac:HOAc:H 0 1:1:1:1
2

Ninhydrin

Silica

Fm: nBuOH:Pyr:HOAc:H 0 6:6:1.2:4.8
2

Ninhydrin

Reaulta:

Fm:

F:

Single spot.

Rf • 0.56

&ingle •pot.

Rf• 0.75

Electrophoresis:
Ninhydrin

·. r; llhatman 3HM Pyr:Acet.,pH3.S; lSOOV., 1 hr.
. ,j· Results:

Single spot traveling towards the cathode.

Rf • 0.60 with reference to arginine.
A~INO

ACID ANALYSIS:

Chro111atogram No.

% of Peptide 88.7%

~

Theory·
Lys
His
:>H3

1
1
l

Asp

1

Thr
S.:r

1

l

Found
Cly

1.00
0.81
1.09
1.02
0.95
1.04

Val
Mt!t

Leu
Phe

Theory

Found

1
1

0.98
0.91
1.07
l. 08
0.95

l
l

1

Carlified by: _ _6._._c:._·6_w-=-~..:.;;;.,f"·'---Quality Control Manager
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BACHEM,H;.
FINE CHEM.ICALS

·_ Certificate of Analysis

PROD•JC'l:,:
LOT

Substance JC (alpha-Neurokinin)

~UMBER:

RELEASE DATE:

5468

December 19€5

2

H N-His-Lys-Thr-Asp-Ser-Phe-:Val-Cly-Leu-Met-l~?.

STRUCTURE:

2

,..

•!

:~OLECULAR

WEICHT:

APPEARANCE:

1133.S

White powder

AMINO ACID ANALYSIS;
ASX
Cl.JC

1.00

Tnr
Pro'

Ala

Met

'

Tyr
Lys

Ser

l.00

Cys
098

Ile
Phe

1.00

Arg

l.02

0.68*

Cly

l.01

Val

1.04

Leu
His

0.!9
0.99

Trp

*Partially destroyed during acid hydrolysis

-

PEPTIDE CONTENT: 76.48\
PEPTIDE PURITY:

>99\

l!,3\ I
(See attached HPLC trace)
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SMG

LOT•
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TUl1TIM~e

a-Neurokinin {Substance K,
Neurornedin L)

NE CHEMICALS
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..... ~ . ..,..,.,..~Dau QI" 1M

5468

HOT "OR HUMAN USE
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,,/
J

oloha-Neuroklnln,Substance K,Neromed!n L

12/3/85

1at#546B

Dr. Cioud

...( Nciu.tu.W'lllcl.:~

-tel)

as'

IS-~

•

FJ.cW /·;;......,_

START

00.00.00.00.

1.~

.110"-~

A-IUP ?·11 .9·3

S·

AT"TEH

11.63

STOP

C-RlB
S~IPL

II

(10

ll

5(•65

FILE II

P.EPT

1

41

METHOD

II

e:.
e

HAME

TIME
10.%
11.63

TOTAL

COHC

MK

,9.•442

0.5557
100

y

F1REA
122219
602
122902

C.Y.:!.CtJ

•
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Substance P (Peninsula):

QUALITY CONTROL RECORD
PENINSULA LABORATORIES, INC.
111 TA.YLOll; WAY. HLWONT,

~L"·

lotOOJ •

tu.a HloUll • IMOJ 1n.1111 • TILU NO. uun

Catalog No.

7451

Date:

.Name:

Substance P

Lot No.: 011989

Sequence:

Arg-Pro-Lys-Pro-Cln-Cln-Phe-Phe-Cly-Leu-Het-NH

2

M.W.:

February 17, 1987

1347.80

LOT ANALYSIS;

THIN LAYER CHROMATOGRAPHY:

F (nBuOH:Pyr:HOAc:H 20, 15:10:3:12)
Fe (nBuOH:Pyr:H0Ac:H 20,21:12:2:15)

Ninhydrin

Silica

Fm (nBuOH:Pyr:HOAc:H 0, 15:15:3:12)

Ninhydrin

P.esults:

F

Silica
Silica

Ninhydrin

2
Single spot running •lightly behind the standard.

R! • 0.36

Fe Single spot running •lightly behind the standard.

Rf • 0.29

Fm Single spot running vith the standard.

Rf • 0.54

ELECTROPHOP.ESIS:
llhat11&n 3HH, pH 3.S(Pyr:Acet.); lSOOV. lhr.
Results:

Ninhydrin

Single spot running vith the standard toward the cathode.

Rf•0.76 vith reference to Arginine.
AMINO ACID ANALYSIS:
Chromatogram No.

% of peptide 86.3%

63-2775

Theory

Found

Met

l
3
l
2
2
l
l

L•u
Phe

2

l.04
2.91
l.18
2.08
l. 97
0.91
0.85
l.01
l.94

Lys
NHJ
Arg
CluPro
Cly

..
Certified by:

t:·

1

awt.c;t
Ou.alily Control Manager

Note:

All peptides should be stored in
a cool & dry place until in use,
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Neurokinin B (Peninsula):

QUALITY CONTROL RECORD
PENINSULA LABORATORIES, INC.
111 TA.YLO« WA'f, lfl.MOMT, (;AL". '6001 • f4U.J ff2..UH • ,.., ID·U11 •

Catalog No.

. Name:

!

nu:x

7357

Date:

Neurokinin 8 (Neuromedin K, Neurokinin s)

Lot No.:

i Sequence: Asp-Met-Hi s-Asp-Phe-Phe-Va 1-Gly-Leu-Met-NH2
I Note: Dissolve in ss:.fonaic acid and dilute with desired

M. W.:
buffer.

LOT ANALYSIS:
Thin Layer Chromatography:
Silica
Results:

n8uOH:EtOAc:HOAc:H 20 (1 :1 :1 :1)

Ninhydrin

Single spot migrating the same as the standard.

Electrophoresis:
Whatman 31111 HCOOH:Acet.,pHl.9; lOOOV., 1 hr.
Results:

NO. " " "

Main spot with tailing.
Rf • 0.42 with reference to arginine.

AMINO ACID ANALYSIS:

% of Peptide 94:

Chromatogram No. CL-7108
Theory
His
NH 3
Asp
Gly
Val
Met
Leu
Phe

1

1
2
1
1

2
1
2

"Found
1.04
1.28
1. 98
1.02
1.03
2.08
0.93
2.06

Ninhydrin

Much 28, 1985
0074 72
1210. 58

:;._;;g;
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Eledoisin (Peninsula)

Catalog No.

7101

Oa~:october 9, 1986

Name:

Eledoisin

Loi No.: 011073

Sequence:

pClu-Pro-S~r-Lys-Asp-Ala-Phe-Ile-Cly-Leu-Het-NH

2

M.W.:

1188.57

LOT ANALYSIS:

i

Thin Laver Chrom.Hographv:

JCellulose
Silica
Results:

Fe: nBuOH:Pyr:H0Ac:H 0 42:24:4:30
2

o-tolidine

Fm: nBuOH:Pyr:HOAc:H 0 6:6:1.2:4.8
2

o-tolidine

Fe:

Single spot running slightly ahead of the standard.

Fm:

Single spot running with the standard.

Rf• 0.71

Rf • 0.64

Electrophnresis:
\Jhatman )HM
~

l·I

Results:

HCOOH:Acet •• pHl.9; lOOOV.,l hr.

o-tolidine

single spot running vith the standard towards the cathode.
Rf • 0. 24 with reference to Arginine.

I

AH I NO ACID ANALYSIS:

\

Chromatogram No. 6,-1439

% of Peptide 90.5%

Theory
Lys
NH
Asp3
Ser·
Clu
Pro

l
l
l
l
l
l

Found
0.98
l. 60
0.95
0.93
l.04
0.96

Certified by: __C_c,._·k,-"-1</-r_~_,,,.,'-----

z

Quality Control Manager

Theory
Cly
Ala
Het
Ile
Leu
Phe

l
l
l
l
l
l

Found
l. 05

l.03
0.99
l.00
l.04
0.95

NOTE: Peptides should be stored in a
cool & ~ry area until in use.
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Kassinin (Peninsula)

QUALITY CONTROL RECORD
PENINSULA LABORATORIES, INC.
1

l
l
l

i Catalog No. 7111

Date: September 19, 1986

\

Lot No.: 010902

I

Name:

Kassinin

Sequence:

Asp-Val-Pro-Lys-Ser-Aip-Cln-Phe-Val-Cly-Leu-Het-NK

M. W.:

2

1334. 74

LOT ANALYSIS:

l
l

Silica
Silica

Fm: nBuOK:Pyr:HOAc:K 0 6:6:1.2:4.8
Ninhydrin
2
nBuOK:Et0Ac:HOAc:H 0 l:l:l:l
Ninhydrin
2
Results: Fm: Main spot running vith the standard vith a faint lover and
negligible upper spot. Rf ~ 0.54
1:1:1:1

Main spot running with the standard with a faint lover spot. Rf • 0.50

Electrophoresis:

.

f
f

Jt
'

\lhatman 3MM
Results:

KCOOH:Ac,,t.,pK 1.9; lOOOV.,l hr.

Single spot running Yith the

Ninhydrin

stand~rd

towards the cathode.

Rf • 0.36 vi ~h reference to Arginine.
AHINO ACID ANALYSIS:

..

Chromatogram No. ~

Lys
NK
Asp3
Ser
Clu

Certified

Theory

Found

l
2

l.07
2.05
l. 78
0.89
l.06

2

l
l

by·__C_._e..,_·tc_IV--'~-'-.,.._-..,-Ou•lily Conlrol Manager

of Peptide 95.1%

Pro
Cly
Val
Met
Leu
Phe

Theory

Found

l
l
2
l
l
l

l.09
l.00
2.00
l.10
l.08
0.99

NOTE: Peptides should be stor"d in a
cool & dry Area until in u~e.
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Physalaemin (Peninsula)

t~

:~

.;

QUALITY CONTROL RECORD

!J

PENINSULA LABORATORIES, INC.

?

'

Catalog No. 7110

Date: April 16, 1986

Name:

J>hysalaemin

Lot No.:

0098 70

Sequence:

pGlu-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-Gly-Leu-Met-NH

M.W.:

1265.61

2

LOT ANALYSIS:

I
i

t

I

Il
I

I
t

!
I

Thin Laver Chromatographv:
Silica

nBuOH:Et0Ac:HOAc:H 0 l:l:l:l
2

l'inhydrin

Silica

F: nBuUH:Pyr:HOAc:H 0 ·15:10:3:12
2

Ninhydrin

Silica

Fm: nBuOH:Pyr:HOAc:H 0 6:6:1.2:4.8

Ninhydrin

2

Results:

Single spot running with the standard.

F:

Fm:

Single spot running with the

l:l:l:l

Sini,:le

~pot.running

Rf • 0.49
Rf • 0.63

stand~rd.

with the standard.

Rf• 0.60

Electrophoresis:
'I/batman 3HM
Results:

Pyr:Acet.,pH6.4; 1500V., l hr.

Sin~le

Rf •
A.~lSO

Ninhydrin

spot runnin; v1th the standard in the neutral zone.

0.~9

•!th

refcrcnc~

to

ar~ininc.

ACID ANALYSIS:

Chromatogram No. CL-10170

% of Peptide 90.3:

Theory
Lys
NH
3
Asp
Glu
Pro

Found

Theory

1.00
3.47
1.82
1.09

Gly
Ala
Mot
Lcu

l
l
l

1.0~

Tyr

l
l

Phi!

Certified by·_

__.;;~_._4...:;;_;'6>=.;w=.:I',_,-..:=-="-tt~-Oua111y Control Manag.,

l

Found
1.02
1.05
0.96
0.94
0.95
0.99
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APPENDIX II .

261
Cannulae Placements
Experiments I - V: Tachykinin Dose-Responses

Fig. A.:

Location of cannula tips (black stars) in the animals used
in Experiments I (b)
V (f).
Schematic diagrams of
coronal sections separated by about 0.5 mm show the
abbreviations of structures (a) and the cannula placements.

Abbreviations:
aq:
cp:
dr:
dtg:
ic:
ipn:
ml:
mr:
pag:
pn:
rtp:
scp:
vtg:
xscp:

cerebral aqueduct
cerebral peduncle
dorsal raphe nucleus
dorsal tegmental nucleus of Gudden
inferior colliculus
interpeduncular nucleus
medial lemniscus
median raphe nucleus
periaqueductal grey
basal pontine nuclei
reticular tegmental nucleus
superior cerebellar peduncle
ventral tegmental nucleus of Gudden
decussation of scp
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Experiment VI:

MR/MFB 5.7 DHT Lesions

Location of cannula tips in the animals used in Experiments VI.
Schematic diagrams of coronal sections
separated by about 0.5 mm show the abbreviations of
structures in Fig. A.
a) black circles - placements for
control group; b) black squares - placements for MR lesion
group; c) black triangles - placements for MFB lesion
group.
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a

b
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Experiment IX: Neurokinin Habituated Open Field

Location of cannula tips (stars) in the animals used in
Experiments IX.
Schematic diagrams of coronal sections
separated by about 0.5 mm show the abbreviations of
structures in Fig. A.
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